| ENSG00000170161.6 |
Ponatinib |
Bladder urothelial carcinoma |
0.023312553 |
Resistant |
| ENSG00000203801.4 |
Ponatinib |
Bladder urothelial carcinoma |
0.030940304 |
Resistant |
| ENSG00000213963.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.038318079 |
Resistant |
| ENSG00000224031.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.042665857 |
Resistant |
| ENSG00000224271.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.03735191 |
Resistant |
| ENSG00000224281.4 |
Ponatinib |
Bladder urothelial carcinoma |
0.049038956 |
Resistant |
| ENSG00000225037.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.034794866 |
Resistant |
| ENSG00000225857.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.013356931 |
Resistant |
| ENSG00000226053.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.004989334 |
Resistant |
| ENSG00000227495.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.03365128 |
Resistant |
| ENSG00000228386.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.047659446 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.037102352 |
Resistant |
| ENSG00000230735.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.017004244 |
Resistant |
| ENSG00000231242.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.048101073 |
Resistant |
| ENSG00000231530.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.015743112 |
Resistant |
| ENSG00000231889.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.018364952 |
Resistant |
| ENSG00000233912.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039364263 |
Resistant |
| ENSG00000235897.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045904643 |
Resistant |
| ENSG00000236269.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.03765801 |
Resistant |
| ENSG00000237768.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.027329986 |
Resistant |
| ENSG00000240571.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.015690472 |
Resistant |
| ENSG00000241042.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.010819528 |
Resistant |
| ENSG00000243637.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.006258609 |
Resistant |
| ENSG00000246451.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.007362734 |
Resistant |
| ENSG00000246560.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.041429048 |
Resistant |
| ENSG00000248690.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.045896742 |
Resistant |
| ENSG00000250410.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.031162359 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.00221232 |
Resistant |
| ENSG00000251555.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.01206947 |
Resistant |
| ENSG00000253161.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007363712 |
Resistant |
| ENSG00000253174.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.032046364 |
Resistant |
| ENSG00000253730.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.014770396 |
Resistant |
| ENSG00000253746.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.003331859 |
Resistant |
| ENSG00000254162.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.009066269 |
Resistant |
| ENSG00000255933.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007780077 |
Resistant |
| ENSG00000256006.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044458587 |
Resistant |
| ENSG00000256973.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.017198883 |
Resistant |
| ENSG00000257285.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.022674491 |
Resistant |
| ENSG00000258101.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.001595123 |
Resistant |
| ENSG00000258303.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.025211684 |
Resistant |
| ENSG00000258520.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.014611879 |
Resistant |
| ENSG00000258658.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.025620697 |
Resistant |
| ENSG00000259709.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.010470905 |
Resistant |
| ENSG00000260034.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.008206103 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.021425704 |
Resistant |
| ENSG00000260626.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045862397 |
Resistant |
| ENSG00000260641.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.029295378 |
Resistant |
| ENSG00000260664.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.041153347 |
Resistant |
| ENSG00000261008.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.049003522 |
Resistant |
| ENSG00000263272.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.047324899 |
Resistant |
| ENSG00000264469.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.010268968 |
Resistant |
| ENSG00000267003.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.048972231 |
Resistant |
| ENSG00000267198.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.035112306 |
Resistant |
| ENSG00000267374.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045964419 |
Resistant |
| ENSG00000267505.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045473753 |
Resistant |
| ENSG00000267522.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.043292869 |
Resistant |
| ENSG00000268583.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.042589645 |
Resistant |
| ENSG00000269906.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.025696897 |
Resistant |
| ENSG00000269999.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.029590267 |
Resistant |
| ENSG00000270103.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.033545391 |
Resistant |
| ENSG00000270108.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.0129662 |
Resistant |
| ENSG00000272081.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.046288738 |
Resistant |
| ENSG00000272121.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.049485185 |
Resistant |
| ENSG00000272192.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.035356127 |
Resistant |
| ENSG00000272273.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.000719886 |
Resistant |
| ENSG00000272379.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.003203999 |
Resistant |
| ENSG00000272468.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.04388292 |
Resistant |
| ENSG00000272800.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.042394778 |
Resistant |
| ENSG00000273353.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045919866 |
Resistant |
| ENSG00000223660.1 |
Ponatinib |
Breast invasive carcinoma |
0.040964612 |
Resistant |
| ENSG00000224614.1 |
Ponatinib |
Breast invasive carcinoma |
0.024511565 |
Resistant |
| ENSG00000226957.1 |
Ponatinib |
Breast invasive carcinoma |
0.038279243 |
Resistant |
| ENSG00000229111.1 |
Ponatinib |
Breast invasive carcinoma |
0.025386134 |
Resistant |
| ENSG00000229272.1 |
Ponatinib |
Breast invasive carcinoma |
0.025081128 |
Resistant |
| ENSG00000230826.1 |
Ponatinib |
Breast invasive carcinoma |
0.022818353 |
Resistant |
| ENSG00000232342.3 |
Ponatinib |
Breast invasive carcinoma |
0.038287496 |
Resistant |
| ENSG00000234437.1 |
Ponatinib |
Breast invasive carcinoma |
0.049123435 |
Resistant |
| ENSG00000237772.1 |
Ponatinib |
Breast invasive carcinoma |
0.04743934 |
Resistant |
| ENSG00000239930.2 |
Ponatinib |
Breast invasive carcinoma |
0.015114011 |
Resistant |
| ENSG00000241772.2 |
Ponatinib |
Breast invasive carcinoma |
0.001269011 |
Resistant |
| ENSG00000243849.1 |
Ponatinib |
Breast invasive carcinoma |
0.032036159 |
Resistant |
| ENSG00000254973.1 |
Ponatinib |
Breast invasive carcinoma |
0.033480821 |
Resistant |
| ENSG00000257002.1 |
Ponatinib |
Breast invasive carcinoma |
0.028678735 |
Resistant |
| ENSG00000257808.1 |
Ponatinib |
Breast invasive carcinoma |
0.03875429 |
Resistant |
| ENSG00000261250.1 |
Ponatinib |
Breast invasive carcinoma |
0.037808976 |
Resistant |
| ENSG00000261396.1 |
Ponatinib |
Breast invasive carcinoma |
0.033243516 |
Resistant |
| ENSG00000263011.1 |
Ponatinib |
Breast invasive carcinoma |
0.022156194 |
Resistant |
| ENSG00000266922.1 |
Ponatinib |
Breast invasive carcinoma |
0.030400295 |
Resistant |
| ENSG00000267251.1 |
Ponatinib |
Breast invasive carcinoma |
0.040570191 |
Resistant |
| ENSG00000268189.2 |
Ponatinib |
Breast invasive carcinoma |
0.047736795 |
Resistant |
| ENSG00000268204.1 |
Ponatinib |
Breast invasive carcinoma |
0.036107992 |
Resistant |
| ENSG00000269352.1 |
Ponatinib |
Breast invasive carcinoma |
0.027814889 |
Resistant |
| ENSG00000269646.1 |
Ponatinib |
Breast invasive carcinoma |
0.013458544 |
Resistant |
| ENSG00000269806.1 |
Ponatinib |
Breast invasive carcinoma |
0.019986299 |
Resistant |
| ENSG00000270168.1 |
Ponatinib |
Breast invasive carcinoma |
0.038045536 |
Resistant |
| ENSG00000273075.1 |
Ponatinib |
Breast invasive carcinoma |
0.046864305 |
Resistant |
| ENSG00000153363.8 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046098551 |
Resistant |
| ENSG00000203886.4 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045429496 |
Resistant |
| ENSG00000226251.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014865671 |
Resistant |
| ENSG00000228624.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022501592 |
Resistant |
| ENSG00000230899.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049250947 |
Resistant |
| ENSG00000233029.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.044317838 |
Resistant |
| ENSG00000233559.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039745043 |
Resistant |
| ENSG00000243176.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039278254 |
Resistant |
| ENSG00000243224.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045256202 |
Resistant |
| ENSG00000247324.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031537915 |
Resistant |
| ENSG00000257702.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03738553 |
Resistant |
| ENSG00000258561.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001873695 |
Resistant |
| ENSG00000258798.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037427606 |
Resistant |
| ENSG00000261824.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039399599 |
Resistant |
| ENSG00000263884.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.037599428 |
Resistant |
| ENSG00000271849.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.032300355 |
Resistant |
| ENSG00000272156.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.010515351 |
Resistant |
| ENSG00000272275.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028754992 |
Resistant |
| ENSG00000273026.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001599398 |
Resistant |
| ENSG00000178803.6 |
Ponatinib |
Colon adenocarcinoma |
0.021649881 |
Resistant |
| ENSG00000188365.3 |
Ponatinib |
Colon adenocarcinoma |
0.037339024 |
Resistant |
| ENSG00000203650.3 |
Ponatinib |
Colon adenocarcinoma |
0.026742382 |
Resistant |
| ENSG00000204706.10 |
Ponatinib |
Colon adenocarcinoma |
0.046840502 |
Resistant |
| ENSG00000214559.3 |
Ponatinib |
Colon adenocarcinoma |
0.020757855 |
Resistant |
| ENSG00000223685.1 |
Ponatinib |
Colon adenocarcinoma |
0.000469883 |
Resistant |
| ENSG00000223891.1 |
Ponatinib |
Colon adenocarcinoma |
0.017754602 |
Resistant |
| ENSG00000224387.1 |
Ponatinib |
Colon adenocarcinoma |
0.040514914 |
Resistant |
| ENSG00000225335.2 |
Ponatinib |
Colon adenocarcinoma |
0.01750673 |
Resistant |
| ENSG00000225725.4 |
Ponatinib |
Colon adenocarcinoma |
0.039862177 |
Resistant |
| ENSG00000227188.1 |
Ponatinib |
Colon adenocarcinoma |
0.049439961 |
Resistant |
| ENSG00000228614.1 |
Ponatinib |
Colon adenocarcinoma |
0.049004309 |
Resistant |
| ENSG00000229195.1 |
Ponatinib |
Colon adenocarcinoma |
0.044167043 |
Resistant |
| ENSG00000230023.2 |
Ponatinib |
Colon adenocarcinoma |
0.013093426 |
Resistant |
| ENSG00000231335.1 |
Ponatinib |
Colon adenocarcinoma |
0.020739571 |
Resistant |
| ENSG00000231704.1 |
Ponatinib |
Colon adenocarcinoma |
0.048497375 |
Resistant |
| ENSG00000232093.1 |
Ponatinib |
Colon adenocarcinoma |
0.021348026 |
Resistant |
| ENSG00000233776.1 |
Ponatinib |
Colon adenocarcinoma |
0.033581546 |
Resistant |
| ENSG00000234460.1 |
Ponatinib |
Colon adenocarcinoma |
0.021986301 |
Resistant |
| ENSG00000235209.1 |
Ponatinib |
Colon adenocarcinoma |
0.003346305 |
Resistant |
| ENSG00000235488.1 |
Ponatinib |
Colon adenocarcinoma |
0.008566604 |
Resistant |
| ENSG00000235781.1 |
Ponatinib |
Colon adenocarcinoma |
0.034470498 |
Resistant |
| ENSG00000237857.2 |
Ponatinib |
Colon adenocarcinoma |
0.041274124 |
Resistant |
| ENSG00000237943.2 |
Ponatinib |
Colon adenocarcinoma |
0.046812781 |
Resistant |
| ENSG00000241269.1 |
Ponatinib |
Colon adenocarcinoma |
0.028912611 |
Resistant |
| ENSG00000241288.3 |
Ponatinib |
Colon adenocarcinoma |
0.037421475 |
Resistant |
| ENSG00000243636.1 |
Ponatinib |
Colon adenocarcinoma |
0.007419808 |
Resistant |
| ENSG00000244998.1 |
Ponatinib |
Colon adenocarcinoma |
0.045738802 |
Resistant |
| ENSG00000249825.1 |
Ponatinib |
Colon adenocarcinoma |
0.049381372 |
Resistant |
| ENSG00000255495.1 |
Ponatinib |
Colon adenocarcinoma |
0.001423686 |
Resistant |
| ENSG00000255507.1 |
Ponatinib |
Colon adenocarcinoma |
0.005350945 |
Resistant |
| ENSG00000257759.2 |
Ponatinib |
Colon adenocarcinoma |
0.010125981 |
Resistant |
| ENSG00000259334.1 |
Ponatinib |
Colon adenocarcinoma |
0.035742468 |
Resistant |
| ENSG00000260476.1 |
Ponatinib |
Colon adenocarcinoma |
0.041736926 |
Resistant |
| ENSG00000260604.1 |
Ponatinib |
Colon adenocarcinoma |
0.032014267 |
Resistant |
| ENSG00000260625.1 |
Ponatinib |
Colon adenocarcinoma |
0.037080135 |
Resistant |
| ENSG00000260805.1 |
Ponatinib |
Colon adenocarcinoma |
0.012852166 |
Resistant |
| ENSG00000261729.1 |
Ponatinib |
Colon adenocarcinoma |
0.000658672 |
Resistant |
| ENSG00000266844.1 |
Ponatinib |
Colon adenocarcinoma |
0.036398797 |
Resistant |
| ENSG00000267575.2 |
Ponatinib |
Colon adenocarcinoma |
0.049325886 |
Resistant |
| ENSG00000268751.1 |
Ponatinib |
Colon adenocarcinoma |
0.003693671 |
Resistant |
| ENSG00000269814.1 |
Ponatinib |
Colon adenocarcinoma |
0.029546097 |
Resistant |
| ENSG00000269961.1 |
Ponatinib |
Colon adenocarcinoma |
0.017236509 |
Resistant |
| ENSG00000270068.1 |
Ponatinib |
Colon adenocarcinoma |
0.018718821 |
Resistant |
| ENSG00000270828.1 |
Ponatinib |
Colon adenocarcinoma |
0.03839095 |
Resistant |
| ENSG00000271888.1 |
Ponatinib |
Colon adenocarcinoma |
0.022118845 |
Resistant |
| ENSG00000272192.1 |
Ponatinib |
Colon adenocarcinoma |
0.028691369 |
Resistant |
| ENSG00000272523.1 |
Ponatinib |
Colon adenocarcinoma |
0.041598622 |
Resistant |
| ENSG00000273473.1 |
Ponatinib |
Colon adenocarcinoma |
0.028849388 |
Resistant |
| ENSG00000175701.6 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014062998 |
Resistant |
| ENSG00000206176.5 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011923535 |
Resistant |
| ENSG00000223356.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048526101 |
Resistant |
| ENSG00000225057.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046939881 |
Resistant |
| ENSG00000225361.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049484245 |
Resistant |
| ENSG00000226380.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013550222 |
Resistant |
| ENSG00000227388.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041830268 |
Resistant |
| ENSG00000228350.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028703765 |
Resistant |
| ENSG00000230736.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040149001 |
Resistant |
| ENSG00000231073.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027911362 |
Resistant |
| ENSG00000232623.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034610117 |
Resistant |
| ENSG00000232656.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049434947 |
Resistant |
| ENSG00000233559.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019319983 |
Resistant |
| ENSG00000234678.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007152067 |
Resistant |
| ENSG00000241770.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020189857 |
Resistant |
| ENSG00000241772.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044788143 |
Resistant |
| ENSG00000244676.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007996618 |
Resistant |
| ENSG00000246331.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003403839 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043739586 |
Resistant |
| ENSG00000251143.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033276872 |
Resistant |
| ENSG00000254315.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00312179 |
Resistant |
| ENSG00000255474.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023836416 |
Resistant |
| ENSG00000257924.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045014761 |
Resistant |
| ENSG00000258486.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021635671 |
Resistant |
| ENSG00000258646.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017576189 |
Resistant |
| ENSG00000259081.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00046529 |
Resistant |
| ENSG00000259807.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020488732 |
Resistant |
| ENSG00000259926.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030985283 |
Resistant |
| ENSG00000262147.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046589904 |
Resistant |
| ENSG00000263069.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021428125 |
Resistant |
| ENSG00000265490.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038450421 |
Resistant |
| ENSG00000266538.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032014616 |
Resistant |
| ENSG00000266941.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04595041 |
Resistant |
| ENSG00000267395.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027059681 |
Resistant |
| ENSG00000267798.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042320087 |
Resistant |
| ENSG00000268266.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036321673 |
Resistant |
| ENSG00000270009.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040669965 |
Resistant |
| ENSG00000270143.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035267107 |
Resistant |
| ENSG00000270346.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017072429 |
Resistant |
| ENSG00000271020.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031287759 |
Resistant |
| ENSG00000271643.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042115762 |
Resistant |
| ENSG00000271778.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031271829 |
Resistant |
| ENSG00000272707.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010678494 |
Resistant |
| ENSG00000180139.10 |
Ponatinib |
Esophageal cancer |
0.008020763 |
Resistant |
| ENSG00000198468.3 |
Ponatinib |
Esophageal cancer |
0.021979602 |
Resistant |
| ENSG00000205500.4 |
Ponatinib |
Esophageal cancer |
0.021397472 |
Resistant |
| ENSG00000223598.1 |
Ponatinib |
Esophageal cancer |
0.025856633 |
Resistant |
| ENSG00000223669.1 |
Ponatinib |
Esophageal cancer |
0.049533007 |
Resistant |
| ENSG00000225744.1 |
Ponatinib |
Esophageal cancer |
0.020061283 |
Resistant |
| ENSG00000226472.3 |
Ponatinib |
Esophageal cancer |
0.009651049 |
Resistant |
| ENSG00000226661.1 |
Ponatinib |
Esophageal cancer |
0.008845896 |
Resistant |
| ENSG00000229723.1 |
Ponatinib |
Esophageal cancer |
0.044288343 |
Resistant |
| ENSG00000231185.2 |
Ponatinib |
Esophageal cancer |
0.023644888 |
Resistant |
| ENSG00000232290.1 |
Ponatinib |
Esophageal cancer |
0.045947336 |
Resistant |
| ENSG00000233783.3 |
Ponatinib |
Esophageal cancer |
0.031251274 |
Resistant |
| ENSG00000233893.1 |
Ponatinib |
Esophageal cancer |
0.042948884 |
Resistant |
| ENSG00000235397.1 |
Ponatinib |
Esophageal cancer |
0.025004675 |
Resistant |
| ENSG00000236559.1 |
Ponatinib |
Esophageal cancer |
0.005610477 |
Resistant |
| ENSG00000237520.1 |
Ponatinib |
Esophageal cancer |
0.043633467 |
Resistant |
| ENSG00000237686.2 |
Ponatinib |
Esophageal cancer |
0.028383994 |
Resistant |
| ENSG00000237998.3 |
Ponatinib |
Esophageal cancer |
0.001634171 |
Resistant |
| ENSG00000238133.2 |
Ponatinib |
Esophageal cancer |
0.034691846 |
Resistant |
| ENSG00000238160.1 |
Ponatinib |
Esophageal cancer |
0.021294979 |
Resistant |
| ENSG00000241544.1 |
Ponatinib |
Esophageal cancer |
0.046975855 |
Resistant |
| ENSG00000244161.1 |
Ponatinib |
Esophageal cancer |
0.041507157 |
Resistant |
| ENSG00000244286.1 |
Ponatinib |
Esophageal cancer |
0.002726976 |
Resistant |
| ENSG00000249806.1 |
Ponatinib |
Esophageal cancer |
0.045258513 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Esophageal cancer |
0.023626606 |
Resistant |
| ENSG00000251523.1 |
Ponatinib |
Esophageal cancer |
0.034593572 |
Resistant |
| ENSG00000254119.1 |
Ponatinib |
Esophageal cancer |
0.026603097 |
Resistant |
| ENSG00000254286.1 |
Ponatinib |
Esophageal cancer |
0.034976333 |
Resistant |
| ENSG00000254431.1 |
Ponatinib |
Esophageal cancer |
0.040897467 |
Resistant |
| ENSG00000254977.1 |
Ponatinib |
Esophageal cancer |
0.003814785 |
Resistant |
| ENSG00000261019.1 |
Ponatinib |
Esophageal cancer |
0.004631861 |
Resistant |
| ENSG00000263466.1 |
Ponatinib |
Esophageal cancer |
0.026696017 |
Resistant |
| ENSG00000265625.1 |
Ponatinib |
Esophageal cancer |
0.039285216 |
Resistant |
| ENSG00000266718.1 |
Ponatinib |
Esophageal cancer |
0.008987547 |
Resistant |
| ENSG00000266936.1 |
Ponatinib |
Esophageal cancer |
0.036131286 |
Resistant |
| ENSG00000267143.1 |
Ponatinib |
Esophageal cancer |
0.032541396 |
Resistant |
| ENSG00000267667.1 |
Ponatinib |
Esophageal cancer |
0.048796849 |
Resistant |
| ENSG00000267737.1 |
Ponatinib |
Esophageal cancer |
0.047135312 |
Resistant |
| ENSG00000268913.1 |
Ponatinib |
Esophageal cancer |
0.017183916 |
Resistant |
| ENSG00000269815.1 |
Ponatinib |
Esophageal cancer |
0.014609248 |
Resistant |
| ENSG00000269873.1 |
Ponatinib |
Esophageal cancer |
0.020455412 |
Resistant |
| ENSG00000271366.1 |
Ponatinib |
Esophageal cancer |
0.018263073 |
Resistant |
| ENSG00000273284.1 |
Ponatinib |
Esophageal cancer |
0.021367881 |
Resistant |
| ENSG00000104691.10 |
Ponatinib |
Brain lower grade glioma |
0.010134117 |
Resistant |
| ENSG00000118412.8 |
Ponatinib |
Brain lower grade glioma |
0.04118959 |
Resistant |
| ENSG00000149656.4 |
Ponatinib |
Brain lower grade glioma |
0.034224102 |
Resistant |
| ENSG00000152487.6 |
Ponatinib |
Brain lower grade glioma |
0.017178643 |
Resistant |
| ENSG00000157306.10 |
Ponatinib |
Brain lower grade glioma |
0.01175821 |
Resistant |
| ENSG00000170590.4 |
Ponatinib |
Brain lower grade glioma |
0.020930967 |
Resistant |
| ENSG00000173867.8 |
Ponatinib |
Brain lower grade glioma |
0.010482987 |
Resistant |
| ENSG00000177640.11 |
Ponatinib |
Brain lower grade glioma |
0.018356717 |
Resistant |
| ENSG00000178440.5 |
Ponatinib |
Brain lower grade glioma |
0.00453596 |
Resistant |
| ENSG00000180458.2 |
Ponatinib |
Brain lower grade glioma |
0.040450027 |
Resistant |
| ENSG00000180846.4 |
Ponatinib |
Brain lower grade glioma |
0.028699271 |
Resistant |
| ENSG00000185495.6 |
Ponatinib |
Brain lower grade glioma |
0.001728595 |
Resistant |
| ENSG00000196553.9 |
Ponatinib |
Brain lower grade glioma |
0.035822233 |
Resistant |
| ENSG00000196951.6 |
Ponatinib |
Brain lower grade glioma |
0.014859933 |
Resistant |
| ENSG00000197210.7 |
Ponatinib |
Brain lower grade glioma |
0.040005408 |
Resistant |
| ENSG00000203441.2 |
Ponatinib |
Brain lower grade glioma |
0.018477941 |
Resistant |
| ENSG00000205424.1 |
Ponatinib |
Brain lower grade glioma |
0.029747917 |
Resistant |
| ENSG00000206142.5 |
Ponatinib |
Brain lower grade glioma |
0.028493631 |
Resistant |
| ENSG00000211683.3 |
Ponatinib |
Brain lower grade glioma |
0.001509486 |
Resistant |
| ENSG00000212694.4 |
Ponatinib |
Brain lower grade glioma |
0.013777817 |
Resistant |
| ENSG00000214725.3 |
Ponatinib |
Brain lower grade glioma |
0.036626094 |
Resistant |
| ENSG00000214770.2 |
Ponatinib |
Brain lower grade glioma |
0.04155758 |
Resistant |
| ENSG00000215159.3 |
Ponatinib |
Brain lower grade glioma |
0.008101613 |
Resistant |
| ENSG00000215866.3 |
Ponatinib |
Brain lower grade glioma |
0.045736798 |
Resistant |
| ENSG00000215908.5 |
Ponatinib |
Brain lower grade glioma |
0.021912726 |
Resistant |
| ENSG00000217576.7 |
Ponatinib |
Brain lower grade glioma |
0.035340497 |
Resistant |
| ENSG00000223356.1 |
Ponatinib |
Brain lower grade glioma |
0.030658911 |
Resistant |
| ENSG00000223374.1 |
Ponatinib |
Brain lower grade glioma |
0.008609055 |
Resistant |
| ENSG00000223537.2 |
Ponatinib |
Brain lower grade glioma |
0.011649902 |
Resistant |
| ENSG00000223745.3 |
Ponatinib |
Brain lower grade glioma |
0.034536411 |
Resistant |
| ENSG00000223754.1 |
Ponatinib |
Brain lower grade glioma |
0.012981628 |
Resistant |
| ENSG00000223884.1 |
Ponatinib |
Brain lower grade glioma |
0.019169878 |
Resistant |
| ENSG00000223949.2 |
Ponatinib |
Brain lower grade glioma |
0.04962306 |
Resistant |
| ENSG00000224031.1 |
Ponatinib |
Brain lower grade glioma |
0.047035842 |
Resistant |
| ENSG00000224032.2 |
Ponatinib |
Brain lower grade glioma |
0.022761878 |
Resistant |
| ENSG00000224043.3 |
Ponatinib |
Brain lower grade glioma |
0.046791966 |
Resistant |
| ENSG00000224078.8 |
Ponatinib |
Brain lower grade glioma |
0.024417332 |
Resistant |
| ENSG00000224276.1 |
Ponatinib |
Brain lower grade glioma |
0.029295632 |
Resistant |
| ENSG00000224356.3 |
Ponatinib |
Brain lower grade glioma |
0.001558285 |
Resistant |
| ENSG00000224358.1 |
Ponatinib |
Brain lower grade glioma |
0.006169463 |
Resistant |
| ENSG00000224429.3 |
Ponatinib |
Brain lower grade glioma |
0.032390445 |
Resistant |
| ENSG00000224490.1 |
Ponatinib |
Brain lower grade glioma |
0.015001222 |
Resistant |
| ENSG00000224616.1 |
Ponatinib |
Brain lower grade glioma |
0.016125904 |
Resistant |
| ENSG00000224699.4 |
Ponatinib |
Brain lower grade glioma |
0.022988394 |
Resistant |
| ENSG00000224713.3 |
Ponatinib |
Brain lower grade glioma |
0.02552847 |
Resistant |
| ENSG00000224799.1 |
Ponatinib |
Brain lower grade glioma |
0.012576783 |
Resistant |
| ENSG00000224849.2 |
Ponatinib |
Brain lower grade glioma |
0.044601421 |
Resistant |
| ENSG00000224977.1 |
Ponatinib |
Brain lower grade glioma |
0.020330135 |
Resistant |
| ENSG00000225218.1 |
Ponatinib |
Brain lower grade glioma |
0.008884872 |
Resistant |
| ENSG00000225234.1 |
Ponatinib |
Brain lower grade glioma |
0.045899724 |
Resistant |
| ENSG00000225265.1 |
Ponatinib |
Brain lower grade glioma |
0.018114631 |
Resistant |
| ENSG00000225278.3 |
Ponatinib |
Brain lower grade glioma |
0.038024667 |
Resistant |
| ENSG00000225411.2 |
Ponatinib |
Brain lower grade glioma |
0.045586042 |
Resistant |
| ENSG00000225527.1 |
Ponatinib |
Brain lower grade glioma |
0.022326613 |
Resistant |
| ENSG00000225532.1 |
Ponatinib |
Brain lower grade glioma |
0.009046573 |
Resistant |
| ENSG00000225836.1 |
Ponatinib |
Brain lower grade glioma |
0.023390896 |
Resistant |
| ENSG00000225891.1 |
Ponatinib |
Brain lower grade glioma |
0.013912261 |
Resistant |
| ENSG00000225930.3 |
Ponatinib |
Brain lower grade glioma |
0.038681588 |
Resistant |
| ENSG00000226009.1 |
Ponatinib |
Brain lower grade glioma |
0.017309089 |
Resistant |
| ENSG00000226029.1 |
Ponatinib |
Brain lower grade glioma |
0.006750379 |
Resistant |
| ENSG00000226245.1 |
Ponatinib |
Brain lower grade glioma |
0.043163474 |
Resistant |
| ENSG00000226276.1 |
Ponatinib |
Brain lower grade glioma |
0.022348717 |
Resistant |
| ENSG00000226352.2 |
Ponatinib |
Brain lower grade glioma |
0.003053999 |
Resistant |
| ENSG00000226465.1 |
Ponatinib |
Brain lower grade glioma |
0.045304454 |
Resistant |
| ENSG00000226581.1 |
Ponatinib |
Brain lower grade glioma |
0.046826609 |
Resistant |
| ENSG00000226609.1 |
Ponatinib |
Brain lower grade glioma |
0.036744786 |
Resistant |
| ENSG00000226851.1 |
Ponatinib |
Brain lower grade glioma |
0.033676521 |
Resistant |
| ENSG00000226862.1 |
Ponatinib |
Brain lower grade glioma |
0.03579237 |
Resistant |
| ENSG00000226877.3 |
Ponatinib |
Brain lower grade glioma |
0.000942398 |
Resistant |
| ENSG00000226904.1 |
Ponatinib |
Brain lower grade glioma |
0.041217596 |
Resistant |
| ENSG00000226920.1 |
Ponatinib |
Brain lower grade glioma |
0.003238889 |
Resistant |
| ENSG00000227210.1 |
Ponatinib |
Brain lower grade glioma |
0.014211023 |
Resistant |
| ENSG00000227245.1 |
Ponatinib |
Brain lower grade glioma |
0.006557029 |
Resistant |
| ENSG00000227285.1 |
Ponatinib |
Brain lower grade glioma |
0.036926835 |
Resistant |
| ENSG00000227354.2 |
Ponatinib |
Brain lower grade glioma |
0.011835816 |
Resistant |
| ENSG00000227487.3 |
Ponatinib |
Brain lower grade glioma |
0.040029131 |
Resistant |
| ENSG00000227542.1 |
Ponatinib |
Brain lower grade glioma |
0.049973365 |
Resistant |
| ENSG00000227627.1 |
Ponatinib |
Brain lower grade glioma |
0.033686311 |
Resistant |
| ENSG00000227630.2 |
Ponatinib |
Brain lower grade glioma |
0.037578389 |
Resistant |
| ENSG00000227698.1 |
Ponatinib |
Brain lower grade glioma |
0.014444289 |
Resistant |
| ENSG00000227740.1 |
Ponatinib |
Brain lower grade glioma |
0.035630927 |
Resistant |
| ENSG00000228079.1 |
Ponatinib |
Brain lower grade glioma |
0.036852427 |
Resistant |
| ENSG00000228192.3 |
Ponatinib |
Brain lower grade glioma |
0.034858242 |
Resistant |
| ENSG00000228222.1 |
Ponatinib |
Brain lower grade glioma |
0.044346781 |
Resistant |
| ENSG00000228251.1 |
Ponatinib |
Brain lower grade glioma |
0.030954529 |
Resistant |
| ENSG00000228302.2 |
Ponatinib |
Brain lower grade glioma |
0.002149219 |
Resistant |
| ENSG00000228315.7 |
Ponatinib |
Brain lower grade glioma |
0.001139538 |
Resistant |
| ENSG00000228327.2 |
Ponatinib |
Brain lower grade glioma |
0.000288993 |
Resistant |
| ENSG00000228352.2 |
Ponatinib |
Brain lower grade glioma |
0.004739693 |
Resistant |
| ENSG00000228363.2 |
Ponatinib |
Brain lower grade glioma |
0.007421946 |
Resistant |
| ENSG00000228486.5 |
Ponatinib |
Brain lower grade glioma |
0.036158556 |
Resistant |
| ENSG00000228625.1 |
Ponatinib |
Brain lower grade glioma |
0.023536249 |
Resistant |
| ENSG00000228629.2 |
Ponatinib |
Brain lower grade glioma |
0.016966937 |
Resistant |
| ENSG00000228723.2 |
Ponatinib |
Brain lower grade glioma |
0.011325343 |
Resistant |
| ENSG00000228784.3 |
Ponatinib |
Brain lower grade glioma |
0.0301029 |
Resistant |
| ENSG00000228794.4 |
Ponatinib |
Brain lower grade glioma |
0.027559689 |
Resistant |
| ENSG00000228889.2 |
Ponatinib |
Brain lower grade glioma |
0.019269665 |
Resistant |
| ENSG00000228939.1 |
Ponatinib |
Brain lower grade glioma |
0.040186265 |
Resistant |
| ENSG00000229102.1 |
Ponatinib |
Brain lower grade glioma |
0.026875285 |
Resistant |
| ENSG00000229127.1 |
Ponatinib |
Brain lower grade glioma |
0.005195632 |
Resistant |
| ENSG00000229348.1 |
Ponatinib |
Brain lower grade glioma |
0.049396352 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Brain lower grade glioma |
0.01039401 |
Resistant |
| ENSG00000229587.2 |
Ponatinib |
Brain lower grade glioma |
0.006578386 |
Resistant |
| ENSG00000229697.1 |
Ponatinib |
Brain lower grade glioma |
0.034450484 |
Resistant |
| ENSG00000229869.1 |
Ponatinib |
Brain lower grade glioma |
0.000598048 |
Resistant |
| ENSG00000229955.1 |
Ponatinib |
Brain lower grade glioma |
0.042094214 |
Resistant |
| ENSG00000229989.3 |
Ponatinib |
Brain lower grade glioma |
0.017611955 |
Resistant |
| ENSG00000229999.2 |
Ponatinib |
Brain lower grade glioma |
0.013037084 |
Resistant |
| ENSG00000230021.3 |
Ponatinib |
Brain lower grade glioma |
0.013156186 |
Resistant |
| ENSG00000230124.2 |
Ponatinib |
Brain lower grade glioma |
0.003919989 |
Resistant |
| ENSG00000230177.1 |
Ponatinib |
Brain lower grade glioma |
0.009544361 |
Resistant |
| ENSG00000230289.1 |
Ponatinib |
Brain lower grade glioma |
0.021181589 |
Resistant |
| ENSG00000230333.2 |
Ponatinib |
Brain lower grade glioma |
0.033053795 |
Resistant |
| ENSG00000230366.5 |
Ponatinib |
Brain lower grade glioma |
0.025847083 |
Resistant |
| ENSG00000230534.2 |
Ponatinib |
Brain lower grade glioma |
0.045037755 |
Resistant |
| ENSG00000230565.1 |
Ponatinib |
Brain lower grade glioma |
0.03279467 |
Resistant |
| ENSG00000230606.6 |
Ponatinib |
Brain lower grade glioma |
0.014679879 |
Resistant |
| ENSG00000230613.1 |
Ponatinib |
Brain lower grade glioma |
0.003903187 |
Resistant |
| ENSG00000230724.5 |
Ponatinib |
Brain lower grade glioma |
0.010897428 |
Resistant |
| ENSG00000230732.3 |
Ponatinib |
Brain lower grade glioma |
0.001652049 |
Resistant |
| ENSG00000230736.2 |
Ponatinib |
Brain lower grade glioma |
0.015676219 |
Resistant |
| ENSG00000230850.3 |
Ponatinib |
Brain lower grade glioma |
0.043562923 |
Resistant |
| ENSG00000230925.3 |
Ponatinib |
Brain lower grade glioma |
0.020491348 |
Resistant |
| ENSG00000231057.3 |
Ponatinib |
Brain lower grade glioma |
0.020751083 |
Resistant |
| ENSG00000231104.4 |
Ponatinib |
Brain lower grade glioma |
0.026580493 |
Resistant |
| ENSG00000231154.1 |
Ponatinib |
Brain lower grade glioma |
0.028195104 |
Resistant |
| ENSG00000231249.1 |
Ponatinib |
Brain lower grade glioma |
0.042195414 |
Resistant |
| ENSG00000231305.3 |
Ponatinib |
Brain lower grade glioma |
0.017285831 |
Resistant |
| ENSG00000231393.1 |
Ponatinib |
Brain lower grade glioma |
0.037564049 |
Resistant |
| ENSG00000231439.3 |
Ponatinib |
Brain lower grade glioma |
0.046601313 |
Resistant |
| ENSG00000231460.2 |
Ponatinib |
Brain lower grade glioma |
0.039630117 |
Resistant |
| ENSG00000231473.2 |
Ponatinib |
Brain lower grade glioma |
0.02274333 |
Resistant |
| ENSG00000231616.4 |
Ponatinib |
Brain lower grade glioma |
0.001014453 |
Resistant |
| ENSG00000231628.1 |
Ponatinib |
Brain lower grade glioma |
0.013965009 |
Resistant |
| ENSG00000231865.1 |
Ponatinib |
Brain lower grade glioma |
0.024686371 |
Resistant |
| ENSG00000231889.3 |
Ponatinib |
Brain lower grade glioma |
0.035042528 |
Resistant |
| ENSG00000231992.1 |
Ponatinib |
Brain lower grade glioma |
0.037725551 |
Resistant |
| ENSG00000232063.1 |
Ponatinib |
Brain lower grade glioma |
0.013484222 |
Resistant |
| ENSG00000232300.1 |
Ponatinib |
Brain lower grade glioma |
0.038083827 |
Resistant |
| ENSG00000232342.3 |
Ponatinib |
Brain lower grade glioma |
0.018079328 |
Resistant |
| ENSG00000232586.1 |
Ponatinib |
Brain lower grade glioma |
0.034659034 |
Resistant |
| ENSG00000232611.1 |
Ponatinib |
Brain lower grade glioma |
0.048643303 |
Resistant |
| ENSG00000232633.3 |
Ponatinib |
Brain lower grade glioma |
0.017907713 |
Resistant |
| ENSG00000232656.3 |
Ponatinib |
Brain lower grade glioma |
0.012467694 |
Resistant |
| ENSG00000232677.2 |
Ponatinib |
Brain lower grade glioma |
0.03714326 |
Resistant |
| ENSG00000232693.2 |
Ponatinib |
Brain lower grade glioma |
0.011141895 |
Resistant |
| ENSG00000232828.1 |
Ponatinib |
Brain lower grade glioma |
0.0000077 |
Resistant |
| ENSG00000232874.1 |
Ponatinib |
Brain lower grade glioma |
0.010491012 |
Resistant |
| ENSG00000232909.1 |
Ponatinib |
Brain lower grade glioma |
0.030368789 |
Resistant |
| ENSG00000232931.1 |
Ponatinib |
Brain lower grade glioma |
0.007188478 |
Resistant |
| ENSG00000232987.1 |
Ponatinib |
Brain lower grade glioma |
0.049415205 |
Resistant |
| ENSG00000233033.1 |
Ponatinib |
Brain lower grade glioma |
0.037617168 |
Resistant |
| ENSG00000233108.1 |
Ponatinib |
Brain lower grade glioma |
0.037730415 |
Resistant |
| ENSG00000233178.3 |
Ponatinib |
Brain lower grade glioma |
0.004685625 |
Resistant |
| ENSG00000233613.1 |
Ponatinib |
Brain lower grade glioma |
0.01504813 |
Resistant |
| ENSG00000233757.2 |
Ponatinib |
Brain lower grade glioma |
0.025934199 |
Resistant |
| ENSG00000233797.1 |
Ponatinib |
Brain lower grade glioma |
0.010053463 |
Resistant |
| ENSG00000233806.3 |
Ponatinib |
Brain lower grade glioma |
0.017827459 |
Resistant |
| ENSG00000233825.1 |
Ponatinib |
Brain lower grade glioma |
0.014330602 |
Resistant |
| ENSG00000233885.3 |
Ponatinib |
Brain lower grade glioma |
0.040340053 |
Resistant |
| ENSG00000233967.2 |
Ponatinib |
Brain lower grade glioma |
0.048061189 |
Resistant |
| ENSG00000234006.1 |
Ponatinib |
Brain lower grade glioma |
0.032434355 |
Resistant |
| ENSG00000234062.3 |
Ponatinib |
Brain lower grade glioma |
0.010035845 |
Resistant |
| ENSG00000234072.1 |
Ponatinib |
Brain lower grade glioma |
0.033305531 |
Resistant |
| ENSG00000234134.1 |
Ponatinib |
Brain lower grade glioma |
0.009231456 |
Resistant |
| ENSG00000234160.1 |
Ponatinib |
Brain lower grade glioma |
0.002847976 |
Resistant |
| ENSG00000234252.1 |
Ponatinib |
Brain lower grade glioma |
0.005326309 |
Resistant |
| ENSG00000234405.1 |
Ponatinib |
Brain lower grade glioma |
0.012097955 |
Resistant |
| ENSG00000234456.3 |
Ponatinib |
Brain lower grade glioma |
0.023278213 |
Resistant |
| ENSG00000234630.1 |
Ponatinib |
Brain lower grade glioma |
0.035478328 |
Resistant |
| ENSG00000234650.1 |
Ponatinib |
Brain lower grade glioma |
0.020181501 |
Resistant |
| ENSG00000234771.2 |
Ponatinib |
Brain lower grade glioma |
0.009443066 |
Resistant |
| ENSG00000234789.1 |
Ponatinib |
Brain lower grade glioma |
0.003783214 |
Resistant |
| ENSG00000234912.5 |
Ponatinib |
Brain lower grade glioma |
0.021944772 |
Resistant |
| ENSG00000234917.1 |
Ponatinib |
Brain lower grade glioma |
0.034021979 |
Resistant |
| ENSG00000234936.1 |
Ponatinib |
Brain lower grade glioma |
0.009830317 |
Resistant |
| ENSG00000234945.3 |
Ponatinib |
Brain lower grade glioma |
0.022970176 |
Resistant |
| ENSG00000234978.1 |
Ponatinib |
Brain lower grade glioma |
0.041828707 |
Resistant |
| ENSG00000234996.3 |
Ponatinib |
Brain lower grade glioma |
0.027378009 |
Resistant |
| ENSG00000235079.1 |
Ponatinib |
Brain lower grade glioma |
0.001316664 |
Resistant |
| ENSG00000235092.1 |
Ponatinib |
Brain lower grade glioma |
0.014589397 |
Resistant |
| ENSG00000235096.1 |
Ponatinib |
Brain lower grade glioma |
0.044430743 |
Resistant |
| ENSG00000235138.1 |
Ponatinib |
Brain lower grade glioma |
0.038380381 |
Resistant |
| ENSG00000235296.1 |
Ponatinib |
Brain lower grade glioma |
0.027604977 |
Resistant |
| ENSG00000235314.1 |
Ponatinib |
Brain lower grade glioma |
0.045664501 |
Resistant |
| ENSG00000235335.2 |
Ponatinib |
Brain lower grade glioma |
0.037276462 |
Resistant |
| ENSG00000235381.1 |
Ponatinib |
Brain lower grade glioma |
0.012407755 |
Resistant |
| ENSG00000235461.1 |
Ponatinib |
Brain lower grade glioma |
0.042662434 |
Resistant |
| ENSG00000235477.2 |
Ponatinib |
Brain lower grade glioma |
0.002366565 |
Resistant |
| ENSG00000235481.2 |
Ponatinib |
Brain lower grade glioma |
0.040975506 |
Resistant |
| ENSG00000235526.1 |
Ponatinib |
Brain lower grade glioma |
0.02710323 |
Resistant |
| ENSG00000235527.2 |
Ponatinib |
Brain lower grade glioma |
0.021947782 |
Resistant |
| ENSG00000235703.1 |
Ponatinib |
Brain lower grade glioma |
0.016629786 |
Resistant |
| ENSG00000235760.3 |
Ponatinib |
Brain lower grade glioma |
0.045982217 |
Resistant |
| ENSG00000235903.3 |
Ponatinib |
Brain lower grade glioma |
0.034853748 |
Resistant |
| ENSG00000236016.3 |
Ponatinib |
Brain lower grade glioma |
0.037204025 |
Resistant |
| ENSG00000236021.1 |
Ponatinib |
Brain lower grade glioma |
0.009159333 |
Resistant |
| ENSG00000236031.1 |
Ponatinib |
Brain lower grade glioma |
0.010617158 |
Resistant |
| ENSG00000236066.1 |
Ponatinib |
Brain lower grade glioma |
0.022938781 |
Resistant |
| ENSG00000236226.1 |
Ponatinib |
Brain lower grade glioma |
0.038113501 |
Resistant |
| ENSG00000236345.1 |
Ponatinib |
Brain lower grade glioma |
0.039063304 |
Resistant |
| ENSG00000236364.2 |
Ponatinib |
Brain lower grade glioma |
0.022278117 |
Resistant |
| ENSG00000236438.2 |
Ponatinib |
Brain lower grade glioma |
0.019175149 |
Resistant |
| ENSG00000236519.1 |
Ponatinib |
Brain lower grade glioma |
0.036211136 |
Resistant |
| ENSG00000236545.1 |
Ponatinib |
Brain lower grade glioma |
0.003523513 |
Resistant |
| ENSG00000236558.2 |
Ponatinib |
Brain lower grade glioma |
0.03961646 |
Resistant |
| ENSG00000236682.1 |
Ponatinib |
Brain lower grade glioma |
0.018608605 |
Resistant |
| ENSG00000236703.1 |
Ponatinib |
Brain lower grade glioma |
0.044044835 |
Resistant |
| ENSG00000236711.2 |
Ponatinib |
Brain lower grade glioma |
0.032787474 |
Resistant |
| ENSG00000236760.1 |
Ponatinib |
Brain lower grade glioma |
0.034028672 |
Resistant |
| ENSG00000236869.1 |
Ponatinib |
Brain lower grade glioma |
0.027128267 |
Resistant |
| ENSG00000236991.2 |
Ponatinib |
Brain lower grade glioma |
0.012490584 |
Resistant |
| ENSG00000237094.7 |
Ponatinib |
Brain lower grade glioma |
0.015136023 |
Resistant |
| ENSG00000237126.4 |
Ponatinib |
Brain lower grade glioma |
0.038312866 |
Resistant |
| ENSG00000237291.2 |
Ponatinib |
Brain lower grade glioma |
0.033311365 |
Resistant |
| ENSG00000237343.1 |
Ponatinib |
Brain lower grade glioma |
0.030956251 |
Resistant |
| ENSG00000237491.4 |
Ponatinib |
Brain lower grade glioma |
0.006594691 |
Resistant |
| ENSG00000237726.1 |
Ponatinib |
Brain lower grade glioma |
0.006138994 |
Resistant |
| ENSG00000237892.1 |
Ponatinib |
Brain lower grade glioma |
0.029466636 |
Resistant |
| ENSG00000237899.1 |
Ponatinib |
Brain lower grade glioma |
0.026913179 |
Resistant |
| ENSG00000237940.3 |
Ponatinib |
Brain lower grade glioma |
0.03011625 |
Resistant |
| ENSG00000237976.1 |
Ponatinib |
Brain lower grade glioma |
0.049364218 |
Resistant |
| ENSG00000237978.1 |
Ponatinib |
Brain lower grade glioma |
0.034997558 |
Resistant |
| ENSG00000238018.1 |
Ponatinib |
Brain lower grade glioma |
0.034058271 |
Resistant |
| ENSG00000238035.4 |
Ponatinib |
Brain lower grade glioma |
0.019502912 |
Resistant |
| ENSG00000238113.2 |
Ponatinib |
Brain lower grade glioma |
0.006213753 |
Resistant |
| ENSG00000238123.1 |
Ponatinib |
Brain lower grade glioma |
0.009625162 |
Resistant |
| ENSG00000238186.1 |
Ponatinib |
Brain lower grade glioma |
0.039044801 |
Resistant |
| ENSG00000239335.4 |
Ponatinib |
Brain lower grade glioma |
0.032574924 |
Resistant |
| ENSG00000240015.2 |
Ponatinib |
Brain lower grade glioma |
0.034056995 |
Resistant |
| ENSG00000240143.1 |
Ponatinib |
Brain lower grade glioma |
0.042554186 |
Resistant |
| ENSG00000240291.1 |
Ponatinib |
Brain lower grade glioma |
0.024376514 |
Resistant |
| ENSG00000240401.4 |
Ponatinib |
Brain lower grade glioma |
0.011836011 |
Resistant |
| ENSG00000240549.2 |
Ponatinib |
Brain lower grade glioma |
0.020940002 |
Resistant |
| ENSG00000240618.1 |
Ponatinib |
Brain lower grade glioma |
0.016112598 |
Resistant |
| ENSG00000240758.2 |
Ponatinib |
Brain lower grade glioma |
0.013254985 |
Resistant |
| ENSG00000240790.1 |
Ponatinib |
Brain lower grade glioma |
0.006631638 |
Resistant |
| ENSG00000241125.1 |
Ponatinib |
Brain lower grade glioma |
0.008467246 |
Resistant |
| ENSG00000241219.1 |
Ponatinib |
Brain lower grade glioma |
0.00707967 |
Resistant |
| ENSG00000241481.2 |
Ponatinib |
Brain lower grade glioma |
0.017477425 |
Resistant |
| ENSG00000241560.1 |
Ponatinib |
Brain lower grade glioma |
0.046968362 |
Resistant |
| ENSG00000241769.3 |
Ponatinib |
Brain lower grade glioma |
0.049882255 |
Resistant |
| ENSG00000241954.1 |
Ponatinib |
Brain lower grade glioma |
0.020457031 |
Resistant |
| ENSG00000242104.3 |
Ponatinib |
Brain lower grade glioma |
0.013989214 |
Resistant |
| ENSG00000242190.1 |
Ponatinib |
Brain lower grade glioma |
0.036991644 |
Resistant |
| ENSG00000242578.1 |
Ponatinib |
Brain lower grade glioma |
0.047316637 |
Resistant |
| ENSG00000243319.3 |
Ponatinib |
Brain lower grade glioma |
0.027349682 |
Resistant |
| ENSG00000243389.1 |
Ponatinib |
Brain lower grade glioma |
0.035156673 |
Resistant |
| ENSG00000243533.2 |
Ponatinib |
Brain lower grade glioma |
0.012393169 |
Resistant |
| ENSG00000243960.1 |
Ponatinib |
Brain lower grade glioma |
0.001529144 |
Resistant |
| ENSG00000244124.1 |
Ponatinib |
Brain lower grade glioma |
0.012563475 |
Resistant |
| ENSG00000244265.1 |
Ponatinib |
Brain lower grade glioma |
0.039219115 |
Resistant |
| ENSG00000244393.3 |
Ponatinib |
Brain lower grade glioma |
0.011974086 |
Resistant |
| ENSG00000244879.3 |
Ponatinib |
Brain lower grade glioma |
0.021249513 |
Resistant |
| ENSG00000245149.3 |
Ponatinib |
Brain lower grade glioma |
0.006333099 |
Resistant |
| ENSG00000245281.2 |
Ponatinib |
Brain lower grade glioma |
0.02927547 |
Resistant |
| ENSG00000245534.2 |
Ponatinib |
Brain lower grade glioma |
0.027679213 |
Resistant |
| ENSG00000245685.2 |
Ponatinib |
Brain lower grade glioma |
0.006035178 |
Resistant |
| ENSG00000245849.2 |
Ponatinib |
Brain lower grade glioma |
0.012853558 |
Resistant |
| ENSG00000245910.4 |
Ponatinib |
Brain lower grade glioma |
0.014375896 |
Resistant |
| ENSG00000246339.4 |
Ponatinib |
Brain lower grade glioma |
0.010675021 |
Resistant |
| ENSG00000246560.2 |
Ponatinib |
Brain lower grade glioma |
0.01786934 |
Resistant |
| ENSG00000246859.2 |
Ponatinib |
Brain lower grade glioma |
0.022289722 |
Resistant |
| ENSG00000246877.1 |
Ponatinib |
Brain lower grade glioma |
0.024324165 |
Resistant |
| ENSG00000247137.4 |
Ponatinib |
Brain lower grade glioma |
0.033747342 |
Resistant |
| ENSG00000247324.2 |
Ponatinib |
Brain lower grade glioma |
0.03284424 |
Resistant |
| ENSG00000247373.2 |
Ponatinib |
Brain lower grade glioma |
0.019988635 |
Resistant |
| ENSG00000247708.3 |
Ponatinib |
Brain lower grade glioma |
0.049138085 |
Resistant |
| ENSG00000248240.1 |
Ponatinib |
Brain lower grade glioma |
0.034753676 |
Resistant |
| ENSG00000248243.1 |
Ponatinib |
Brain lower grade glioma |
0.00730737 |
Resistant |
| ENSG00000248445.1 |
Ponatinib |
Brain lower grade glioma |
0.043510301 |
Resistant |
| ENSG00000248468.1 |
Ponatinib |
Brain lower grade glioma |
0.02276129 |
Resistant |
| ENSG00000248476.1 |
Ponatinib |
Brain lower grade glioma |
0.025727448 |
Resistant |
| ENSG00000248508.2 |
Ponatinib |
Brain lower grade glioma |
0.005890397 |
Resistant |
| ENSG00000248559.1 |
Ponatinib |
Brain lower grade glioma |
0.038476708 |
Resistant |
| ENSG00000248576.1 |
Ponatinib |
Brain lower grade glioma |
0.04630766 |
Resistant |
| ENSG00000248664.1 |
Ponatinib |
Brain lower grade glioma |
0.011227956 |
Resistant |
| ENSG00000248671.3 |
Ponatinib |
Brain lower grade glioma |
0.003801595 |
Resistant |
| ENSG00000248758.1 |
Ponatinib |
Brain lower grade glioma |
0.028337712 |
Resistant |
| ENSG00000248774.1 |
Ponatinib |
Brain lower grade glioma |
0.035091703 |
Resistant |
| ENSG00000248779.1 |
Ponatinib |
Brain lower grade glioma |
0.044438688 |
Resistant |
| ENSG00000248896.2 |
Ponatinib |
Brain lower grade glioma |
0.049454758 |
Resistant |
| ENSG00000248968.1 |
Ponatinib |
Brain lower grade glioma |
0.043145204 |
Resistant |
| ENSG00000249307.1 |
Ponatinib |
Brain lower grade glioma |
0.010443573 |
Resistant |
| ENSG00000249602.1 |
Ponatinib |
Brain lower grade glioma |
0.031881432 |
Resistant |
| ENSG00000249635.1 |
Ponatinib |
Brain lower grade glioma |
0.005701403 |
Resistant |
| ENSG00000249650.1 |
Ponatinib |
Brain lower grade glioma |
0.03173063 |
Resistant |
| ENSG00000249786.3 |
Ponatinib |
Brain lower grade glioma |
0.038668303 |
Resistant |
| ENSG00000249791.1 |
Ponatinib |
Brain lower grade glioma |
0.023763653 |
Resistant |
| ENSG00000249870.1 |
Ponatinib |
Brain lower grade glioma |
0.016864269 |
Resistant |
| ENSG00000249898.3 |
Ponatinib |
Brain lower grade glioma |
0.040810866 |
Resistant |
| ENSG00000250015.1 |
Ponatinib |
Brain lower grade glioma |
0.018454303 |
Resistant |
| ENSG00000250027.1 |
Ponatinib |
Brain lower grade glioma |
0.037767431 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Brain lower grade glioma |
0.008492997 |
Resistant |
| ENSG00000250220.1 |
Ponatinib |
Brain lower grade glioma |
0.024187672 |
Resistant |
| ENSG00000250260.1 |
Ponatinib |
Brain lower grade glioma |
0.036427885 |
Resistant |
| ENSG00000250326.1 |
Ponatinib |
Brain lower grade glioma |
0.026815943 |
Resistant |
| ENSG00000250616.2 |
Ponatinib |
Brain lower grade glioma |
0.032732805 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Brain lower grade glioma |
0.01287204 |
Resistant |
| ENSG00000250765.1 |
Ponatinib |
Brain lower grade glioma |
0.011568003 |
Resistant |
| ENSG00000250790.3 |
Ponatinib |
Brain lower grade glioma |
0.028215025 |
Resistant |
| ENSG00000250802.2 |
Ponatinib |
Brain lower grade glioma |
0.039346411 |
Resistant |
| ENSG00000250910.3 |
Ponatinib |
Brain lower grade glioma |
0.046644938 |
Resistant |
| ENSG00000250948.1 |
Ponatinib |
Brain lower grade glioma |
0.025594177 |
Resistant |
| ENSG00000250950.1 |
Ponatinib |
Brain lower grade glioma |
0.000550662 |
Resistant |
| ENSG00000250988.3 |
Ponatinib |
Brain lower grade glioma |
0.006259466 |
Resistant |
| ENSG00000251141.1 |
Ponatinib |
Brain lower grade glioma |
0.03379565 |
Resistant |
| ENSG00000251221.1 |
Ponatinib |
Brain lower grade glioma |
0.04044637 |
Resistant |
| ENSG00000251298.1 |
Ponatinib |
Brain lower grade glioma |
0.0349613 |
Resistant |
| ENSG00000251455.1 |
Ponatinib |
Brain lower grade glioma |
0.010594702 |
Resistant |
| ENSG00000251523.1 |
Ponatinib |
Brain lower grade glioma |
0.042782039 |
Resistant |
| ENSG00000251555.1 |
Ponatinib |
Brain lower grade glioma |
0.032913175 |
Resistant |
| ENSG00000253106.1 |
Ponatinib |
Brain lower grade glioma |
0.028871091 |
Resistant |
| ENSG00000253167.1 |
Ponatinib |
Brain lower grade glioma |
0.016575305 |
Resistant |
| ENSG00000253559.1 |
Ponatinib |
Brain lower grade glioma |
0.024677689 |
Resistant |
| ENSG00000253562.1 |
Ponatinib |
Brain lower grade glioma |
0.043848179 |
Resistant |
| ENSG00000253704.1 |
Ponatinib |
Brain lower grade glioma |
0.043992699 |
Resistant |
| ENSG00000253848.1 |
Ponatinib |
Brain lower grade glioma |
0.02368722 |
Resistant |
| ENSG00000253875.1 |
Ponatinib |
Brain lower grade glioma |
0.040209322 |
Resistant |
| ENSG00000253948.1 |
Ponatinib |
Brain lower grade glioma |
0.009969073 |
Resistant |
| ENSG00000253978.1 |
Ponatinib |
Brain lower grade glioma |
0.045410004 |
Resistant |
| ENSG00000254042.1 |
Ponatinib |
Brain lower grade glioma |
0.03473111 |
Resistant |
| ENSG00000254165.1 |
Ponatinib |
Brain lower grade glioma |
0.00489666 |
Resistant |
| ENSG00000254192.1 |
Ponatinib |
Brain lower grade glioma |
0.019856641 |
Resistant |
| ENSG00000254224.1 |
Ponatinib |
Brain lower grade glioma |
0.005570087 |
Resistant |
| ENSG00000254266.1 |
Ponatinib |
Brain lower grade glioma |
0.040477259 |
Resistant |
| ENSG00000254370.1 |
Ponatinib |
Brain lower grade glioma |
0.003229707 |
Resistant |
| ENSG00000254458.1 |
Ponatinib |
Brain lower grade glioma |
0.042486674 |
Resistant |
| ENSG00000254485.1 |
Ponatinib |
Brain lower grade glioma |
0.028032353 |
Resistant |
| ENSG00000254615.2 |
Ponatinib |
Brain lower grade glioma |
0.046433803 |
Resistant |
| ENSG00000254691.1 |
Ponatinib |
Brain lower grade glioma |
0.01810637 |
Resistant |
| ENSG00000254812.1 |
Ponatinib |
Brain lower grade glioma |
0.023634728 |
Resistant |
| ENSG00000254869.1 |
Ponatinib |
Brain lower grade glioma |
0.035652041 |
Resistant |
| ENSG00000255027.2 |
Ponatinib |
Brain lower grade glioma |
0.043258167 |
Resistant |
| ENSG00000255164.1 |
Ponatinib |
Brain lower grade glioma |
0.012630648 |
Resistant |
| ENSG00000255182.1 |
Ponatinib |
Brain lower grade glioma |
0.043249086 |
Resistant |
| ENSG00000255334.1 |
Ponatinib |
Brain lower grade glioma |
0.01638397 |
Resistant |
| ENSG00000255474.1 |
Ponatinib |
Brain lower grade glioma |
0.004552464 |
Resistant |
| ENSG00000255559.1 |
Ponatinib |
Brain lower grade glioma |
0.008594294 |
Resistant |
| ENSG00000255727.1 |
Ponatinib |
Brain lower grade glioma |
0.0484658 |
Resistant |
| ENSG00000255843.1 |
Ponatinib |
Brain lower grade glioma |
0.030891833 |
Resistant |
| ENSG00000255886.1 |
Ponatinib |
Brain lower grade glioma |
0.040681955 |
Resistant |
| ENSG00000255933.1 |
Ponatinib |
Brain lower grade glioma |
0.009327452 |
Resistant |
| ENSG00000255966.1 |
Ponatinib |
Brain lower grade glioma |
0.044735521 |
Resistant |
| ENSG00000255983.1 |
Ponatinib |
Brain lower grade glioma |
0.019763501 |
Resistant |
| ENSG00000256150.1 |
Ponatinib |
Brain lower grade glioma |
0.040575765 |
Resistant |
| ENSG00000256196.1 |
Ponatinib |
Brain lower grade glioma |
0.033325609 |
Resistant |
| ENSG00000256712.1 |
Ponatinib |
Brain lower grade glioma |
0.043238165 |
Resistant |
| ENSG00000256973.1 |
Ponatinib |
Brain lower grade glioma |
0.045987615 |
Resistant |
| ENSG00000257135.1 |
Ponatinib |
Brain lower grade glioma |
0.022197179 |
Resistant |
| ENSG00000257151.1 |
Ponatinib |
Brain lower grade glioma |
0.021908346 |
Resistant |
| ENSG00000257176.1 |
Ponatinib |
Brain lower grade glioma |
0.020460273 |
Resistant |
| ENSG00000257270.1 |
Ponatinib |
Brain lower grade glioma |
0.026593663 |
Resistant |
| ENSG00000257354.1 |
Ponatinib |
Brain lower grade glioma |
0.003154736 |
Resistant |
| ENSG00000257366.1 |
Ponatinib |
Brain lower grade glioma |
0.015993525 |
Resistant |
| ENSG00000257391.1 |
Ponatinib |
Brain lower grade glioma |
0.001875619 |
Resistant |
| ENSG00000257534.1 |
Ponatinib |
Brain lower grade glioma |
0.022904146 |
Resistant |
| ENSG00000257563.1 |
Ponatinib |
Brain lower grade glioma |
0.003011492 |
Resistant |
| ENSG00000257568.1 |
Ponatinib |
Brain lower grade glioma |
0.024315071 |
Resistant |
| ENSG00000257613.1 |
Ponatinib |
Brain lower grade glioma |
0.029249865 |
Resistant |
| ENSG00000257647.1 |
Ponatinib |
Brain lower grade glioma |
0.018872968 |
Resistant |
| ENSG00000257740.1 |
Ponatinib |
Brain lower grade glioma |
0.001322508 |
Resistant |
| ENSG00000257809.1 |
Ponatinib |
Brain lower grade glioma |
0.006387877 |
Resistant |
| ENSG00000257815.1 |
Ponatinib |
Brain lower grade glioma |
0.031851916 |
Resistant |
| ENSG00000257964.1 |
Ponatinib |
Brain lower grade glioma |
0.007640633 |
Resistant |
| ENSG00000258102.1 |
Ponatinib |
Brain lower grade glioma |
0.029710701 |
Resistant |
| ENSG00000258172.1 |
Ponatinib |
Brain lower grade glioma |
0.038274701 |
Resistant |
| ENSG00000258260.1 |
Ponatinib |
Brain lower grade glioma |
0.033199006 |
Resistant |
| ENSG00000258302.1 |
Ponatinib |
Brain lower grade glioma |
0.025446379 |
Resistant |
| ENSG00000258323.1 |
Ponatinib |
Brain lower grade glioma |
0.035314469 |
Resistant |
| ENSG00000258344.1 |
Ponatinib |
Brain lower grade glioma |
0.038561886 |
Resistant |
| ENSG00000258354.1 |
Ponatinib |
Brain lower grade glioma |
0.003039073 |
Resistant |
| ENSG00000258441.1 |
Ponatinib |
Brain lower grade glioma |
0.000458379 |
Resistant |
| ENSG00000258443.1 |
Ponatinib |
Brain lower grade glioma |
0.038291253 |
Resistant |
| ENSG00000258450.1 |
Ponatinib |
Brain lower grade glioma |
0.043879964 |
Resistant |
| ENSG00000258515.1 |
Ponatinib |
Brain lower grade glioma |
0.006697248 |
Resistant |
| ENSG00000258561.1 |
Ponatinib |
Brain lower grade glioma |
0.00705547 |
Resistant |
| ENSG00000258633.1 |
Ponatinib |
Brain lower grade glioma |
0.048716552 |
Resistant |
| ENSG00000258766.1 |
Ponatinib |
Brain lower grade glioma |
0.000284032 |
Resistant |
| ENSG00000258789.1 |
Ponatinib |
Brain lower grade glioma |
0.042796197 |
Resistant |
| ENSG00000258819.1 |
Ponatinib |
Brain lower grade glioma |
0.009754931 |
Resistant |
| ENSG00000258891.1 |
Ponatinib |
Brain lower grade glioma |
0.003851846 |
Resistant |
| ENSG00000258922.1 |
Ponatinib |
Brain lower grade glioma |
0.037103394 |
Resistant |
| ENSG00000259083.1 |
Ponatinib |
Brain lower grade glioma |
0.023791154 |
Resistant |
| ENSG00000259138.1 |
Ponatinib |
Brain lower grade glioma |
0.01021986 |
Resistant |
| ENSG00000259153.1 |
Ponatinib |
Brain lower grade glioma |
0.007892667 |
Resistant |
| ENSG00000259172.1 |
Ponatinib |
Brain lower grade glioma |
0.009970145 |
Resistant |
| ENSG00000259215.1 |
Ponatinib |
Brain lower grade glioma |
0.047529028 |
Resistant |
| ENSG00000259287.1 |
Ponatinib |
Brain lower grade glioma |
0.037630574 |
Resistant |
| ENSG00000259364.1 |
Ponatinib |
Brain lower grade glioma |
0.015586683 |
Resistant |
| ENSG00000259366.1 |
Ponatinib |
Brain lower grade glioma |
0.015209783 |
Resistant |
| ENSG00000259408.1 |
Ponatinib |
Brain lower grade glioma |
0.021691625 |
Resistant |
| ENSG00000259418.1 |
Ponatinib |
Brain lower grade glioma |
0.036829732 |
Resistant |
| ENSG00000259442.1 |
Ponatinib |
Brain lower grade glioma |
0.019028496 |
Resistant |
| ENSG00000259488.1 |
Ponatinib |
Brain lower grade glioma |
0.012066923 |
Resistant |
| ENSG00000259540.1 |
Ponatinib |
Brain lower grade glioma |
0.016319382 |
Resistant |
| ENSG00000259548.1 |
Ponatinib |
Brain lower grade glioma |
0.025801253 |
Resistant |
| ENSG00000259618.1 |
Ponatinib |
Brain lower grade glioma |
0.017286514 |
Resistant |
| ENSG00000259715.1 |
Ponatinib |
Brain lower grade glioma |
0.026184008 |
Resistant |
| ENSG00000259783.1 |
Ponatinib |
Brain lower grade glioma |
0.014938782 |
Resistant |
| ENSG00000259806.2 |
Ponatinib |
Brain lower grade glioma |
0.003318748 |
Resistant |
| ENSG00000259818.1 |
Ponatinib |
Brain lower grade glioma |
0.002207104 |
Resistant |
| ENSG00000259820.1 |
Ponatinib |
Brain lower grade glioma |
0.013934715 |
Resistant |
| ENSG00000259935.1 |
Ponatinib |
Brain lower grade glioma |
0.047106445 |
Resistant |
| ENSG00000259953.1 |
Ponatinib |
Brain lower grade glioma |
0.018409277 |
Resistant |
| ENSG00000259959.1 |
Ponatinib |
Brain lower grade glioma |
0.006463296 |
Resistant |
| ENSG00000259994.1 |
Ponatinib |
Brain lower grade glioma |
0.008851898 |
Resistant |
| ENSG00000259999.1 |
Ponatinib |
Brain lower grade glioma |
0.024565506 |
Resistant |
| ENSG00000260083.1 |
Ponatinib |
Brain lower grade glioma |
0.04710375 |
Resistant |
| ENSG00000260123.1 |
Ponatinib |
Brain lower grade glioma |
0.026368093 |
Resistant |
| ENSG00000260167.1 |
Ponatinib |
Brain lower grade glioma |
0.027993543 |
Resistant |
| ENSG00000260176.1 |
Ponatinib |
Brain lower grade glioma |
0.01493525 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Brain lower grade glioma |
0.048674458 |
Resistant |
| ENSG00000260261.1 |
Ponatinib |
Brain lower grade glioma |
0.006185644 |
Resistant |
| ENSG00000260269.1 |
Ponatinib |
Brain lower grade glioma |
0.009928005 |
Resistant |
| ENSG00000260293.1 |
Ponatinib |
Brain lower grade glioma |
0.042704971 |
Resistant |
| ENSG00000260296.1 |
Ponatinib |
Brain lower grade glioma |
0.024723947 |
Resistant |
| ENSG00000260361.1 |
Ponatinib |
Brain lower grade glioma |
0.014501673 |
Resistant |
| ENSG00000260366.1 |
Ponatinib |
Brain lower grade glioma |
0.048663647 |
Resistant |
| ENSG00000260367.1 |
Ponatinib |
Brain lower grade glioma |
0.003749473 |
Resistant |
| ENSG00000260381.2 |
Ponatinib |
Brain lower grade glioma |
0.039172255 |
Resistant |
| ENSG00000260388.1 |
Ponatinib |
Brain lower grade glioma |
0.020846357 |
Resistant |
| ENSG00000260425.1 |
Ponatinib |
Brain lower grade glioma |
0.002175073 |
Resistant |
| ENSG00000260464.1 |
Ponatinib |
Brain lower grade glioma |
0.034377873 |
Resistant |
| ENSG00000260583.1 |
Ponatinib |
Brain lower grade glioma |
0.030241815 |
Resistant |
| ENSG00000260589.1 |
Ponatinib |
Brain lower grade glioma |
0.02842558 |
Resistant |
| ENSG00000260591.1 |
Ponatinib |
Brain lower grade glioma |
0.016911475 |
Resistant |
| ENSG00000260637.1 |
Ponatinib |
Brain lower grade glioma |
0.027461211 |
Resistant |
| ENSG00000260645.1 |
Ponatinib |
Brain lower grade glioma |
0.039944992 |
Resistant |
| ENSG00000260646.1 |
Ponatinib |
Brain lower grade glioma |
0.024579107 |
Resistant |
| ENSG00000260698.1 |
Ponatinib |
Brain lower grade glioma |
0.030825634 |
Resistant |
| ENSG00000260751.2 |
Ponatinib |
Brain lower grade glioma |
0.002119877 |
Resistant |
| ENSG00000260774.1 |
Ponatinib |
Brain lower grade glioma |
0.011004806 |
Resistant |
| ENSG00000260814.2 |
Ponatinib |
Brain lower grade glioma |
0.046774958 |
Resistant |
| ENSG00000260853.1 |
Ponatinib |
Brain lower grade glioma |
0.002994994 |
Resistant |
| ENSG00000260884.1 |
Ponatinib |
Brain lower grade glioma |
0.013227555 |
Resistant |
| ENSG00000260917.1 |
Ponatinib |
Brain lower grade glioma |
0.003094805 |
Resistant |
| ENSG00000260920.1 |
Ponatinib |
Brain lower grade glioma |
0.000022 |
Resistant |
| ENSG00000260931.1 |
Ponatinib |
Brain lower grade glioma |
0.047817175 |
Resistant |
| ENSG00000260932.1 |
Ponatinib |
Brain lower grade glioma |
0.019437697 |
Resistant |
| ENSG00000260948.1 |
Ponatinib |
Brain lower grade glioma |
0.023627464 |
Resistant |
| ENSG00000261002.1 |
Ponatinib |
Brain lower grade glioma |
0.002159756 |
Resistant |
| ENSG00000261019.1 |
Ponatinib |
Brain lower grade glioma |
0.031567116 |
Resistant |
| ENSG00000261069.2 |
Ponatinib |
Brain lower grade glioma |
0.029663816 |
Resistant |
| ENSG00000261094.2 |
Ponatinib |
Brain lower grade glioma |
0.007803576 |
Resistant |
| ENSG00000261096.1 |
Ponatinib |
Brain lower grade glioma |
0.005864508 |
Resistant |
| ENSG00000261131.1 |
Ponatinib |
Brain lower grade glioma |
0.017330062 |
Resistant |
| ENSG00000261135.1 |
Ponatinib |
Brain lower grade glioma |
0.023915356 |
Resistant |
| ENSG00000261140.1 |
Ponatinib |
Brain lower grade glioma |
0.017874858 |
Resistant |
| ENSG00000261167.1 |
Ponatinib |
Brain lower grade glioma |
0.006889673 |
Resistant |
| ENSG00000261254.1 |
Ponatinib |
Brain lower grade glioma |
0.003469686 |
Resistant |
| ENSG00000261288.1 |
Ponatinib |
Brain lower grade glioma |
0.017563544 |
Resistant |
| ENSG00000261355.1 |
Ponatinib |
Brain lower grade glioma |
0.021421052 |
Resistant |
| ENSG00000261357.1 |
Ponatinib |
Brain lower grade glioma |
0.012441027 |
Resistant |
| ENSG00000261366.1 |
Ponatinib |
Brain lower grade glioma |
0.020446001 |
Resistant |
| ENSG00000261399.1 |
Ponatinib |
Brain lower grade glioma |
0.028515958 |
Resistant |
| ENSG00000261428.1 |
Ponatinib |
Brain lower grade glioma |
0.028164147 |
Resistant |
| ENSG00000261433.1 |
Ponatinib |
Brain lower grade glioma |
0.038313293 |
Resistant |
| ENSG00000261533.1 |
Ponatinib |
Brain lower grade glioma |
0.005506215 |
Resistant |
| ENSG00000261596.1 |
Ponatinib |
Brain lower grade glioma |
0.007872852 |
Resistant |
| ENSG00000261613.2 |
Ponatinib |
Brain lower grade glioma |
0.017900224 |
Resistant |
| ENSG00000261731.2 |
Ponatinib |
Brain lower grade glioma |
0.003852967 |
Resistant |
| ENSG00000261758.1 |
Ponatinib |
Brain lower grade glioma |
0.014574167 |
Resistant |
| ENSG00000261770.1 |
Ponatinib |
Brain lower grade glioma |
0.00883368 |
Resistant |
| ENSG00000261775.1 |
Ponatinib |
Brain lower grade glioma |
0.021504287 |
Resistant |
| ENSG00000261799.1 |
Ponatinib |
Brain lower grade glioma |
0.011596431 |
Resistant |
| ENSG00000261823.1 |
Ponatinib |
Brain lower grade glioma |
0.03803267 |
Resistant |
| ENSG00000261840.1 |
Ponatinib |
Brain lower grade glioma |
0.021388606 |
Resistant |
| ENSG00000261886.1 |
Ponatinib |
Brain lower grade glioma |
0.005497557 |
Resistant |
| ENSG00000262119.1 |
Ponatinib |
Brain lower grade glioma |
0.037105791 |
Resistant |
| ENSG00000262222.1 |
Ponatinib |
Brain lower grade glioma |
0.035242323 |
Resistant |
| ENSG00000262412.1 |
Ponatinib |
Brain lower grade glioma |
0.039803512 |
Resistant |
| ENSG00000262514.1 |
Ponatinib |
Brain lower grade glioma |
0.001773006 |
Resistant |
| ENSG00000262652.1 |
Ponatinib |
Brain lower grade glioma |
0.010297592 |
Resistant |
| ENSG00000262703.1 |
Ponatinib |
Brain lower grade glioma |
0.014403336 |
Resistant |
| ENSG00000262721.1 |
Ponatinib |
Brain lower grade glioma |
0.028334012 |
Resistant |
| ENSG00000262951.1 |
Ponatinib |
Brain lower grade glioma |
0.041543343 |
Resistant |
| ENSG00000262973.1 |
Ponatinib |
Brain lower grade glioma |
0.020142845 |
Resistant |
| ENSG00000263011.1 |
Ponatinib |
Brain lower grade glioma |
0.032019988 |
Resistant |
| ENSG00000263013.1 |
Ponatinib |
Brain lower grade glioma |
0.040713735 |
Resistant |
| ENSG00000263033.1 |
Ponatinib |
Brain lower grade glioma |
0.01495833 |
Resistant |
| ENSG00000263069.1 |
Ponatinib |
Brain lower grade glioma |
0.025406451 |
Resistant |
| ENSG00000263080.1 |
Ponatinib |
Brain lower grade glioma |
0.03034975 |
Resistant |
| ENSG00000263182.1 |
Ponatinib |
Brain lower grade glioma |
0.002098889 |
Resistant |
| ENSG00000263307.1 |
Ponatinib |
Brain lower grade glioma |
0.017855477 |
Resistant |
| ENSG00000263331.1 |
Ponatinib |
Brain lower grade glioma |
0.026406794 |
Resistant |
| ENSG00000263345.1 |
Ponatinib |
Brain lower grade glioma |
0.00395245 |
Resistant |
| ENSG00000263612.1 |
Ponatinib |
Brain lower grade glioma |
0.044071357 |
Resistant |
| ENSG00000264007.1 |
Ponatinib |
Brain lower grade glioma |
0.031223242 |
Resistant |
| ENSG00000264853.1 |
Ponatinib |
Brain lower grade glioma |
0.022672747 |
Resistant |
| ENSG00000264860.1 |
Ponatinib |
Brain lower grade glioma |
0.036767379 |
Resistant |
| ENSG00000265148.1 |
Ponatinib |
Brain lower grade glioma |
0.049317536 |
Resistant |
| ENSG00000265242.1 |
Ponatinib |
Brain lower grade glioma |
0.027146356 |
Resistant |
| ENSG00000265496.2 |
Ponatinib |
Brain lower grade glioma |
0.006848994 |
Resistant |
| ENSG00000265912.1 |
Ponatinib |
Brain lower grade glioma |
0.001457316 |
Resistant |
| ENSG00000266126.1 |
Ponatinib |
Brain lower grade glioma |
0.037806951 |
Resistant |
| ENSG00000266236.1 |
Ponatinib |
Brain lower grade glioma |
0.026144989 |
Resistant |
| ENSG00000266289.1 |
Ponatinib |
Brain lower grade glioma |
0.045090073 |
Resistant |
| ENSG00000266538.1 |
Ponatinib |
Brain lower grade glioma |
0.035113815 |
Resistant |
| ENSG00000266921.1 |
Ponatinib |
Brain lower grade glioma |
0.013081107 |
Resistant |
| ENSG00000266926.1 |
Ponatinib |
Brain lower grade glioma |
0.024240457 |
Resistant |
| ENSG00000266935.1 |
Ponatinib |
Brain lower grade glioma |
0.030309273 |
Resistant |
| ENSG00000266936.1 |
Ponatinib |
Brain lower grade glioma |
0.021897985 |
Resistant |
| ENSG00000266957.1 |
Ponatinib |
Brain lower grade glioma |
0.005504312 |
Resistant |
| ENSG00000266975.1 |
Ponatinib |
Brain lower grade glioma |
0.008285147 |
Resistant |
| ENSG00000267002.1 |
Ponatinib |
Brain lower grade glioma |
0.017909917 |
Resistant |
| ENSG00000267006.1 |
Ponatinib |
Brain lower grade glioma |
0.017211987 |
Resistant |
| ENSG00000267144.1 |
Ponatinib |
Brain lower grade glioma |
0.027144571 |
Resistant |
| ENSG00000267150.1 |
Ponatinib |
Brain lower grade glioma |
0.014659771 |
Resistant |
| ENSG00000267161.1 |
Ponatinib |
Brain lower grade glioma |
0.031651625 |
Resistant |
| ENSG00000267163.1 |
Ponatinib |
Brain lower grade glioma |
0.037926105 |
Resistant |
| ENSG00000267167.1 |
Ponatinib |
Brain lower grade glioma |
0.028624579 |
Resistant |
| ENSG00000267194.1 |
Ponatinib |
Brain lower grade glioma |
0.043258107 |
Resistant |
| ENSG00000267212.1 |
Ponatinib |
Brain lower grade glioma |
0.007800493 |
Resistant |
| ENSG00000267230.1 |
Ponatinib |
Brain lower grade glioma |
0.023965861 |
Resistant |
| ENSG00000267231.1 |
Ponatinib |
Brain lower grade glioma |
0.032095315 |
Resistant |
| ENSG00000267251.1 |
Ponatinib |
Brain lower grade glioma |
0.049387429 |
Resistant |
| ENSG00000267254.1 |
Ponatinib |
Brain lower grade glioma |
0.013764219 |
Resistant |
| ENSG00000267272.1 |
Ponatinib |
Brain lower grade glioma |
0.015797104 |
Resistant |
| ENSG00000267273.1 |
Ponatinib |
Brain lower grade glioma |
0.029654096 |
Resistant |
| ENSG00000267274.1 |
Ponatinib |
Brain lower grade glioma |
0.04725159 |
Resistant |
| ENSG00000267280.1 |
Ponatinib |
Brain lower grade glioma |
0.023970439 |
Resistant |
| ENSG00000267298.1 |
Ponatinib |
Brain lower grade glioma |
0.039560611 |
Resistant |
| ENSG00000267334.1 |
Ponatinib |
Brain lower grade glioma |
0.042552891 |
Resistant |
| ENSG00000267348.2 |
Ponatinib |
Brain lower grade glioma |
0.00639662 |
Resistant |
| ENSG00000267470.1 |
Ponatinib |
Brain lower grade glioma |
0.030244468 |
Resistant |
| ENSG00000267605.1 |
Ponatinib |
Brain lower grade glioma |
0.033808885 |
Resistant |
| ENSG00000267613.1 |
Ponatinib |
Brain lower grade glioma |
0.007870743 |
Resistant |
| ENSG00000267651.1 |
Ponatinib |
Brain lower grade glioma |
0.014498935 |
Resistant |
| ENSG00000267682.1 |
Ponatinib |
Brain lower grade glioma |
0.026888171 |
Resistant |
| ENSG00000267765.1 |
Ponatinib |
Brain lower grade glioma |
0.030302306 |
Resistant |
| ENSG00000267834.1 |
Ponatinib |
Brain lower grade glioma |
0.002115836 |
Resistant |
| ENSG00000267898.1 |
Ponatinib |
Brain lower grade glioma |
0.008320563 |
Resistant |
| ENSG00000268015.1 |
Ponatinib |
Brain lower grade glioma |
0.014984877 |
Resistant |
| ENSG00000268047.1 |
Ponatinib |
Brain lower grade glioma |
0.009981685 |
Resistant |
| ENSG00000268307.1 |
Ponatinib |
Brain lower grade glioma |
0.010804283 |
Resistant |
| ENSG00000268471.3 |
Ponatinib |
Brain lower grade glioma |
0.004694536 |
Resistant |
| ENSG00000268573.1 |
Ponatinib |
Brain lower grade glioma |
0.034953241 |
Resistant |
| ENSG00000268670.1 |
Ponatinib |
Brain lower grade glioma |
0.024212505 |
Resistant |
| ENSG00000268683.1 |
Ponatinib |
Brain lower grade glioma |
0.001690337 |
Resistant |
| ENSG00000268764.1 |
Ponatinib |
Brain lower grade glioma |
0.043337629 |
Resistant |
| ENSG00000268836.1 |
Ponatinib |
Brain lower grade glioma |
0.010811136 |
Resistant |
| ENSG00000268912.1 |
Ponatinib |
Brain lower grade glioma |
0.005318152 |
Resistant |
| ENSG00000268945.1 |
Ponatinib |
Brain lower grade glioma |
0.023474305 |
Resistant |
| ENSG00000269086.2 |
Ponatinib |
Brain lower grade glioma |
0.032530647 |
Resistant |
| ENSG00000269148.1 |
Ponatinib |
Brain lower grade glioma |
0.010337934 |
Resistant |
| ENSG00000269194.1 |
Ponatinib |
Brain lower grade glioma |
0.008106628 |
Resistant |
| ENSG00000269321.1 |
Ponatinib |
Brain lower grade glioma |
0.024846984 |
Resistant |
| ENSG00000269352.1 |
Ponatinib |
Brain lower grade glioma |
0.022002741 |
Resistant |
| ENSG00000269444.1 |
Ponatinib |
Brain lower grade glioma |
0.010499039 |
Resistant |
| ENSG00000269473.1 |
Ponatinib |
Brain lower grade glioma |
0.017685677 |
Resistant |
| ENSG00000269489.1 |
Ponatinib |
Brain lower grade glioma |
0.043350063 |
Resistant |
| ENSG00000269893.2 |
Ponatinib |
Brain lower grade glioma |
0.025578708 |
Resistant |
| ENSG00000269938.1 |
Ponatinib |
Brain lower grade glioma |
0.015905763 |
Resistant |
| ENSG00000269947.1 |
Ponatinib |
Brain lower grade glioma |
0.037073615 |
Resistant |
| ENSG00000269951.1 |
Ponatinib |
Brain lower grade glioma |
0.031033657 |
Resistant |
| ENSG00000269973.1 |
Ponatinib |
Brain lower grade glioma |
0.003950179 |
Resistant |
| ENSG00000269997.1 |
Ponatinib |
Brain lower grade glioma |
0.02393192 |
Resistant |
| ENSG00000270012.1 |
Ponatinib |
Brain lower grade glioma |
0.008169008 |
Resistant |
| ENSG00000270018.1 |
Ponatinib |
Brain lower grade glioma |
0.030420558 |
Resistant |
| ENSG00000270028.1 |
Ponatinib |
Brain lower grade glioma |
0.041148392 |
Resistant |
| ENSG00000270048.1 |
Ponatinib |
Brain lower grade glioma |
0.020806957 |
Resistant |
| ENSG00000270061.1 |
Ponatinib |
Brain lower grade glioma |
0.010731954 |
Resistant |
| ENSG00000270084.1 |
Ponatinib |
Brain lower grade glioma |
0.016847367 |
Resistant |
| ENSG00000270095.1 |
Ponatinib |
Brain lower grade glioma |
0.015110977 |
Resistant |
| ENSG00000270109.1 |
Ponatinib |
Brain lower grade glioma |
0.01691971 |
Resistant |
| ENSG00000270117.1 |
Ponatinib |
Brain lower grade glioma |
0.028468081 |
Resistant |
| ENSG00000270127.1 |
Ponatinib |
Brain lower grade glioma |
0.01440339 |
Resistant |
| ENSG00000270130.1 |
Ponatinib |
Brain lower grade glioma |
0.019349104 |
Resistant |
| ENSG00000270133.1 |
Ponatinib |
Brain lower grade glioma |
0.002102337 |
Resistant |
| ENSG00000270189.1 |
Ponatinib |
Brain lower grade glioma |
0.002213853 |
Resistant |
| ENSG00000270223.1 |
Ponatinib |
Brain lower grade glioma |
0.006270728 |
Resistant |
| ENSG00000270237.1 |
Ponatinib |
Brain lower grade glioma |
0.012749662 |
Resistant |
| ENSG00000270332.1 |
Ponatinib |
Brain lower grade glioma |
0.015114037 |
Resistant |
| ENSG00000270557.1 |
Ponatinib |
Brain lower grade glioma |
0.024209157 |
Resistant |
| ENSG00000270604.1 |
Ponatinib |
Brain lower grade glioma |
0.010933659 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Brain lower grade glioma |
0.011099676 |
Resistant |
| ENSG00000270704.2 |
Ponatinib |
Brain lower grade glioma |
0.035287696 |
Resistant |
| ENSG00000270750.1 |
Ponatinib |
Brain lower grade glioma |
0.034611956 |
Resistant |
| ENSG00000270996.1 |
Ponatinib |
Brain lower grade glioma |
0.038631899 |
Resistant |
| ENSG00000271119.1 |
Ponatinib |
Brain lower grade glioma |
0.008343129 |
Resistant |
| ENSG00000271265.1 |
Ponatinib |
Brain lower grade glioma |
0.008319457 |
Resistant |
| ENSG00000271335.1 |
Ponatinib |
Brain lower grade glioma |
0.001770229 |
Resistant |
| ENSG00000271347.1 |
Ponatinib |
Brain lower grade glioma |
0.020531997 |
Resistant |
| ENSG00000271551.1 |
Ponatinib |
Brain lower grade glioma |
0.019150303 |
Resistant |
| ENSG00000271576.1 |
Ponatinib |
Brain lower grade glioma |
0.024339553 |
Resistant |
| ENSG00000271659.1 |
Ponatinib |
Brain lower grade glioma |
0.039445923 |
Resistant |
| ENSG00000271738.1 |
Ponatinib |
Brain lower grade glioma |
0.018309941 |
Resistant |
| ENSG00000271789.1 |
Ponatinib |
Brain lower grade glioma |
0.008530035 |
Resistant |
| ENSG00000271840.1 |
Ponatinib |
Brain lower grade glioma |
0.026008421 |
Resistant |
| ENSG00000271862.1 |
Ponatinib |
Brain lower grade glioma |
0.00845676 |
Resistant |
| ENSG00000271914.1 |
Ponatinib |
Brain lower grade glioma |
0.008993371 |
Resistant |
| ENSG00000271927.1 |
Ponatinib |
Brain lower grade glioma |
0.00396876 |
Resistant |
| ENSG00000271948.1 |
Ponatinib |
Brain lower grade glioma |
0.030339211 |
Resistant |
| ENSG00000271963.1 |
Ponatinib |
Brain lower grade glioma |
0.031745926 |
Resistant |
| ENSG00000271964.1 |
Ponatinib |
Brain lower grade glioma |
0.00852361 |
Resistant |
| ENSG00000271993.1 |
Ponatinib |
Brain lower grade glioma |
0.012501024 |
Resistant |
| ENSG00000271997.1 |
Ponatinib |
Brain lower grade glioma |
0.015396766 |
Resistant |
| ENSG00000272048.1 |
Ponatinib |
Brain lower grade glioma |
0.03901458 |
Resistant |
| ENSG00000272049.1 |
Ponatinib |
Brain lower grade glioma |
0.010485107 |
Resistant |
| ENSG00000272072.1 |
Ponatinib |
Brain lower grade glioma |
0.004421817 |
Resistant |
| ENSG00000272076.1 |
Ponatinib |
Brain lower grade glioma |
0.003668853 |
Resistant |
| ENSG00000272077.1 |
Ponatinib |
Brain lower grade glioma |
0.041819866 |
Resistant |
| ENSG00000272093.1 |
Ponatinib |
Brain lower grade glioma |
0.000758755 |
Resistant |
| ENSG00000272137.1 |
Ponatinib |
Brain lower grade glioma |
0.039078676 |
Resistant |
| ENSG00000272192.1 |
Ponatinib |
Brain lower grade glioma |
0.029263082 |
Resistant |
| ENSG00000272205.1 |
Ponatinib |
Brain lower grade glioma |
0.037948056 |
Resistant |
| ENSG00000272216.1 |
Ponatinib |
Brain lower grade glioma |
0.016061651 |
Resistant |
| ENSG00000272217.1 |
Ponatinib |
Brain lower grade glioma |
0.007867888 |
Resistant |
| ENSG00000272225.1 |
Ponatinib |
Brain lower grade glioma |
0.018346906 |
Resistant |
| ENSG00000272240.1 |
Ponatinib |
Brain lower grade glioma |
0.010414742 |
Resistant |
| ENSG00000272248.1 |
Ponatinib |
Brain lower grade glioma |
0.03674823 |
Resistant |
| ENSG00000272263.1 |
Ponatinib |
Brain lower grade glioma |
0.001094359 |
Resistant |
| ENSG00000272308.1 |
Ponatinib |
Brain lower grade glioma |
0.007071424 |
Resistant |
| ENSG00000272316.1 |
Ponatinib |
Brain lower grade glioma |
0.029064725 |
Resistant |
| ENSG00000272334.1 |
Ponatinib |
Brain lower grade glioma |
0.045781469 |
Resistant |
| ENSG00000272354.1 |
Ponatinib |
Brain lower grade glioma |
0.028804132 |
Resistant |
| ENSG00000272365.1 |
Ponatinib |
Brain lower grade glioma |
0.000789944 |
Resistant |
| ENSG00000272370.1 |
Ponatinib |
Brain lower grade glioma |
0.028873965 |
Resistant |
| ENSG00000272375.1 |
Ponatinib |
Brain lower grade glioma |
0.041110578 |
Resistant |
| ENSG00000272420.1 |
Ponatinib |
Brain lower grade glioma |
0.033212402 |
Resistant |
| ENSG00000272452.1 |
Ponatinib |
Brain lower grade glioma |
0.025473503 |
Resistant |
| ENSG00000272455.1 |
Ponatinib |
Brain lower grade glioma |
0.023412653 |
Resistant |
| ENSG00000272524.1 |
Ponatinib |
Brain lower grade glioma |
0.049178197 |
Resistant |
| ENSG00000272529.1 |
Ponatinib |
Brain lower grade glioma |
0.016094182 |
Resistant |
| ENSG00000272562.1 |
Ponatinib |
Brain lower grade glioma |
0.041344931 |
Resistant |
| ENSG00000272576.1 |
Ponatinib |
Brain lower grade glioma |
0.041647923 |
Resistant |
| ENSG00000272620.1 |
Ponatinib |
Brain lower grade glioma |
0.048539592 |
Resistant |
| ENSG00000272660.1 |
Ponatinib |
Brain lower grade glioma |
0.014561429 |
Resistant |
| ENSG00000272682.1 |
Ponatinib |
Brain lower grade glioma |
0.020411715 |
Resistant |
| ENSG00000272690.1 |
Ponatinib |
Brain lower grade glioma |
0.046266313 |
Resistant |
| ENSG00000272692.1 |
Ponatinib |
Brain lower grade glioma |
0.025401878 |
Resistant |
| ENSG00000272719.1 |
Ponatinib |
Brain lower grade glioma |
0.032288036 |
Resistant |
| ENSG00000272720.1 |
Ponatinib |
Brain lower grade glioma |
0.037997051 |
Resistant |
| ENSG00000272732.1 |
Ponatinib |
Brain lower grade glioma |
0.040721292 |
Resistant |
| ENSG00000272744.1 |
Ponatinib |
Brain lower grade glioma |
0.007728517 |
Resistant |
| ENSG00000272777.1 |
Ponatinib |
Brain lower grade glioma |
0.016312499 |
Resistant |
| ENSG00000272787.1 |
Ponatinib |
Brain lower grade glioma |
0.029934946 |
Resistant |
| ENSG00000272792.1 |
Ponatinib |
Brain lower grade glioma |
0.006795054 |
Resistant |
| ENSG00000272795.1 |
Ponatinib |
Brain lower grade glioma |
0.024966643 |
Resistant |
| ENSG00000272798.1 |
Ponatinib |
Brain lower grade glioma |
0.049702602 |
Resistant |
| ENSG00000272800.1 |
Ponatinib |
Brain lower grade glioma |
0.018952959 |
Resistant |
| ENSG00000272812.1 |
Ponatinib |
Brain lower grade glioma |
0.002157526 |
Resistant |
| ENSG00000272823.1 |
Ponatinib |
Brain lower grade glioma |
0.032598513 |
Resistant |
| ENSG00000272846.1 |
Ponatinib |
Brain lower grade glioma |
0.038858938 |
Resistant |
| ENSG00000272849.1 |
Ponatinib |
Brain lower grade glioma |
0.0277759 |
Resistant |
| ENSG00000272862.1 |
Ponatinib |
Brain lower grade glioma |
0.034372444 |
Resistant |
| ENSG00000272864.1 |
Ponatinib |
Brain lower grade glioma |
0.008412413 |
Resistant |
| ENSG00000272912.1 |
Ponatinib |
Brain lower grade glioma |
0.047617123 |
Resistant |
| ENSG00000272954.1 |
Ponatinib |
Brain lower grade glioma |
0.035851034 |
Resistant |
| ENSG00000272960.1 |
Ponatinib |
Brain lower grade glioma |
0.012931154 |
Resistant |
| ENSG00000272977.1 |
Ponatinib |
Brain lower grade glioma |
0.022575187 |
Resistant |
| ENSG00000272983.1 |
Ponatinib |
Brain lower grade glioma |
0.004745738 |
Resistant |
| ENSG00000272995.1 |
Ponatinib |
Brain lower grade glioma |
0.040640691 |
Resistant |
| ENSG00000273000.1 |
Ponatinib |
Brain lower grade glioma |
0.001631926 |
Resistant |
| ENSG00000273015.1 |
Ponatinib |
Brain lower grade glioma |
0.037586896 |
Resistant |
| ENSG00000273017.1 |
Ponatinib |
Brain lower grade glioma |
0.044718974 |
Resistant |
| ENSG00000273026.1 |
Ponatinib |
Brain lower grade glioma |
0.037416359 |
Resistant |
| ENSG00000273035.1 |
Ponatinib |
Brain lower grade glioma |
0.042896884 |
Resistant |
| ENSG00000273066.1 |
Ponatinib |
Brain lower grade glioma |
0.025584649 |
Resistant |
| ENSG00000273075.1 |
Ponatinib |
Brain lower grade glioma |
0.014528968 |
Resistant |
| ENSG00000273156.1 |
Ponatinib |
Brain lower grade glioma |
0.016064623 |
Resistant |
| ENSG00000273181.1 |
Ponatinib |
Brain lower grade glioma |
0.048771419 |
Resistant |
| ENSG00000273203.1 |
Ponatinib |
Brain lower grade glioma |
0.040957089 |
Resistant |
| ENSG00000273247.1 |
Ponatinib |
Brain lower grade glioma |
0.014324689 |
Resistant |
| ENSG00000273290.1 |
Ponatinib |
Brain lower grade glioma |
0.017020169 |
Resistant |
| ENSG00000273297.1 |
Ponatinib |
Brain lower grade glioma |
0.01433614 |
Resistant |
| ENSG00000273306.1 |
Ponatinib |
Brain lower grade glioma |
0.001951981 |
Resistant |
| ENSG00000273308.1 |
Ponatinib |
Brain lower grade glioma |
0.025975256 |
Resistant |
| ENSG00000273321.1 |
Ponatinib |
Brain lower grade glioma |
0.018870364 |
Resistant |
| ENSG00000273373.1 |
Ponatinib |
Brain lower grade glioma |
0.026052492 |
Resistant |
| ENSG00000273402.1 |
Ponatinib |
Brain lower grade glioma |
0.040455332 |
Resistant |
| ENSG00000273437.1 |
Ponatinib |
Brain lower grade glioma |
0.019425523 |
Resistant |
| ENSG00000273442.1 |
Ponatinib |
Brain lower grade glioma |
0.048644125 |
Resistant |
| ENSG00000273449.1 |
Ponatinib |
Brain lower grade glioma |
0.010437434 |
Resistant |
| ENSG00000273472.1 |
Ponatinib |
Brain lower grade glioma |
0.029269535 |
Resistant |
| ENSG00000273488.1 |
Ponatinib |
Brain lower grade glioma |
0.007731056 |
Resistant |
| ENSG00000182376.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.001666978 |
Resistant |
| ENSG00000188660.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.018457953 |
Resistant |
| ENSG00000203356.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.047173163 |
Resistant |
| ENSG00000206195.6 |
Ponatinib |
Liver hepatocellular carcinoma |
0.026117795 |
Resistant |
| ENSG00000223380.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.003904176 |
Resistant |
| ENSG00000223791.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.037083461 |
Resistant |
| ENSG00000223975.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.023676881 |
Resistant |
| ENSG00000224356.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.035516343 |
Resistant |
| ENSG00000225210.5 |
Ponatinib |
Liver hepatocellular carcinoma |
0.044291397 |
Resistant |
| ENSG00000225493.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.004591143 |
Resistant |
| ENSG00000226758.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.045398449 |
Resistant |
| ENSG00000226985.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.011424618 |
Resistant |
| ENSG00000227496.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.047338295 |
Resistant |
| ENSG00000227598.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.04677311 |
Resistant |
| ENSG00000228294.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022502532 |
Resistant |
| ENSG00000228649.4 |
Ponatinib |
Liver hepatocellular carcinoma |
0.038630768 |
Resistant |
| ENSG00000228719.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.004598023 |
Resistant |
| ENSG00000228737.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.04476436 |
Resistant |
| ENSG00000228742.5 |
Ponatinib |
Liver hepatocellular carcinoma |
0.025962151 |
Resistant |
| ENSG00000229498.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.015139022 |
Resistant |
| ENSG00000229801.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.014336722 |
Resistant |
| ENSG00000229873.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.031499582 |
Resistant |
| ENSG00000229931.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.004803403 |
Resistant |
| ENSG00000230417.6 |
Ponatinib |
Liver hepatocellular carcinoma |
0.019549579 |
Resistant |
| ENSG00000230537.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.005843408 |
Resistant |
| ENSG00000231890.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.021728031 |
Resistant |
| ENSG00000232117.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.034944105 |
Resistant |
| ENSG00000232973.7 |
Ponatinib |
Liver hepatocellular carcinoma |
0.015785435 |
Resistant |
| ENSG00000233651.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.048731497 |
Resistant |
| ENSG00000233695.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.006438325 |
Resistant |
| ENSG00000234630.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.004018855 |
Resistant |
| ENSG00000235172.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.001870223 |
Resistant |
| ENSG00000235488.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.005898368 |
Resistant |
| ENSG00000235641.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028470802 |
Resistant |
| ENSG00000235664.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.01804622 |
Resistant |
| ENSG00000235770.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.0000663 |
Resistant |
| ENSG00000236017.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.040707696 |
Resistant |
| ENSG00000236066.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022143929 |
Resistant |
| ENSG00000236230.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.038916884 |
Resistant |
| ENSG00000237520.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.013380119 |
Resistant |
| ENSG00000237664.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.01684336 |
Resistant |
| ENSG00000237686.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.045646293 |
Resistant |
| ENSG00000243819.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.019971994 |
Resistant |
| ENSG00000244564.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.012834221 |
Resistant |
| ENSG00000244625.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.046086242 |
Resistant |
| ENSG00000244649.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.018164105 |
Resistant |
| ENSG00000246334.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.045038264 |
Resistant |
| ENSG00000246422.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.043565453 |
Resistant |
| ENSG00000248758.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.00734435 |
Resistant |
| ENSG00000249249.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.03124021 |
Resistant |
| ENSG00000249328.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.024162151 |
Resistant |
| ENSG00000250240.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.004365626 |
Resistant |
| ENSG00000250282.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.041492301 |
Resistant |
| ENSG00000251085.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.039253087 |
Resistant |
| ENSG00000251497.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.032626849 |
Resistant |
| ENSG00000253227.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.014381452 |
Resistant |
| ENSG00000254691.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.040032301 |
Resistant |
| ENSG00000254854.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.012089267 |
Resistant |
| ENSG00000255100.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.010493164 |
Resistant |
| ENSG00000255621.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.044740366 |
Resistant |
| ENSG00000256452.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028846118 |
Resistant |
| ENSG00000256458.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.007830166 |
Resistant |
| ENSG00000258325.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.019929993 |
Resistant |
| ENSG00000258620.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.038277122 |
Resistant |
| ENSG00000258623.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.003085396 |
Resistant |
| ENSG00000258942.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.0261698 |
Resistant |
| ENSG00000259343.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.026564525 |
Resistant |
| ENSG00000260228.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.014573498 |
Resistant |
| ENSG00000260273.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.029334307 |
Resistant |
| ENSG00000260646.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.037154916 |
Resistant |
| ENSG00000260735.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.020741599 |
Resistant |
| ENSG00000260910.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.020382693 |
Resistant |
| ENSG00000261103.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.046433774 |
Resistant |
| ENSG00000261200.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.01432686 |
Resistant |
| ENSG00000261560.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.049267423 |
Resistant |
| ENSG00000261888.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.016101128 |
Resistant |
| ENSG00000262171.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.045804067 |
Resistant |
| ENSG00000262745.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.006289584 |
Resistant |
| ENSG00000263176.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028571379 |
Resistant |
| ENSG00000263624.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.013588612 |
Resistant |
| ENSG00000266835.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.045286705 |
Resistant |
| ENSG00000267064.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022041226 |
Resistant |
| ENSG00000267123.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.014742267 |
Resistant |
| ENSG00000268066.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.017023371 |
Resistant |
| ENSG00000268743.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.010633895 |
Resistant |
| ENSG00000269836.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.010740867 |
Resistant |
| ENSG00000270190.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.034100629 |
Resistant |
| ENSG00000270426.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.009137359 |
Resistant |
| ENSG00000271127.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.007577726 |
Resistant |
| ENSG00000271734.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.006392989 |
Resistant |
| ENSG00000272216.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.007667134 |
Resistant |
| ENSG00000272341.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.047784146 |
Resistant |
| ENSG00000272389.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.011402359 |
Resistant |
| ENSG00000272870.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.000754157 |
Resistant |
| ENSG00000273143.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.000686832 |
Resistant |
| ENSG00000273148.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.011679264 |
Resistant |
| ENSG00000273443.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.02728267 |
Resistant |
| ENSG00000273454.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.044175112 |
Resistant |
| ENSG00000088970.11 |
Ponatinib |
Lung squamous cell carcinoma |
0.045564899 |
Resistant |
| ENSG00000157306.10 |
Ponatinib |
Lung squamous cell carcinoma |
0.018935727 |
Resistant |
| ENSG00000167912.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.039790172 |
Resistant |
| ENSG00000178947.8 |
Ponatinib |
Lung squamous cell carcinoma |
0.049149055 |
Resistant |
| ENSG00000179935.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.019520913 |
Resistant |
| ENSG00000185044.10 |
Ponatinib |
Lung squamous cell carcinoma |
0.013795218 |
Resistant |
| ENSG00000185203.7 |
Ponatinib |
Lung squamous cell carcinoma |
0.002421267 |
Resistant |
| ENSG00000185847.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.047360622 |
Resistant |
| ENSG00000186842.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.038640033 |
Resistant |
| ENSG00000189196.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.026564812 |
Resistant |
| ENSG00000196421.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.012663115 |
Resistant |
| ENSG00000197291.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.021499625 |
Resistant |
| ENSG00000197558.7 |
Ponatinib |
Lung squamous cell carcinoma |
0.032975415 |
Resistant |
| ENSG00000203280.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.031228397 |
Resistant |
| ENSG00000203987.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.023257287 |
Resistant |
| ENSG00000204091.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.042667181 |
Resistant |
| ENSG00000204110.6 |
Ponatinib |
Lung squamous cell carcinoma |
0.047065967 |
Resistant |
| ENSG00000204119.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034775945 |
Resistant |
| ENSG00000204791.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.04484132 |
Resistant |
| ENSG00000205632.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.02826482 |
Resistant |
| ENSG00000212694.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.048460798 |
Resistant |
| ENSG00000213468.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.042878188 |
Resistant |
| ENSG00000214546.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.038765877 |
Resistant |
| ENSG00000214770.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.030242547 |
Resistant |
| ENSG00000215483.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.03782506 |
Resistant |
| ENSG00000215692.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020575324 |
Resistant |
| ENSG00000220161.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.04068592 |
Resistant |
| ENSG00000223379.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.002266561 |
Resistant |
| ENSG00000223486.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010538198 |
Resistant |
| ENSG00000223561.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020923758 |
Resistant |
| ENSG00000223669.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039021676 |
Resistant |
| ENSG00000223764.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024918769 |
Resistant |
| ENSG00000223770.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043143703 |
Resistant |
| ENSG00000224050.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026908615 |
Resistant |
| ENSG00000224142.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018593766 |
Resistant |
| ENSG00000224189.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011950592 |
Resistant |
| ENSG00000224387.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011750949 |
Resistant |
| ENSG00000224541.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016628521 |
Resistant |
| ENSG00000224885.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010881595 |
Resistant |
| ENSG00000224995.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019505847 |
Resistant |
| ENSG00000225057.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011192294 |
Resistant |
| ENSG00000225156.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.015818441 |
Resistant |
| ENSG00000225194.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.042827093 |
Resistant |
| ENSG00000225226.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044794333 |
Resistant |
| ENSG00000225255.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.040333615 |
Resistant |
| ENSG00000225280.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.034311021 |
Resistant |
| ENSG00000225353.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.047686238 |
Resistant |
| ENSG00000225411.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.037677886 |
Resistant |
| ENSG00000225413.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044900424 |
Resistant |
| ENSG00000225417.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034778483 |
Resistant |
| ENSG00000225431.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044930048 |
Resistant |
| ENSG00000225446.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017310586 |
Resistant |
| ENSG00000225465.6 |
Ponatinib |
Lung squamous cell carcinoma |
0.041749501 |
Resistant |
| ENSG00000225595.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043201416 |
Resistant |
| ENSG00000225647.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035174427 |
Resistant |
| ENSG00000225891.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001878484 |
Resistant |
| ENSG00000225905.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022895785 |
Resistant |
| ENSG00000225930.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.047446015 |
Resistant |
| ENSG00000225946.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048319108 |
Resistant |
| ENSG00000226087.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036847293 |
Resistant |
| ENSG00000226374.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024713738 |
Resistant |
| ENSG00000226383.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018105661 |
Resistant |
| ENSG00000226390.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031136204 |
Resistant |
| ENSG00000226627.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039724115 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008873962 |
Resistant |
| ENSG00000226702.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033332596 |
Resistant |
| ENSG00000226709.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03005106 |
Resistant |
| ENSG00000226746.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.031697134 |
Resistant |
| ENSG00000226786.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.014580232 |
Resistant |
| ENSG00000226891.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033039035 |
Resistant |
| ENSG00000226904.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02170963 |
Resistant |
| ENSG00000226954.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038155841 |
Resistant |
| ENSG00000226957.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036409789 |
Resistant |
| ENSG00000226965.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022252667 |
Resistant |
| ENSG00000227060.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.01094271 |
Resistant |
| ENSG00000227091.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035821552 |
Resistant |
| ENSG00000227116.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015057013 |
Resistant |
| ENSG00000227155.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.006148807 |
Resistant |
| ENSG00000227165.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.028118714 |
Resistant |
| ENSG00000227256.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003852152 |
Resistant |
| ENSG00000227374.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016000447 |
Resistant |
| ENSG00000227555.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019811673 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040625879 |
Resistant |
| ENSG00000227704.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014884012 |
Resistant |
| ENSG00000227719.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020550801 |
Resistant |
| ENSG00000227811.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.048460177 |
Resistant |
| ENSG00000227945.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038474352 |
Resistant |
| ENSG00000228016.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015869035 |
Resistant |
| ENSG00000228115.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033074773 |
Resistant |
| ENSG00000228133.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.018811065 |
Resistant |
| ENSG00000228135.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02898792 |
Resistant |
| ENSG00000228139.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031271674 |
Resistant |
| ENSG00000228204.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.007829046 |
Resistant |
| ENSG00000228487.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012976977 |
Resistant |
| ENSG00000228512.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044659518 |
Resistant |
| ENSG00000228679.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016515186 |
Resistant |
| ENSG00000228839.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010247675 |
Resistant |
| ENSG00000228862.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.020646777 |
Resistant |
| ENSG00000229105.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037281255 |
Resistant |
| ENSG00000229294.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029863511 |
Resistant |
| ENSG00000229393.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007504065 |
Resistant |
| ENSG00000229558.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035469074 |
Resistant |
| ENSG00000229766.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.032777965 |
Resistant |
| ENSG00000229891.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014682621 |
Resistant |
| ENSG00000229901.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01446501 |
Resistant |
| ENSG00000229980.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.045951832 |
Resistant |
| ENSG00000230126.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025704478 |
Resistant |
| ENSG00000230394.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00444957 |
Resistant |
| ENSG00000230537.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042021679 |
Resistant |
| ENSG00000230699.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.04578439 |
Resistant |
| ENSG00000230735.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022172871 |
Resistant |
| ENSG00000230945.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043327688 |
Resistant |
| ENSG00000231227.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04885883 |
Resistant |
| ENSG00000231294.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032298568 |
Resistant |
| ENSG00000231327.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037477743 |
Resistant |
| ENSG00000231383.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024950707 |
Resistant |
| ENSG00000231439.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.008952789 |
Resistant |
| ENSG00000231460.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046195135 |
Resistant |
| ENSG00000231481.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036197235 |
Resistant |
| ENSG00000231485.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02769098 |
Resistant |
| ENSG00000231533.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02911401 |
Resistant |
| ENSG00000231840.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049356793 |
Resistant |
| ENSG00000231842.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013647665 |
Resistant |
| ENSG00000231856.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015722673 |
Resistant |
| ENSG00000231882.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046301497 |
Resistant |
| ENSG00000231901.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041148537 |
Resistant |
| ENSG00000231999.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.026609157 |
Resistant |
| ENSG00000232006.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.022816081 |
Resistant |
| ENSG00000232044.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.030821919 |
Resistant |
| ENSG00000232057.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032032986 |
Resistant |
| ENSG00000232518.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043201895 |
Resistant |
| ENSG00000232640.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010884009 |
Resistant |
| ENSG00000232732.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.043883483 |
Resistant |
| ENSG00000232837.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027158674 |
Resistant |
| ENSG00000233008.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032044854 |
Resistant |
| ENSG00000233038.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009876458 |
Resistant |
| ENSG00000233056.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004462525 |
Resistant |
| ENSG00000233060.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028187158 |
Resistant |
| ENSG00000233086.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.0487362 |
Resistant |
| ENSG00000233208.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043627849 |
Resistant |
| ENSG00000233242.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020731255 |
Resistant |
| ENSG00000233246.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.002020674 |
Resistant |
| ENSG00000233251.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.042664054 |
Resistant |
| ENSG00000233255.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030235741 |
Resistant |
| ENSG00000233293.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046139242 |
Resistant |
| ENSG00000233304.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024346371 |
Resistant |
| ENSG00000233334.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.027615463 |
Resistant |
| ENSG00000233714.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048521594 |
Resistant |
| ENSG00000233775.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004353269 |
Resistant |
| ENSG00000233806.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.020708898 |
Resistant |
| ENSG00000234215.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.048502077 |
Resistant |
| ENSG00000234445.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040426161 |
Resistant |
| ENSG00000234571.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041824065 |
Resistant |
| ENSG00000234630.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025798068 |
Resistant |
| ENSG00000234688.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027539794 |
Resistant |
| ENSG00000234693.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039142945 |
Resistant |
| ENSG00000234884.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02037416 |
Resistant |
| ENSG00000234892.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024810886 |
Resistant |
| ENSG00000234921.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018374107 |
Resistant |
| ENSG00000234928.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021255894 |
Resistant |
| ENSG00000235021.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047253388 |
Resistant |
| ENSG00000235023.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027485796 |
Resistant |
| ENSG00000235024.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003914086 |
Resistant |
| ENSG00000235029.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042612893 |
Resistant |
| ENSG00000235051.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.047663363 |
Resistant |
| ENSG00000235092.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036670038 |
Resistant |
| ENSG00000235117.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.014366956 |
Resistant |
| ENSG00000235209.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041279573 |
Resistant |
| ENSG00000235296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023957137 |
Resistant |
| ENSG00000235314.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022467057 |
Resistant |
| ENSG00000235475.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009466769 |
Resistant |
| ENSG00000235494.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047293921 |
Resistant |
| ENSG00000235526.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012715736 |
Resistant |
| ENSG00000235545.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014638193 |
Resistant |
| ENSG00000235560.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.004944915 |
Resistant |
| ENSG00000235660.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006753315 |
Resistant |
| ENSG00000235785.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04241389 |
Resistant |
| ENSG00000235806.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049340564 |
Resistant |
| ENSG00000235890.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012671531 |
Resistant |
| ENSG00000236008.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019531078 |
Resistant |
| ENSG00000236066.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03179133 |
Resistant |
| ENSG00000236394.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020110192 |
Resistant |
| ENSG00000236423.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010418635 |
Resistant |
| ENSG00000236558.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024251035 |
Resistant |
| ENSG00000236611.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017993878 |
Resistant |
| ENSG00000236665.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044660958 |
Resistant |
| ENSG00000236668.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.041027638 |
Resistant |
| ENSG00000236790.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027617962 |
Resistant |
| ENSG00000236846.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00771567 |
Resistant |
| ENSG00000236886.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046227848 |
Resistant |
| ENSG00000237021.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.035275075 |
Resistant |
| ENSG00000237159.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013852181 |
Resistant |
| ENSG00000237336.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0230014 |
Resistant |
| ENSG00000237387.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043720343 |
Resistant |
| ENSG00000237404.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005608851 |
Resistant |
| ENSG00000237410.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042667831 |
Resistant |
| ENSG00000237419.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021727156 |
Resistant |
| ENSG00000237429.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025534317 |
Resistant |
| ENSG00000237438.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011076855 |
Resistant |
| ENSG00000237457.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.025152037 |
Resistant |
| ENSG00000237587.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.006866226 |
Resistant |
| ENSG00000237750.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.016298866 |
Resistant |
| ENSG00000237853.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.018279955 |
Resistant |
| ENSG00000237928.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042352386 |
Resistant |
| ENSG00000237940.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.033788372 |
Resistant |
| ENSG00000238062.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022721768 |
Resistant |
| ENSG00000238113.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.012649938 |
Resistant |
| ENSG00000238197.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01666534 |
Resistant |
| ENSG00000238260.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016935486 |
Resistant |
| ENSG00000238261.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.01709563 |
Resistant |
| ENSG00000238279.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041268273 |
Resistant |
| ENSG00000239265.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01292844 |
Resistant |
| ENSG00000239911.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036210616 |
Resistant |
| ENSG00000240990.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.024353394 |
Resistant |
| ENSG00000241054.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027485927 |
Resistant |
| ENSG00000241449.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0397224 |
Resistant |
| ENSG00000241505.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014338079 |
Resistant |
| ENSG00000241679.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.035338655 |
Resistant |
| ENSG00000241832.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039087973 |
Resistant |
| ENSG00000242078.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044004418 |
Resistant |
| ENSG00000242082.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03322675 |
Resistant |
| ENSG00000242540.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033121278 |
Resistant |
| ENSG00000243479.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.015666561 |
Resistant |
| ENSG00000243485.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.014710502 |
Resistant |
| ENSG00000243810.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0282028 |
Resistant |
| ENSG00000244124.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005604572 |
Resistant |
| ENSG00000244203.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.027885469 |
Resistant |
| ENSG00000244215.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027615426 |
Resistant |
| ENSG00000245719.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03180658 |
Resistant |
| ENSG00000246379.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033530026 |
Resistant |
| ENSG00000246465.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00576 |
Resistant |
| ENSG00000246528.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.004637658 |
Resistant |
| ENSG00000246820.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.040997267 |
Resistant |
| ENSG00000247131.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040319168 |
Resistant |
| ENSG00000247363.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.005717405 |
Resistant |
| ENSG00000248245.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025421634 |
Resistant |
| ENSG00000248986.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02682424 |
Resistant |
| ENSG00000249307.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04630849 |
Resistant |
| ENSG00000249487.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.035920318 |
Resistant |
| ENSG00000250046.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.011057319 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017448572 |
Resistant |
| ENSG00000250073.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044177448 |
Resistant |
| ENSG00000250366.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.006011427 |
Resistant |
| ENSG00000250409.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023660956 |
Resistant |
| ENSG00000251164.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037589865 |
Resistant |
| ENSG00000251187.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048602073 |
Resistant |
| ENSG00000251331.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011668169 |
Resistant |
| ENSG00000251408.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026732257 |
Resistant |
| ENSG00000251497.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.027895539 |
Resistant |
| ENSG00000251665.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038030192 |
Resistant |
| ENSG00000253181.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044249312 |
Resistant |
| ENSG00000253230.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046574916 |
Resistant |
| ENSG00000253477.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022159001 |
Resistant |
| ENSG00000253508.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038525539 |
Resistant |
| ENSG00000253576.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012925984 |
Resistant |
| ENSG00000253618.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034727581 |
Resistant |
| ENSG00000253641.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018691602 |
Resistant |
| ENSG00000253695.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020300258 |
Resistant |
| ENSG00000253878.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042805708 |
Resistant |
| ENSG00000253973.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.042046618 |
Resistant |
| ENSG00000253978.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042415491 |
Resistant |
| ENSG00000254246.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040505613 |
Resistant |
| ENSG00000254370.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021270481 |
Resistant |
| ENSG00000254427.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006418496 |
Resistant |
| ENSG00000254468.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011523899 |
Resistant |
| ENSG00000254610.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015463729 |
Resistant |
| ENSG00000254615.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.048914595 |
Resistant |
| ENSG00000254814.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04654193 |
Resistant |
| ENSG00000254936.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.048726168 |
Resistant |
| ENSG00000255020.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003450767 |
Resistant |
| ENSG00000255027.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.048974309 |
Resistant |
| ENSG00000255101.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033300086 |
Resistant |
| ENSG00000255118.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0236209 |
Resistant |
| ENSG00000255310.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.023924335 |
Resistant |
| ENSG00000255367.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047286141 |
Resistant |
| ENSG00000255571.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003619698 |
Resistant |
| ENSG00000255669.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010279698 |
Resistant |
| ENSG00000255693.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008119137 |
Resistant |
| ENSG00000255808.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044728744 |
Resistant |
| ENSG00000256008.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010708313 |
Resistant |
| ENSG00000256232.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019548468 |
Resistant |
| ENSG00000256278.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011156826 |
Resistant |
| ENSG00000256650.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028951616 |
Resistant |
| ENSG00000256757.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031560565 |
Resistant |
| ENSG00000257056.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.017205758 |
Resistant |
| ENSG00000257151.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035057804 |
Resistant |
| ENSG00000257467.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0488129 |
Resistant |
| ENSG00000257499.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.04531844 |
Resistant |
| ENSG00000258325.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010806763 |
Resistant |
| ENSG00000258422.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013365603 |
Resistant |
| ENSG00000258443.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041740029 |
Resistant |
| ENSG00000258520.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03520766 |
Resistant |
| ENSG00000258525.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011193279 |
Resistant |
| ENSG00000258592.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011125839 |
Resistant |
| ENSG00000258601.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011131221 |
Resistant |
| ENSG00000258612.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049724301 |
Resistant |
| ENSG00000258636.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029858376 |
Resistant |
| ENSG00000258661.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034841897 |
Resistant |
| ENSG00000258698.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026382876 |
Resistant |
| ENSG00000259055.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01660249 |
Resistant |
| ENSG00000259058.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043594696 |
Resistant |
| ENSG00000259069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045912644 |
Resistant |
| ENSG00000259129.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049265673 |
Resistant |
| ENSG00000259251.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.013980846 |
Resistant |
| ENSG00000259296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013827909 |
Resistant |
| ENSG00000259372.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018914589 |
Resistant |
| ENSG00000259376.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047879941 |
Resistant |
| ENSG00000259377.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033823016 |
Resistant |
| ENSG00000259422.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039790725 |
Resistant |
| ENSG00000259424.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032061289 |
Resistant |
| ENSG00000259443.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014462468 |
Resistant |
| ENSG00000259462.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007869717 |
Resistant |
| ENSG00000259485.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035238461 |
Resistant |
| ENSG00000259543.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034177581 |
Resistant |
| ENSG00000259553.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.041457068 |
Resistant |
| ENSG00000259561.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040196005 |
Resistant |
| ENSG00000259589.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.025908606 |
Resistant |
| ENSG00000259664.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043069787 |
Resistant |
| ENSG00000259678.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007853591 |
Resistant |
| ENSG00000259714.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039284122 |
Resistant |
| ENSG00000259793.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049121174 |
Resistant |
| ENSG00000259834.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019602354 |
Resistant |
| ENSG00000259840.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023741112 |
Resistant |
| ENSG00000260011.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.045118107 |
Resistant |
| ENSG00000260196.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033409521 |
Resistant |
| ENSG00000260198.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037175257 |
Resistant |
| ENSG00000260281.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033708415 |
Resistant |
| ENSG00000260293.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026092229 |
Resistant |
| ENSG00000260296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011981237 |
Resistant |
| ENSG00000260331.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039240516 |
Resistant |
| ENSG00000260418.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036790137 |
Resistant |
| ENSG00000260469.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020695042 |
Resistant |
| ENSG00000260492.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040973933 |
Resistant |
| ENSG00000260519.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045890472 |
Resistant |
| ENSG00000260555.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023950206 |
Resistant |
| ENSG00000260614.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012625391 |
Resistant |
| ENSG00000260626.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035552047 |
Resistant |
| ENSG00000260655.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024416666 |
Resistant |
| ENSG00000260660.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004053516 |
Resistant |
| ENSG00000260711.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018693772 |
Resistant |
| ENSG00000260831.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048918088 |
Resistant |
| ENSG00000260837.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044501292 |
Resistant |
| ENSG00000260918.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048521265 |
Resistant |
| ENSG00000260920.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032186184 |
Resistant |
| ENSG00000260926.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.049391215 |
Resistant |
| ENSG00000260947.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012885994 |
Resistant |
| ENSG00000260986.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030239609 |
Resistant |
| ENSG00000261024.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.027777111 |
Resistant |
| ENSG00000261044.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044589925 |
Resistant |
| ENSG00000261168.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019831072 |
Resistant |
| ENSG00000261191.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030305965 |
Resistant |
| ENSG00000261268.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034687221 |
Resistant |
| ENSG00000261350.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038281636 |
Resistant |
| ENSG00000261374.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04625494 |
Resistant |
| ENSG00000261384.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022809758 |
Resistant |
| ENSG00000261411.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036906593 |
Resistant |
| ENSG00000261420.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005810442 |
Resistant |
| ENSG00000261462.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023453338 |
Resistant |
| ENSG00000261496.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024322846 |
Resistant |
| ENSG00000261504.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001468263 |
Resistant |
| ENSG00000261523.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011569098 |
Resistant |
| ENSG00000261695.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008878588 |
Resistant |
| ENSG00000261798.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029604923 |
Resistant |
| ENSG00000261978.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045780567 |
Resistant |
| ENSG00000262119.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008827682 |
Resistant |
| ENSG00000262410.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00114818 |
Resistant |
| ENSG00000262482.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013616494 |
Resistant |
| ENSG00000262768.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027225926 |
Resistant |
| ENSG00000262772.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001045149 |
Resistant |
| ENSG00000263393.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007580486 |
Resistant |
| ENSG00000263427.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049362557 |
Resistant |
| ENSG00000263586.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024063701 |
Resistant |
| ENSG00000263720.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037725734 |
Resistant |
| ENSG00000263862.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037769535 |
Resistant |
| ENSG00000264167.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045609939 |
Resistant |
| ENSG00000264647.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027527058 |
Resistant |
| ENSG00000264659.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041431394 |
Resistant |
| ENSG00000265043.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007149159 |
Resistant |
| ENSG00000265094.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001816649 |
Resistant |
| ENSG00000265130.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019467543 |
Resistant |
| ENSG00000265490.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021854762 |
Resistant |
| ENSG00000265962.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016490214 |
Resistant |
| ENSG00000266290.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004543462 |
Resistant |
| ENSG00000266446.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010761057 |
Resistant |
| ENSG00000266560.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030874086 |
Resistant |
| ENSG00000266677.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022009422 |
Resistant |
| ENSG00000266911.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00547348 |
Resistant |
| ENSG00000267064.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015066398 |
Resistant |
| ENSG00000267095.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024697257 |
Resistant |
| ENSG00000267167.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005765516 |
Resistant |
| ENSG00000267211.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023440015 |
Resistant |
| ENSG00000267251.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044143591 |
Resistant |
| ENSG00000267388.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022768326 |
Resistant |
| ENSG00000267414.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037943351 |
Resistant |
| ENSG00000267642.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047655328 |
Resistant |
| ENSG00000267649.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011454084 |
Resistant |
| ENSG00000267651.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024465498 |
Resistant |
| ENSG00000267778.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039388596 |
Resistant |
| ENSG00000267786.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032253218 |
Resistant |
| ENSG00000267868.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018280862 |
Resistant |
| ENSG00000267874.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012008669 |
Resistant |
| ENSG00000268204.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030512567 |
Resistant |
| ENSG00000268231.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035508333 |
Resistant |
| ENSG00000268262.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033261055 |
Resistant |
| ENSG00000268307.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016762306 |
Resistant |
| ENSG00000268499.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016959464 |
Resistant |
| ENSG00000269356.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025834861 |
Resistant |
| ENSG00000269425.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045565987 |
Resistant |
| ENSG00000269489.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04152131 |
Resistant |
| ENSG00000269621.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015507883 |
Resistant |
| ENSG00000269694.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008402682 |
Resistant |
| ENSG00000269752.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017491727 |
Resistant |
| ENSG00000269792.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040983116 |
Resistant |
| ENSG00000269908.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024294419 |
Resistant |
| ENSG00000269918.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021056406 |
Resistant |
| ENSG00000269970.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04515539 |
Resistant |
| ENSG00000269978.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026716408 |
Resistant |
| ENSG00000270035.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024020767 |
Resistant |
| ENSG00000270112.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.023153367 |
Resistant |
| ENSG00000270154.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01622943 |
Resistant |
| ENSG00000270171.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035463012 |
Resistant |
| ENSG00000270189.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009712868 |
Resistant |
| ENSG00000270523.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040681397 |
Resistant |
| ENSG00000270557.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008172712 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010757916 |
Resistant |
| ENSG00000270720.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012846306 |
Resistant |
| ENSG00000270988.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029750263 |
Resistant |
| ENSG00000270996.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023400616 |
Resistant |
| ENSG00000271265.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008154424 |
Resistant |
| ENSG00000271398.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015287025 |
Resistant |
| ENSG00000271732.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025713407 |
Resistant |
| ENSG00000271738.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012967824 |
Resistant |
| ENSG00000271757.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013768714 |
Resistant |
| ENSG00000271830.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016619446 |
Resistant |
| ENSG00000271833.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016077224 |
Resistant |
| ENSG00000271916.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011628123 |
Resistant |
| ENSG00000271938.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029786297 |
Resistant |
| ENSG00000272005.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01408059 |
Resistant |
| ENSG00000272216.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03013428 |
Resistant |
| ENSG00000272273.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029361583 |
Resistant |
| ENSG00000272301.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009307746 |
Resistant |
| ENSG00000272372.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020356589 |
Resistant |
| ENSG00000272416.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032625363 |
Resistant |
| ENSG00000272438.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034841791 |
Resistant |
| ENSG00000272468.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024915908 |
Resistant |
| ENSG00000272512.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02685252 |
Resistant |
| ENSG00000272619.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036705074 |
Resistant |
| ENSG00000272677.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015734599 |
Resistant |
| ENSG00000272682.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026752007 |
Resistant |
| ENSG00000272699.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011985839 |
Resistant |
| ENSG00000272717.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008930376 |
Resistant |
| ENSG00000272732.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035638755 |
Resistant |
| ENSG00000272780.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039252085 |
Resistant |
| ENSG00000272788.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041246919 |
Resistant |
| ENSG00000272798.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00663939 |
Resistant |
| ENSG00000272839.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039610888 |
Resistant |
| ENSG00000272849.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039305186 |
Resistant |
| ENSG00000272872.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036790587 |
Resistant |
| ENSG00000272915.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030137733 |
Resistant |
| ENSG00000272931.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0189339 |
Resistant |
| ENSG00000272940.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01317363 |
Resistant |
| ENSG00000272942.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010031434 |
Resistant |
| ENSG00000272966.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007222649 |
Resistant |
| ENSG00000272971.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005703944 |
Resistant |
| ENSG00000272989.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037576509 |
Resistant |
| ENSG00000272993.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012947077 |
Resistant |
| ENSG00000273056.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017093621 |
Resistant |
| ENSG00000273081.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013530128 |
Resistant |
| ENSG00000273176.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03251948 |
Resistant |
| ENSG00000273203.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012881368 |
Resistant |
| ENSG00000273325.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01689169 |
Resistant |
| ENSG00000273442.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035551257 |
Resistant |
| ENSG00000273487.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044235426 |
Resistant |
| ENSG00000273492.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047444312 |
Resistant |
| ENSG00000204802.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037364903 |
Resistant |
| ENSG00000214770.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043493279 |
Resistant |
| ENSG00000225725.4 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011606846 |
Resistant |
| ENSG00000226007.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014193958 |
Resistant |
| ENSG00000226009.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00036596 |
Resistant |
| ENSG00000228192.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04158562 |
Resistant |
| ENSG00000228436.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022723059 |
Resistant |
| ENSG00000229267.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013765943 |
Resistant |
| ENSG00000234141.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039534701 |
Resistant |
| ENSG00000236345.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003899661 |
Resistant |
| ENSG00000238062.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006958548 |
Resistant |
| ENSG00000239653.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035044281 |
Resistant |
| ENSG00000241732.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024826779 |
Resistant |
| ENSG00000244332.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013795456 |
Resistant |
| ENSG00000244459.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005559089 |
Resistant |
| ENSG00000246898.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002741704 |
Resistant |
| ENSG00000249476.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038243872 |
Resistant |
| ENSG00000249509.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005485662 |
Resistant |
| ENSG00000253476.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012645688 |
Resistant |
| ENSG00000257027.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000347394 |
Resistant |
| ENSG00000258017.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034197901 |
Resistant |
| ENSG00000259212.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02307194 |
Resistant |
| ENSG00000263753.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027730047 |
Resistant |
| ENSG00000263847.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025415752 |
Resistant |
| ENSG00000264575.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010330078 |
Resistant |
| ENSG00000265091.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018682341 |
Resistant |
| ENSG00000265242.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000848534 |
Resistant |
| ENSG00000268751.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041640354 |
Resistant |
| ENSG00000270074.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004393819 |
Resistant |
| ENSG00000270109.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02641892 |
Resistant |
| ENSG00000270246.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008046881 |
Resistant |
| ENSG00000270344.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00975353 |
Resistant |
| ENSG00000272334.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044104364 |
Resistant |
| ENSG00000184274.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.034815287 |
Resistant |
| ENSG00000185837.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.01028962 |
Resistant |
| ENSG00000185904.7 |
Ponatinib |
Pancreatic adenocarcinoma |
0.043214347 |
Resistant |
| ENSG00000203321.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.016214706 |
Resistant |
| ENSG00000203496.4 |
Ponatinib |
Pancreatic adenocarcinoma |
0.032573191 |
Resistant |
| ENSG00000214773.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.023262513 |
Resistant |
| ENSG00000214837.4 |
Ponatinib |
Pancreatic adenocarcinoma |
0.04953857 |
Resistant |
| ENSG00000223842.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.013768548 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.011344262 |
Resistant |
| ENSG00000227627.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045500172 |
Resistant |
| ENSG00000228487.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.000525082 |
Resistant |
| ENSG00000228561.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.023251947 |
Resistant |
| ENSG00000228661.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.002355264 |
Resistant |
| ENSG00000229368.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03053168 |
Resistant |
| ENSG00000229582.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.001384301 |
Resistant |
| ENSG00000231512.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.035987264 |
Resistant |
| ENSG00000232063.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.024609254 |
Resistant |
| ENSG00000233483.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.007462433 |
Resistant |
| ENSG00000235326.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039052387 |
Resistant |
| ENSG00000236498.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029316784 |
Resistant |
| ENSG00000237328.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042057268 |
Resistant |
| ENSG00000237489.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.02937692 |
Resistant |
| ENSG00000238009.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.01044193 |
Resistant |
| ENSG00000238160.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.008167077 |
Resistant |
| ENSG00000239945.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.017678213 |
Resistant |
| ENSG00000240710.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.047582866 |
Resistant |
| ENSG00000248254.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03263422 |
Resistant |
| ENSG00000248671.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.000246011 |
Resistant |
| ENSG00000249412.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.01411406 |
Resistant |
| ENSG00000249655.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.031295125 |
Resistant |
| ENSG00000249738.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.025708707 |
Resistant |
| ENSG00000249846.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033258982 |
Resistant |
| ENSG00000249996.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033666496 |
Resistant |
| ENSG00000250159.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03056099 |
Resistant |
| ENSG00000253513.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.001189991 |
Resistant |
| ENSG00000253636.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.004487347 |
Resistant |
| ENSG00000253986.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.038238954 |
Resistant |
| ENSG00000255135.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039079051 |
Resistant |
| ENSG00000255495.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.030287204 |
Resistant |
| ENSG00000259172.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.000864685 |
Resistant |
| ENSG00000259274.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.002933864 |
Resistant |
| ENSG00000260281.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.020436042 |
Resistant |
| ENSG00000260288.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.020341344 |
Resistant |
| ENSG00000260351.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.012232395 |
Resistant |
| ENSG00000261476.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.038894701 |
Resistant |
| ENSG00000262172.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042199159 |
Resistant |
| ENSG00000263300.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.027045165 |
Resistant |
| ENSG00000263567.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.021261266 |
Resistant |
| ENSG00000265443.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.01580157 |
Resistant |
| ENSG00000266541.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.006070964 |
Resistant |
| ENSG00000267374.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.048749236 |
Resistant |
| ENSG00000268375.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045571558 |
Resistant |
| ENSG00000268683.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.009873577 |
Resistant |
| ENSG00000269425.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.040502428 |
Resistant |
| ENSG00000272870.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.022388135 |
Resistant |
| ENSG00000272911.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045504067 |
Resistant |
| ENSG00000273248.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.003759975 |
Resistant |
| ENSG00000174171.4 |
Ponatinib |
Sarcoma |
0.010359979 |
Resistant |
| ENSG00000187229.3 |
Ponatinib |
Sarcoma |
0.016822471 |
Resistant |
| ENSG00000203356.2 |
Ponatinib |
Sarcoma |
0.027557849 |
Resistant |
| ENSG00000214783.5 |
Ponatinib |
Sarcoma |
0.027100999 |
Resistant |
| ENSG00000215190.4 |
Ponatinib |
Sarcoma |
0.044218187 |
Resistant |
| ENSG00000225075.1 |
Ponatinib |
Sarcoma |
0.013105988 |
Resistant |
| ENSG00000225793.2 |
Ponatinib |
Sarcoma |
0.032936178 |
Resistant |
| ENSG00000226876.2 |
Ponatinib |
Sarcoma |
0.029707353 |
Resistant |
| ENSG00000227110.2 |
Ponatinib |
Sarcoma |
0.017657526 |
Resistant |
| ENSG00000227200.1 |
Ponatinib |
Sarcoma |
0.049420941 |
Resistant |
| ENSG00000228775.3 |
Ponatinib |
Sarcoma |
0.03537575 |
Resistant |
| ENSG00000229118.1 |
Ponatinib |
Sarcoma |
0.026231985 |
Resistant |
| ENSG00000229388.1 |
Ponatinib |
Sarcoma |
0.021803012 |
Resistant |
| ENSG00000229563.2 |
Ponatinib |
Sarcoma |
0.021265907 |
Resistant |
| ENSG00000230751.1 |
Ponatinib |
Sarcoma |
0.007661811 |
Resistant |
| ENSG00000231365.1 |
Ponatinib |
Sarcoma |
0.043560538 |
Resistant |
| ENSG00000232453.1 |
Ponatinib |
Sarcoma |
0.020450679 |
Resistant |
| ENSG00000235319.1 |
Ponatinib |
Sarcoma |
0.034219667 |
Resistant |
| ENSG00000235609.4 |
Ponatinib |
Sarcoma |
0.037779959 |
Resistant |
| ENSG00000237380.2 |
Ponatinib |
Sarcoma |
0.041177128 |
Resistant |
| ENSG00000237753.1 |
Ponatinib |
Sarcoma |
0.01908016 |
Resistant |
| ENSG00000240990.5 |
Ponatinib |
Sarcoma |
0.047852568 |
Resistant |
| ENSG00000242687.2 |
Ponatinib |
Sarcoma |
0.018801589 |
Resistant |
| ENSG00000244968.2 |
Ponatinib |
Sarcoma |
0.029973958 |
Resistant |
| ENSG00000247934.3 |
Ponatinib |
Sarcoma |
0.032946644 |
Resistant |
| ENSG00000248476.1 |
Ponatinib |
Sarcoma |
0.016619675 |
Resistant |
| ENSG00000254418.1 |
Ponatinib |
Sarcoma |
0.026552725 |
Resistant |
| ENSG00000254812.1 |
Ponatinib |
Sarcoma |
0.021492471 |
Resistant |
| ENSG00000255094.1 |
Ponatinib |
Sarcoma |
0.010787644 |
Resistant |
| ENSG00000256381.1 |
Ponatinib |
Sarcoma |
0.032128283 |
Resistant |
| ENSG00000260949.1 |
Ponatinib |
Sarcoma |
0.028132075 |
Resistant |
| ENSG00000261428.1 |
Ponatinib |
Sarcoma |
0.039365934 |
Resistant |
| ENSG00000261578.1 |
Ponatinib |
Sarcoma |
0.041851985 |
Resistant |
| ENSG00000262172.1 |
Ponatinib |
Sarcoma |
0.048732479 |
Resistant |
| ENSG00000262888.1 |
Ponatinib |
Sarcoma |
0.044926417 |
Resistant |
| ENSG00000262905.1 |
Ponatinib |
Sarcoma |
0.010579047 |
Resistant |
| ENSG00000266993.1 |
Ponatinib |
Sarcoma |
0.048938345 |
Resistant |
| ENSG00000267010.1 |
Ponatinib |
Sarcoma |
0.042833877 |
Resistant |
| ENSG00000267053.2 |
Ponatinib |
Sarcoma |
0.044124912 |
Resistant |
| ENSG00000267274.1 |
Ponatinib |
Sarcoma |
0.035549754 |
Resistant |
| ENSG00000267397.1 |
Ponatinib |
Sarcoma |
0.008781136 |
Resistant |
| ENSG00000268364.1 |
Ponatinib |
Sarcoma |
0.003302228 |
Resistant |
| ENSG00000268392.1 |
Ponatinib |
Sarcoma |
0.007527904 |
Resistant |
| ENSG00000268970.1 |
Ponatinib |
Sarcoma |
0.012585652 |
Resistant |
| ENSG00000269082.1 |
Ponatinib |
Sarcoma |
0.014016766 |
Resistant |
| ENSG00000270108.1 |
Ponatinib |
Sarcoma |
0.035273131 |
Resistant |
| ENSG00000270178.1 |
Ponatinib |
Sarcoma |
0.029169792 |
Resistant |
| ENSG00000272029.1 |
Ponatinib |
Sarcoma |
0.034905726 |
Resistant |
| ENSG00000272604.1 |
Ponatinib |
Sarcoma |
0.042571294 |
Resistant |
| ENSG00000272732.1 |
Ponatinib |
Sarcoma |
0.041132549 |
Resistant |
| ENSG00000272989.1 |
Ponatinib |
Sarcoma |
0.033487159 |
Resistant |
| ENSG00000273142.1 |
Ponatinib |
Sarcoma |
0.044417257 |
Resistant |
| ENSG00000175147.7 |
Ponatinib |
Skin cutaneous melanoma |
0.043519019 |
Resistant |
| ENSG00000203356.2 |
Ponatinib |
Skin cutaneous melanoma |
0.036952616 |
Resistant |
| ENSG00000203496.4 |
Ponatinib |
Skin cutaneous melanoma |
0.020872747 |
Resistant |
| ENSG00000204588.5 |
Ponatinib |
Skin cutaneous melanoma |
0.047764307 |
Resistant |
| ENSG00000224621.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040910089 |
Resistant |
| ENSG00000224888.3 |
Ponatinib |
Skin cutaneous melanoma |
0.039642557 |
Resistant |
| ENSG00000225039.1 |
Ponatinib |
Skin cutaneous melanoma |
0.009313759 |
Resistant |
| ENSG00000226245.1 |
Ponatinib |
Skin cutaneous melanoma |
0.030034014 |
Resistant |
| ENSG00000226367.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00490314 |
Resistant |
| ENSG00000227372.6 |
Ponatinib |
Skin cutaneous melanoma |
0.00000726 |
Resistant |
| ENSG00000231459.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048669332 |
Resistant |
| ENSG00000231856.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001257997 |
Resistant |
| ENSG00000232065.1 |
Ponatinib |
Skin cutaneous melanoma |
0.019939781 |
Resistant |
| ENSG00000232611.1 |
Ponatinib |
Skin cutaneous melanoma |
0.024831841 |
Resistant |
| ENSG00000232640.1 |
Ponatinib |
Skin cutaneous melanoma |
0.01799941 |
Resistant |
| ENSG00000233806.3 |
Ponatinib |
Skin cutaneous melanoma |
0.04259122 |
Resistant |
| ENSG00000234230.1 |
Ponatinib |
Skin cutaneous melanoma |
0.031153355 |
Resistant |
| ENSG00000237253.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020475735 |
Resistant |
| ENSG00000237436.1 |
Ponatinib |
Skin cutaneous melanoma |
0.033793959 |
Resistant |
| ENSG00000238280.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039654414 |
Resistant |
| ENSG00000242357.1 |
Ponatinib |
Skin cutaneous melanoma |
0.032820925 |
Resistant |
| ENSG00000242767.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049208031 |
Resistant |
| ENSG00000243766.3 |
Ponatinib |
Skin cutaneous melanoma |
0.027614053 |
Resistant |
| ENSG00000245694.4 |
Ponatinib |
Skin cutaneous melanoma |
0.031593598 |
Resistant |
| ENSG00000248150.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036172144 |
Resistant |
| ENSG00000249532.2 |
Ponatinib |
Skin cutaneous melanoma |
0.030348384 |
Resistant |
| ENSG00000250786.1 |
Ponatinib |
Skin cutaneous melanoma |
0.024092836 |
Resistant |
| ENSG00000251867.2 |
Ponatinib |
Skin cutaneous melanoma |
0.02570606 |
Resistant |
| ENSG00000253197.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020965751 |
Resistant |
| ENSG00000253317.1 |
Ponatinib |
Skin cutaneous melanoma |
0.025260519 |
Resistant |
| ENSG00000253687.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035342432 |
Resistant |
| ENSG00000255100.1 |
Ponatinib |
Skin cutaneous melanoma |
0.032912892 |
Resistant |
| ENSG00000255165.1 |
Ponatinib |
Skin cutaneous melanoma |
0.002332084 |
Resistant |
| ENSG00000257507.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041306589 |
Resistant |
| ENSG00000258260.1 |
Ponatinib |
Skin cutaneous melanoma |
0.032803723 |
Resistant |
| ENSG00000258825.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048548404 |
Resistant |
| ENSG00000259364.1 |
Ponatinib |
Skin cutaneous melanoma |
0.011167244 |
Resistant |
| ENSG00000259474.1 |
Ponatinib |
Skin cutaneous melanoma |
0.046553328 |
Resistant |
| ENSG00000259768.3 |
Ponatinib |
Skin cutaneous melanoma |
0.020985573 |
Resistant |
| ENSG00000260206.1 |
Ponatinib |
Skin cutaneous melanoma |
0.04587451 |
Resistant |
| ENSG00000260693.1 |
Ponatinib |
Skin cutaneous melanoma |
0.043252287 |
Resistant |
| ENSG00000260891.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039754351 |
Resistant |
| ENSG00000260907.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040793785 |
Resistant |
| ENSG00000261186.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037778838 |
Resistant |
| ENSG00000261211.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038680586 |
Resistant |
| ENSG00000262686.1 |
Ponatinib |
Skin cutaneous melanoma |
0.005856092 |
Resistant |
| ENSG00000267150.1 |
Ponatinib |
Skin cutaneous melanoma |
0.014561864 |
Resistant |
| ENSG00000267194.1 |
Ponatinib |
Skin cutaneous melanoma |
0.033184467 |
Resistant |
| ENSG00000267280.1 |
Ponatinib |
Skin cutaneous melanoma |
0.019719601 |
Resistant |
| ENSG00000267344.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040801855 |
Resistant |
| ENSG00000267546.2 |
Ponatinib |
Skin cutaneous melanoma |
0.037079665 |
Resistant |
| ENSG00000267582.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023970105 |
Resistant |
| ENSG00000267934.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044294496 |
Resistant |
| ENSG00000270055.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02080565 |
Resistant |
| ENSG00000271032.1 |
Ponatinib |
Skin cutaneous melanoma |
0.013724838 |
Resistant |
| ENSG00000271551.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049692692 |
Resistant |
| ENSG00000271840.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008013761 |
Resistant |
| ENSG00000272097.1 |
Ponatinib |
Skin cutaneous melanoma |
0.026861239 |
Resistant |
| ENSG00000272386.1 |
Ponatinib |
Skin cutaneous melanoma |
0.031634886 |
Resistant |
| ENSG00000272489.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017127912 |
Resistant |
| ENSG00000272858.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036963603 |
Resistant |
| ENSG00000273156.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023780891 |
Resistant |
| ENSG00000273160.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036724417 |
Resistant |
| ENSG00000273308.1 |
Ponatinib |
Skin cutaneous melanoma |
0.046820276 |
Resistant |
| ENSG00000273406.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0415944 |
Resistant |
| ENSG00000204588.5 |
Ponatinib |
Stomach adenocarcinoma |
0.003276604 |
Resistant |
| ENSG00000230300.1 |
Ponatinib |
Stomach adenocarcinoma |
0.028797208 |
Resistant |
| ENSG00000236426.3 |
Ponatinib |
Stomach adenocarcinoma |
0.025405914 |
Resistant |
| ENSG00000247774.2 |
Ponatinib |
Stomach adenocarcinoma |
0.030284781 |
Resistant |
| ENSG00000250920.1 |
Ponatinib |
Stomach adenocarcinoma |
0.018561969 |
Resistant |
| ENSG00000251577.1 |
Ponatinib |
Stomach adenocarcinoma |
0.016361631 |
Resistant |
| ENSG00000264868.1 |
Ponatinib |
Stomach adenocarcinoma |
0.046856165 |
Resistant |
| ENSG00000265992.1 |
Ponatinib |
Stomach adenocarcinoma |
0.016076338 |
Resistant |
| ENSG00000272627.1 |
Ponatinib |
Stomach adenocarcinoma |
0.046959064 |
Resistant |
| ENSG00000203650.3 |
Ponatinib |
Thyroid carcinoma |
0.031152122 |
Resistant |
| ENSG00000204011.4 |
Ponatinib |
Thyroid carcinoma |
0.016429414 |
Resistant |
| ENSG00000223969.1 |
Ponatinib |
Thyroid carcinoma |
0.049788814 |
Resistant |
| ENSG00000226869.2 |
Ponatinib |
Thyroid carcinoma |
0.023714731 |
Resistant |
| ENSG00000227036.2 |
Ponatinib |
Thyroid carcinoma |
0.00421439 |
Resistant |
| ENSG00000228340.1 |
Ponatinib |
Thyroid carcinoma |
0.022015679 |
Resistant |
| ENSG00000231073.1 |
Ponatinib |
Thyroid carcinoma |
0.00646535 |
Resistant |
| ENSG00000231419.2 |
Ponatinib |
Thyroid carcinoma |
0.045856919 |
Resistant |
| ENSG00000232259.1 |
Ponatinib |
Thyroid carcinoma |
0.034595761 |
Resistant |
| ENSG00000233069.1 |
Ponatinib |
Thyroid carcinoma |
0.012613415 |
Resistant |
| ENSG00000237380.2 |
Ponatinib |
Thyroid carcinoma |
0.035627261 |
Resistant |
| ENSG00000237773.1 |
Ponatinib |
Thyroid carcinoma |
0.032136974 |
Resistant |
| ENSG00000240449.1 |
Ponatinib |
Thyroid carcinoma |
0.046780118 |
Resistant |
| ENSG00000248698.1 |
Ponatinib |
Thyroid carcinoma |
0.029326594 |
Resistant |
| ENSG00000250303.2 |
Ponatinib |
Thyroid carcinoma |
0.044435748 |
Resistant |
| ENSG00000251026.1 |
Ponatinib |
Thyroid carcinoma |
0.042381275 |
Resistant |
| ENSG00000251031.1 |
Ponatinib |
Thyroid carcinoma |
0.017664045 |
Resistant |
| ENSG00000253661.1 |
Ponatinib |
Thyroid carcinoma |
0.022100654 |
Resistant |
| ENSG00000254802.1 |
Ponatinib |
Thyroid carcinoma |
0.024789361 |
Resistant |
| ENSG00000257894.1 |
Ponatinib |
Thyroid carcinoma |
0.026321804 |
Resistant |
| ENSG00000258413.1 |
Ponatinib |
Thyroid carcinoma |
0.037442535 |
Resistant |
| ENSG00000259129.1 |
Ponatinib |
Thyroid carcinoma |
0.049478127 |
Resistant |
| ENSG00000260871.1 |
Ponatinib |
Thyroid carcinoma |
0.03066212 |
Resistant |
| ENSG00000268518.1 |
Ponatinib |
Thyroid carcinoma |
0.023152928 |
Resistant |
| ENSG00000269397.1 |
Ponatinib |
Thyroid carcinoma |
0.003863522 |
Resistant |
| ENSG00000270000.1 |
Ponatinib |
Thyroid carcinoma |
0.017717759 |
Resistant |
| ENSG00000270210.1 |
Ponatinib |
Thyroid carcinoma |
0.014074682 |
Resistant |
| ENSG00000272327.1 |
Ponatinib |
Thyroid carcinoma |
0.024414658 |
Resistant |
| ENSG00000273344.1 |
Ponatinib |
Thyroid carcinoma |
0.01865005 |
Resistant |
| ENSG00000184274.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.048929141 |
Sensitive |
| ENSG00000203280.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.024104004 |
Sensitive |
| ENSG00000224023.6 |
Ponatinib |
Bladder urothelial carcinoma |
0.037617539 |
Sensitive |
| ENSG00000224034.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.031794303 |
Sensitive |
| ENSG00000224969.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.023735077 |
Sensitive |
| ENSG00000225725.4 |
Ponatinib |
Bladder urothelial carcinoma |
0.028667086 |
Sensitive |
| ENSG00000225963.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.043598975 |
Sensitive |
| ENSG00000226310.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.009271327 |
Sensitive |
| ENSG00000228021.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.010107001 |
Sensitive |
| ENSG00000228293.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.003513075 |
Sensitive |
| ENSG00000228791.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.001367618 |
Sensitive |
| ENSG00000229512.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.019838449 |
Sensitive |
| ENSG00000229848.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039726367 |
Sensitive |
| ENSG00000230470.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.016143576 |
Sensitive |
| ENSG00000231064.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.019112944 |
Sensitive |
| ENSG00000231794.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.033285208 |
Sensitive |
| ENSG00000231830.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.009932603 |
Sensitive |
| ENSG00000232973.7 |
Ponatinib |
Bladder urothelial carcinoma |
0.033257062 |
Sensitive |
| ENSG00000233255.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007847607 |
Sensitive |
| ENSG00000233725.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.011057089 |
Sensitive |
| ENSG00000234936.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.034756744 |
Sensitive |
| ENSG00000237643.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.021525827 |
Sensitive |
| ENSG00000237773.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.003333124 |
Sensitive |
| ENSG00000238260.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.049401809 |
Sensitive |
| ENSG00000239828.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.044740538 |
Sensitive |
| ENSG00000247199.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.022829022 |
Sensitive |
| ENSG00000248858.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.019929151 |
Sensitive |
| ENSG00000249234.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007203203 |
Sensitive |
| ENSG00000250786.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.024723308 |
Sensitive |
| ENSG00000253552.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.010587525 |
Sensitive |
| ENSG00000254109.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.036710834 |
Sensitive |
| ENSG00000254664.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.033182911 |
Sensitive |
| ENSG00000255343.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.005787931 |
Sensitive |
| ENSG00000255970.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.03939628 |
Sensitive |
| ENSG00000259275.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.016084698 |
Sensitive |
| ENSG00000261087.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.010276592 |
Sensitive |
| ENSG00000264745.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.008282449 |
Sensitive |
| ENSG00000266717.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.036903239 |
Sensitive |
| ENSG00000266805.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.004337729 |
Sensitive |
| ENSG00000266895.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.04385242 |
Sensitive |
| ENSG00000271192.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.029319206 |
Sensitive |
| ENSG00000272079.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.023859156 |
Sensitive |
| ENSG00000272264.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.017233677 |
Sensitive |
| ENSG00000272554.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.033960412 |
Sensitive |
| ENSG00000272769.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.006319261 |
Sensitive |
| ENSG00000272861.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007146253 |
Sensitive |
| ENSG00000273011.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.033810499 |
Sensitive |
| ENSG00000273240.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.026760896 |
Sensitive |
| ENSG00000273308.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.036806544 |
Sensitive |
| ENSG00000273355.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.002868934 |
Sensitive |
| ENSG00000163597.10 |
Ponatinib |
Breast invasive carcinoma |
0.040245807 |
Sensitive |
| ENSG00000175061.13 |
Ponatinib |
Breast invasive carcinoma |
0.040214303 |
Sensitive |
| ENSG00000182165.13 |
Ponatinib |
Breast invasive carcinoma |
0.048384146 |
Sensitive |
| ENSG00000186594.8 |
Ponatinib |
Breast invasive carcinoma |
0.023867658 |
Sensitive |
| ENSG00000203808.6 |
Ponatinib |
Breast invasive carcinoma |
0.029768499 |
Sensitive |
| ENSG00000205662.2 |
Ponatinib |
Breast invasive carcinoma |
0.02191578 |
Sensitive |
| ENSG00000213963.2 |
Ponatinib |
Breast invasive carcinoma |
0.029532331 |
Sensitive |
| ENSG00000214719.7 |
Ponatinib |
Breast invasive carcinoma |
0.010999306 |
Sensitive |
| ENSG00000215808.2 |
Ponatinib |
Breast invasive carcinoma |
0.008629833 |
Sensitive |
| ENSG00000223725.2 |
Ponatinib |
Breast invasive carcinoma |
0.041568246 |
Sensitive |
| ENSG00000223960.2 |
Ponatinib |
Breast invasive carcinoma |
0.027939005 |
Sensitive |
| ENSG00000224292.1 |
Ponatinib |
Breast invasive carcinoma |
0.037410366 |
Sensitive |
| ENSG00000225439.2 |
Ponatinib |
Breast invasive carcinoma |
0.030130551 |
Sensitive |
| ENSG00000225761.1 |
Ponatinib |
Breast invasive carcinoma |
0.009034029 |
Sensitive |
| ENSG00000227036.2 |
Ponatinib |
Breast invasive carcinoma |
0.007124879 |
Sensitive |
| ENSG00000227279.1 |
Ponatinib |
Breast invasive carcinoma |
0.027969312 |
Sensitive |
| ENSG00000227733.4 |
Ponatinib |
Breast invasive carcinoma |
0.049811341 |
Sensitive |
| ENSG00000227920.2 |
Ponatinib |
Breast invasive carcinoma |
0.04331924 |
Sensitive |
| ENSG00000228549.2 |
Ponatinib |
Breast invasive carcinoma |
0.033481118 |
Sensitive |
| ENSG00000228933.3 |
Ponatinib |
Breast invasive carcinoma |
0.008841468 |
Sensitive |
| ENSG00000229647.1 |
Ponatinib |
Breast invasive carcinoma |
0.038484187 |
Sensitive |
| ENSG00000229951.1 |
Ponatinib |
Breast invasive carcinoma |
0.014051646 |
Sensitive |
| ENSG00000230061.1 |
Ponatinib |
Breast invasive carcinoma |
0.010331461 |
Sensitive |
| ENSG00000230499.1 |
Ponatinib |
Breast invasive carcinoma |
0.019493876 |
Sensitive |
| ENSG00000230648.1 |
Ponatinib |
Breast invasive carcinoma |
0.041315034 |
Sensitive |
| ENSG00000231721.2 |
Ponatinib |
Breast invasive carcinoma |
0.010964559 |
Sensitive |
| ENSG00000232028.1 |
Ponatinib |
Breast invasive carcinoma |
0.039453664 |
Sensitive |
| ENSG00000232453.1 |
Ponatinib |
Breast invasive carcinoma |
0.028120569 |
Sensitive |
| ENSG00000232527.3 |
Ponatinib |
Breast invasive carcinoma |
0.004795948 |
Sensitive |
| ENSG00000233509.2 |
Ponatinib |
Breast invasive carcinoma |
0.045099098 |
Sensitive |
| ENSG00000233559.1 |
Ponatinib |
Breast invasive carcinoma |
0.015231331 |
Sensitive |
| ENSG00000233922.1 |
Ponatinib |
Breast invasive carcinoma |
0.019109903 |
Sensitive |
| ENSG00000234292.3 |
Ponatinib |
Breast invasive carcinoma |
0.006754376 |
Sensitive |
| ENSG00000234449.2 |
Ponatinib |
Breast invasive carcinoma |
0.029114646 |
Sensitive |
| ENSG00000234695.1 |
Ponatinib |
Breast invasive carcinoma |
0.046189604 |
Sensitive |
| ENSG00000234883.2 |
Ponatinib |
Breast invasive carcinoma |
0.01013913 |
Sensitive |
| ENSG00000238279.1 |
Ponatinib |
Breast invasive carcinoma |
0.022528092 |
Sensitive |
| ENSG00000238287.1 |
Ponatinib |
Breast invasive carcinoma |
0.014978455 |
Sensitive |
| ENSG00000239445.1 |
Ponatinib |
Breast invasive carcinoma |
0.01651487 |
Sensitive |
| ENSG00000242104.3 |
Ponatinib |
Breast invasive carcinoma |
0.021962087 |
Sensitive |
| ENSG00000243637.1 |
Ponatinib |
Breast invasive carcinoma |
0.008482589 |
Sensitive |
| ENSG00000244586.1 |
Ponatinib |
Breast invasive carcinoma |
0.046068616 |
Sensitive |
| ENSG00000247081.3 |
Ponatinib |
Breast invasive carcinoma |
0.046157309 |
Sensitive |
| ENSG00000248690.2 |
Ponatinib |
Breast invasive carcinoma |
0.029660188 |
Sensitive |
| ENSG00000248890.1 |
Ponatinib |
Breast invasive carcinoma |
0.022675653 |
Sensitive |
| ENSG00000249207.1 |
Ponatinib |
Breast invasive carcinoma |
0.011299243 |
Sensitive |
| ENSG00000249894.1 |
Ponatinib |
Breast invasive carcinoma |
0.021066288 |
Sensitive |
| ENSG00000250282.1 |
Ponatinib |
Breast invasive carcinoma |
0.049735594 |
Sensitive |
| ENSG00000250303.2 |
Ponatinib |
Breast invasive carcinoma |
0.04318322 |
Sensitive |
| ENSG00000251138.2 |
Ponatinib |
Breast invasive carcinoma |
0.046044659 |
Sensitive |
| ENSG00000251314.2 |
Ponatinib |
Breast invasive carcinoma |
0.012779966 |
Sensitive |
| ENSG00000253893.2 |
Ponatinib |
Breast invasive carcinoma |
0.033780908 |
Sensitive |
| ENSG00000254710.1 |
Ponatinib |
Breast invasive carcinoma |
0.023533141 |
Sensitive |
| ENSG00000255495.1 |
Ponatinib |
Breast invasive carcinoma |
0.034608885 |
Sensitive |
| ENSG00000255983.1 |
Ponatinib |
Breast invasive carcinoma |
0.032810495 |
Sensitive |
| ENSG00000256417.1 |
Ponatinib |
Breast invasive carcinoma |
0.042153627 |
Sensitive |
| ENSG00000256690.1 |
Ponatinib |
Breast invasive carcinoma |
0.044053345 |
Sensitive |
| ENSG00000257497.1 |
Ponatinib |
Breast invasive carcinoma |
0.024008933 |
Sensitive |
| ENSG00000257556.1 |
Ponatinib |
Breast invasive carcinoma |
0.042989995 |
Sensitive |
| ENSG00000257702.3 |
Ponatinib |
Breast invasive carcinoma |
0.048224557 |
Sensitive |
| ENSG00000258355.1 |
Ponatinib |
Breast invasive carcinoma |
0.037307783 |
Sensitive |
| ENSG00000258857.1 |
Ponatinib |
Breast invasive carcinoma |
0.043366716 |
Sensitive |
| ENSG00000259275.1 |
Ponatinib |
Breast invasive carcinoma |
0.011171158 |
Sensitive |
| ENSG00000259424.1 |
Ponatinib |
Breast invasive carcinoma |
0.044872656 |
Sensitive |
| ENSG00000259583.1 |
Ponatinib |
Breast invasive carcinoma |
0.0000139 |
Sensitive |
| ENSG00000259694.1 |
Ponatinib |
Breast invasive carcinoma |
0.036205496 |
Sensitive |
| ENSG00000259744.1 |
Ponatinib |
Breast invasive carcinoma |
0.049798379 |
Sensitive |
| ENSG00000260475.1 |
Ponatinib |
Breast invasive carcinoma |
0.028031007 |
Sensitive |
| ENSG00000261252.1 |
Ponatinib |
Breast invasive carcinoma |
0.021618536 |
Sensitive |
| ENSG00000261839.1 |
Ponatinib |
Breast invasive carcinoma |
0.028931392 |
Sensitive |
| ENSG00000262668.1 |
Ponatinib |
Breast invasive carcinoma |
0.008054406 |
Sensitive |
| ENSG00000262873.1 |
Ponatinib |
Breast invasive carcinoma |
0.048394008 |
Sensitive |
| ENSG00000263069.1 |
Ponatinib |
Breast invasive carcinoma |
0.037502692 |
Sensitive |
| ENSG00000263680.2 |
Ponatinib |
Breast invasive carcinoma |
0.018801699 |
Sensitive |
| ENSG00000263766.1 |
Ponatinib |
Breast invasive carcinoma |
0.023307638 |
Sensitive |
| ENSG00000264007.1 |
Ponatinib |
Breast invasive carcinoma |
0.049807826 |
Sensitive |
| ENSG00000264026.1 |
Ponatinib |
Breast invasive carcinoma |
0.027344806 |
Sensitive |
| ENSG00000264469.1 |
Ponatinib |
Breast invasive carcinoma |
0.024236911 |
Sensitive |
| ENSG00000266598.1 |
Ponatinib |
Breast invasive carcinoma |
0.044552792 |
Sensitive |
| ENSG00000267042.1 |
Ponatinib |
Breast invasive carcinoma |
0.043058841 |
Sensitive |
| ENSG00000267272.1 |
Ponatinib |
Breast invasive carcinoma |
0.034970001 |
Sensitive |
| ENSG00000267325.1 |
Ponatinib |
Breast invasive carcinoma |
0.018121828 |
Sensitive |
| ENSG00000267543.1 |
Ponatinib |
Breast invasive carcinoma |
0.027455992 |
Sensitive |
| ENSG00000267919.1 |
Ponatinib |
Breast invasive carcinoma |
0.009239847 |
Sensitive |
| ENSG00000267939.1 |
Ponatinib |
Breast invasive carcinoma |
0.03964253 |
Sensitive |
| ENSG00000268061.1 |
Ponatinib |
Breast invasive carcinoma |
0.047134126 |
Sensitive |
| ENSG00000269947.1 |
Ponatinib |
Breast invasive carcinoma |
0.022025227 |
Sensitive |
| ENSG00000270001.1 |
Ponatinib |
Breast invasive carcinoma |
0.013254671 |
Sensitive |
| ENSG00000270154.1 |
Ponatinib |
Breast invasive carcinoma |
0.043235848 |
Sensitive |
| ENSG00000270640.1 |
Ponatinib |
Breast invasive carcinoma |
0.036799777 |
Sensitive |
| ENSG00000271204.1 |
Ponatinib |
Breast invasive carcinoma |
0.011157258 |
Sensitive |
| ENSG00000271874.1 |
Ponatinib |
Breast invasive carcinoma |
0.010952118 |
Sensitive |
| ENSG00000272057.1 |
Ponatinib |
Breast invasive carcinoma |
0.033866937 |
Sensitive |
| ENSG00000272146.1 |
Ponatinib |
Breast invasive carcinoma |
0.030767189 |
Sensitive |
| ENSG00000272870.1 |
Ponatinib |
Breast invasive carcinoma |
0.018674511 |
Sensitive |
| ENSG00000273209.1 |
Ponatinib |
Breast invasive carcinoma |
0.042022513 |
Sensitive |
| ENSG00000273297.1 |
Ponatinib |
Breast invasive carcinoma |
0.024412206 |
Sensitive |
| ENSG00000125804.9 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.028682026 |
Sensitive |
| ENSG00000174171.4 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027453347 |
Sensitive |
| ENSG00000223576.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021250567 |
Sensitive |
| ENSG00000224905.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024363547 |
Sensitive |
| ENSG00000225234.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027199741 |
Sensitive |
| ENSG00000225393.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.024608789 |
Sensitive |
| ENSG00000225493.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009808165 |
Sensitive |
| ENSG00000225721.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023165907 |
Sensitive |
| ENSG00000227372.6 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.033228522 |
Sensitive |
| ENSG00000228389.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04366353 |
Sensitive |
| ENSG00000228661.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.02256056 |
Sensitive |
| ENSG00000228763.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039618558 |
Sensitive |
| ENSG00000229233.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049238037 |
Sensitive |
| ENSG00000229839.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025737722 |
Sensitive |
| ENSG00000233098.4 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.009420338 |
Sensitive |
| ENSG00000234255.4 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046936219 |
Sensitive |
| ENSG00000234945.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003720655 |
Sensitive |
| ENSG00000235298.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008016541 |
Sensitive |
| ENSG00000235387.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031007434 |
Sensitive |
| ENSG00000235772.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014559863 |
Sensitive |
| ENSG00000237298.4 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.038874554 |
Sensitive |
| ENSG00000237903.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.008496031 |
Sensitive |
| ENSG00000238018.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.027679271 |
Sensitive |
| ENSG00000238186.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.023795272 |
Sensitive |
| ENSG00000250260.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031885611 |
Sensitive |
| ENSG00000250909.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.005566894 |
Sensitive |
| ENSG00000253559.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039492399 |
Sensitive |
| ENSG00000254099.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.021231082 |
Sensitive |
| ENSG00000256751.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.030593874 |
Sensitive |
| ENSG00000257527.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049321072 |
Sensitive |
| ENSG00000259031.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.035193905 |
Sensitive |
| ENSG00000259806.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025719875 |
Sensitive |
| ENSG00000259883.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020964025 |
Sensitive |
| ENSG00000260495.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.011343893 |
Sensitive |
| ENSG00000260743.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020504859 |
Sensitive |
| ENSG00000260973.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047282801 |
Sensitive |
| ENSG00000261002.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.043452234 |
Sensitive |
| ENSG00000261079.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001277781 |
Sensitive |
| ENSG00000264043.2 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.015258674 |
Sensitive |
| ENSG00000265443.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.042880273 |
Sensitive |
| ENSG00000265474.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.047106579 |
Sensitive |
| ENSG00000267108.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.04060336 |
Sensitive |
| ENSG00000267395.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.036011978 |
Sensitive |
| ENSG00000267505.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.040439825 |
Sensitive |
| ENSG00000269925.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020221861 |
Sensitive |
| ENSG00000269956.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022528144 |
Sensitive |
| ENSG00000270028.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.01909204 |
Sensitive |
| ENSG00000270062.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.001697901 |
Sensitive |
| ENSG00000270184.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.014557881 |
Sensitive |
| ENSG00000270580.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.03800544 |
Sensitive |
| ENSG00000271147.3 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.025638487 |
Sensitive |
| ENSG00000271228.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.049038155 |
Sensitive |
| ENSG00000271554.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.019468694 |
Sensitive |
| ENSG00000271824.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.020130144 |
Sensitive |
| ENSG00000271851.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000653329 |
Sensitive |
| ENSG00000272003.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.039583922 |
Sensitive |
| ENSG00000272040.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.031350712 |
Sensitive |
| ENSG00000272077.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.016785886 |
Sensitive |
| ENSG00000272361.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034326991 |
Sensitive |
| ENSG00000273203.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.034617048 |
Sensitive |
| ENSG00000273233.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.046989043 |
Sensitive |
| ENSG00000273325.1 |
Ponatinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.017800798 |
Sensitive |
| ENSG00000163364.5 |
Ponatinib |
Colon adenocarcinoma |
0.033371871 |
Sensitive |
| ENSG00000182648.7 |
Ponatinib |
Colon adenocarcinoma |
0.022945806 |
Sensitive |
| ENSG00000203999.4 |
Ponatinib |
Colon adenocarcinoma |
0.0421639 |
Sensitive |
| ENSG00000214650.2 |
Ponatinib |
Colon adenocarcinoma |
0.024383 |
Sensitive |
| ENSG00000215692.2 |
Ponatinib |
Colon adenocarcinoma |
0.012091235 |
Sensitive |
| ENSG00000223473.1 |
Ponatinib |
Colon adenocarcinoma |
0.022379226 |
Sensitive |
| ENSG00000225595.2 |
Ponatinib |
Colon adenocarcinoma |
0.036371238 |
Sensitive |
| ENSG00000227215.1 |
Ponatinib |
Colon adenocarcinoma |
0.025448511 |
Sensitive |
| ENSG00000228677.1 |
Ponatinib |
Colon adenocarcinoma |
0.027551111 |
Sensitive |
| ENSG00000229325.1 |
Ponatinib |
Colon adenocarcinoma |
0.010895778 |
Sensitive |
| ENSG00000229832.1 |
Ponatinib |
Colon adenocarcinoma |
0.036952953 |
Sensitive |
| ENSG00000232729.3 |
Ponatinib |
Colon adenocarcinoma |
0.030051203 |
Sensitive |
| ENSG00000234197.1 |
Ponatinib |
Colon adenocarcinoma |
0.031687472 |
Sensitive |
| ENSG00000234350.1 |
Ponatinib |
Colon adenocarcinoma |
0.043121648 |
Sensitive |
| ENSG00000234617.1 |
Ponatinib |
Colon adenocarcinoma |
0.028106761 |
Sensitive |
| ENSG00000236200.1 |
Ponatinib |
Colon adenocarcinoma |
0.036682205 |
Sensitive |
| ENSG00000236558.2 |
Ponatinib |
Colon adenocarcinoma |
0.015882827 |
Sensitive |
| ENSG00000237015.1 |
Ponatinib |
Colon adenocarcinoma |
0.037567978 |
Sensitive |
| ENSG00000239467.1 |
Ponatinib |
Colon adenocarcinoma |
0.015801446 |
Sensitive |
| ENSG00000240401.4 |
Ponatinib |
Colon adenocarcinoma |
0.006525335 |
Sensitive |
| ENSG00000242798.1 |
Ponatinib |
Colon adenocarcinoma |
0.004143251 |
Sensitive |
| ENSG00000244124.1 |
Ponatinib |
Colon adenocarcinoma |
0.004655733 |
Sensitive |
| ENSG00000245694.4 |
Ponatinib |
Colon adenocarcinoma |
0.036394732 |
Sensitive |
| ENSG00000246851.1 |
Ponatinib |
Colon adenocarcinoma |
0.027689018 |
Sensitive |
| ENSG00000248636.2 |
Ponatinib |
Colon adenocarcinoma |
0.031872336 |
Sensitive |
| ENSG00000249084.1 |
Ponatinib |
Colon adenocarcinoma |
0.020494703 |
Sensitive |
| ENSG00000250764.1 |
Ponatinib |
Colon adenocarcinoma |
0.045165511 |
Sensitive |
| ENSG00000254605.1 |
Ponatinib |
Colon adenocarcinoma |
0.026388458 |
Sensitive |
| ENSG00000259442.1 |
Ponatinib |
Colon adenocarcinoma |
0.030965571 |
Sensitive |
| ENSG00000259563.1 |
Ponatinib |
Colon adenocarcinoma |
0.042084764 |
Sensitive |
| ENSG00000260194.1 |
Ponatinib |
Colon adenocarcinoma |
0.007351892 |
Sensitive |
| ENSG00000260986.1 |
Ponatinib |
Colon adenocarcinoma |
0.008726065 |
Sensitive |
| ENSG00000261096.1 |
Ponatinib |
Colon adenocarcinoma |
0.005187805 |
Sensitive |
| ENSG00000263603.1 |
Ponatinib |
Colon adenocarcinoma |
0.049687098 |
Sensitive |
| ENSG00000264304.1 |
Ponatinib |
Colon adenocarcinoma |
0.046217175 |
Sensitive |
| ENSG00000264520.1 |
Ponatinib |
Colon adenocarcinoma |
0.005908156 |
Sensitive |
| ENSG00000264577.1 |
Ponatinib |
Colon adenocarcinoma |
0.00362302 |
Sensitive |
| ENSG00000264895.1 |
Ponatinib |
Colon adenocarcinoma |
0.001252782 |
Sensitive |
| ENSG00000265908.1 |
Ponatinib |
Colon adenocarcinoma |
0.022712477 |
Sensitive |
| ENSG00000267798.1 |
Ponatinib |
Colon adenocarcinoma |
0.012612224 |
Sensitive |
| ENSG00000269925.1 |
Ponatinib |
Colon adenocarcinoma |
0.049142745 |
Sensitive |
| ENSG00000270157.1 |
Ponatinib |
Colon adenocarcinoma |
0.015225087 |
Sensitive |
| ENSG00000272087.1 |
Ponatinib |
Colon adenocarcinoma |
0.044560384 |
Sensitive |
| ENSG00000272440.1 |
Ponatinib |
Colon adenocarcinoma |
0.035690262 |
Sensitive |
| ENSG00000272576.1 |
Ponatinib |
Colon adenocarcinoma |
0.014160491 |
Sensitive |
| ENSG00000272744.1 |
Ponatinib |
Colon adenocarcinoma |
0.049460792 |
Sensitive |
| ENSG00000273014.1 |
Ponatinib |
Colon adenocarcinoma |
0.032341755 |
Sensitive |
| ENSG00000273245.1 |
Ponatinib |
Colon adenocarcinoma |
0.049315332 |
Sensitive |
| ENSG00000177853.10 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023546145 |
Sensitive |
| ENSG00000179743.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011028298 |
Sensitive |
| ENSG00000196810.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031497659 |
Sensitive |
| ENSG00000203849.6 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008260612 |
Sensitive |
| ENSG00000204706.10 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026712534 |
Sensitive |
| ENSG00000205041.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015772448 |
Sensitive |
| ENSG00000220161.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043481335 |
Sensitive |
| ENSG00000225278.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046125394 |
Sensitive |
| ENSG00000226856.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004513138 |
Sensitive |
| ENSG00000226904.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036175005 |
Sensitive |
| ENSG00000227071.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027970626 |
Sensitive |
| ENSG00000227698.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045173207 |
Sensitive |
| ENSG00000228005.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046252973 |
Sensitive |
| ENSG00000228839.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017718251 |
Sensitive |
| ENSG00000229267.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040654354 |
Sensitive |
| ENSG00000229582.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007217623 |
Sensitive |
| ENSG00000229611.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020952734 |
Sensitive |
| ENSG00000230658.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005650112 |
Sensitive |
| ENSG00000230880.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02484788 |
Sensitive |
| ENSG00000231607.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004853826 |
Sensitive |
| ENSG00000231728.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036993394 |
Sensitive |
| ENSG00000232274.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031918962 |
Sensitive |
| ENSG00000232648.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037895989 |
Sensitive |
| ENSG00000232909.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031994247 |
Sensitive |
| ENSG00000233776.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010678702 |
Sensitive |
| ENSG00000234134.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033942624 |
Sensitive |
| ENSG00000235029.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038447269 |
Sensitive |
| ENSG00000235545.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048993291 |
Sensitive |
| ENSG00000236426.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025675238 |
Sensitive |
| ENSG00000236896.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044004221 |
Sensitive |
| ENSG00000237119.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022489295 |
Sensitive |
| ENSG00000237280.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013463696 |
Sensitive |
| ENSG00000237594.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002408951 |
Sensitive |
| ENSG00000238261.5 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001538321 |
Sensitive |
| ENSG00000239377.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0104486 |
Sensitive |
| ENSG00000240050.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010625635 |
Sensitive |
| ENSG00000240449.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025761596 |
Sensitive |
| ENSG00000242569.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030152984 |
Sensitive |
| ENSG00000242687.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024275204 |
Sensitive |
| ENSG00000243193.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038171122 |
Sensitive |
| ENSG00000247735.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022743896 |
Sensitive |
| ENSG00000248774.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034256583 |
Sensitive |
| ENSG00000249494.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041606631 |
Sensitive |
| ENSG00000250116.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014814298 |
Sensitive |
| ENSG00000250132.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026880674 |
Sensitive |
| ENSG00000254837.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047078541 |
Sensitive |
| ENSG00000256742.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012233439 |
Sensitive |
| ENSG00000257105.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028084545 |
Sensitive |
| ENSG00000257488.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036707139 |
Sensitive |
| ENSG00000258199.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030284335 |
Sensitive |
| ENSG00000258325.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03293247 |
Sensitive |
| ENSG00000258701.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001496274 |
Sensitive |
| ENSG00000258811.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002183778 |
Sensitive |
| ENSG00000258920.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030624962 |
Sensitive |
| ENSG00000259377.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016075532 |
Sensitive |
| ENSG00000259488.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003738296 |
Sensitive |
| ENSG00000259700.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031695931 |
Sensitive |
| ENSG00000259709.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023048932 |
Sensitive |
| ENSG00000259804.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04424138 |
Sensitive |
| ENSG00000259881.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031210268 |
Sensitive |
| ENSG00000260296.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023813053 |
Sensitive |
| ENSG00000261064.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037039802 |
Sensitive |
| ENSG00000261131.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002432683 |
Sensitive |
| ENSG00000261200.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045938372 |
Sensitive |
| ENSG00000261693.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047442223 |
Sensitive |
| ENSG00000261777.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03631061 |
Sensitive |
| ENSG00000264808.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035629664 |
Sensitive |
| ENSG00000264885.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033657281 |
Sensitive |
| ENSG00000265791.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018904869 |
Sensitive |
| ENSG00000266803.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046525301 |
Sensitive |
| ENSG00000267308.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043561128 |
Sensitive |
| ENSG00000268931.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043333847 |
Sensitive |
| ENSG00000269463.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024632096 |
Sensitive |
| ENSG00000270659.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015625982 |
Sensitive |
| ENSG00000271849.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039084357 |
Sensitive |
| ENSG00000271856.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037010633 |
Sensitive |
| ENSG00000272070.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04547779 |
Sensitive |
| ENSG00000272221.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036638196 |
Sensitive |
| ENSG00000272650.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021025921 |
Sensitive |
| ENSG00000272667.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044103016 |
Sensitive |
| ENSG00000273056.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00469389 |
Sensitive |
| ENSG00000273175.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00167704 |
Sensitive |
| ENSG00000203441.2 |
Ponatinib |
Esophageal cancer |
0.041576503 |
Sensitive |
| ENSG00000219665.4 |
Ponatinib |
Esophageal cancer |
0.036203018 |
Sensitive |
| ENSG00000224818.1 |
Ponatinib |
Esophageal cancer |
0.04960553 |
Sensitive |
| ENSG00000224977.1 |
Ponatinib |
Esophageal cancer |
0.024248755 |
Sensitive |
| ENSG00000225411.2 |
Ponatinib |
Esophageal cancer |
0.001482843 |
Sensitive |
| ENSG00000227354.2 |
Ponatinib |
Esophageal cancer |
0.043836272 |
Sensitive |
| ENSG00000227617.4 |
Ponatinib |
Esophageal cancer |
0.009874995 |
Sensitive |
| ENSG00000229852.2 |
Ponatinib |
Esophageal cancer |
0.049795125 |
Sensitive |
| ENSG00000230427.1 |
Ponatinib |
Esophageal cancer |
0.026924595 |
Sensitive |
| ENSG00000232316.1 |
Ponatinib |
Esophageal cancer |
0.035401413 |
Sensitive |
| ENSG00000232618.1 |
Ponatinib |
Esophageal cancer |
0.041031374 |
Sensitive |
| ENSG00000235214.1 |
Ponatinib |
Esophageal cancer |
0.010889032 |
Sensitive |
| ENSG00000235298.1 |
Ponatinib |
Esophageal cancer |
0.046378476 |
Sensitive |
| ENSG00000237301.1 |
Ponatinib |
Esophageal cancer |
0.043761334 |
Sensitive |
| ENSG00000238113.2 |
Ponatinib |
Esophageal cancer |
0.016768543 |
Sensitive |
| ENSG00000238141.2 |
Ponatinib |
Esophageal cancer |
0.047177187 |
Sensitive |
| ENSG00000243701.1 |
Ponatinib |
Esophageal cancer |
0.028173786 |
Sensitive |
| ENSG00000244300.2 |
Ponatinib |
Esophageal cancer |
0.03646107 |
Sensitive |
| ENSG00000244926.2 |
Ponatinib |
Esophageal cancer |
0.006752974 |
Sensitive |
| ENSG00000246174.3 |
Ponatinib |
Esophageal cancer |
0.014376561 |
Sensitive |
| ENSG00000248668.1 |
Ponatinib |
Esophageal cancer |
0.036578684 |
Sensitive |
| ENSG00000249790.2 |
Ponatinib |
Esophageal cancer |
0.045718795 |
Sensitive |
| ENSG00000250582.1 |
Ponatinib |
Esophageal cancer |
0.027004025 |
Sensitive |
| ENSG00000250920.1 |
Ponatinib |
Esophageal cancer |
0.048539529 |
Sensitive |
| ENSG00000250988.3 |
Ponatinib |
Esophageal cancer |
0.02290288 |
Sensitive |
| ENSG00000250999.1 |
Ponatinib |
Esophageal cancer |
0.022628109 |
Sensitive |
| ENSG00000251359.3 |
Ponatinib |
Esophageal cancer |
0.036984531 |
Sensitive |
| ENSG00000253878.1 |
Ponatinib |
Esophageal cancer |
0.019909954 |
Sensitive |
| ENSG00000254900.1 |
Ponatinib |
Esophageal cancer |
0.011788719 |
Sensitive |
| ENSG00000256248.1 |
Ponatinib |
Esophageal cancer |
0.027500445 |
Sensitive |
| ENSG00000257740.1 |
Ponatinib |
Esophageal cancer |
0.01571466 |
Sensitive |
| ENSG00000258789.1 |
Ponatinib |
Esophageal cancer |
0.034295399 |
Sensitive |
| ENSG00000259248.1 |
Ponatinib |
Esophageal cancer |
0.031477208 |
Sensitive |
| ENSG00000259488.1 |
Ponatinib |
Esophageal cancer |
0.0254093 |
Sensitive |
| ENSG00000259594.1 |
Ponatinib |
Esophageal cancer |
0.020221273 |
Sensitive |
| ENSG00000259692.1 |
Ponatinib |
Esophageal cancer |
0.044965399 |
Sensitive |
| ENSG00000259768.3 |
Ponatinib |
Esophageal cancer |
0.037194872 |
Sensitive |
| ENSG00000259901.1 |
Ponatinib |
Esophageal cancer |
0.014400253 |
Sensitive |
| ENSG00000260095.1 |
Ponatinib |
Esophageal cancer |
0.024041502 |
Sensitive |
| ENSG00000260228.1 |
Ponatinib |
Esophageal cancer |
0.024413078 |
Sensitive |
| ENSG00000260369.2 |
Ponatinib |
Esophageal cancer |
0.037215809 |
Sensitive |
| ENSG00000260577.1 |
Ponatinib |
Esophageal cancer |
0.033297461 |
Sensitive |
| ENSG00000260898.1 |
Ponatinib |
Esophageal cancer |
0.043823876 |
Sensitive |
| ENSG00000261101.1 |
Ponatinib |
Esophageal cancer |
0.04065735 |
Sensitive |
| ENSG00000261513.1 |
Ponatinib |
Esophageal cancer |
0.044388729 |
Sensitive |
| ENSG00000261840.1 |
Ponatinib |
Esophageal cancer |
0.028078391 |
Sensitive |
| ENSG00000264078.1 |
Ponatinib |
Esophageal cancer |
0.02453631 |
Sensitive |
| ENSG00000264247.1 |
Ponatinib |
Esophageal cancer |
0.017123228 |
Sensitive |
| ENSG00000264745.1 |
Ponatinib |
Esophageal cancer |
0.021136487 |
Sensitive |
| ENSG00000265342.1 |
Ponatinib |
Esophageal cancer |
0.024421139 |
Sensitive |
| ENSG00000265750.1 |
Ponatinib |
Esophageal cancer |
0.029874839 |
Sensitive |
| ENSG00000267284.1 |
Ponatinib |
Esophageal cancer |
0.006111554 |
Sensitive |
| ENSG00000267325.1 |
Ponatinib |
Esophageal cancer |
0.02936445 |
Sensitive |
| ENSG00000267381.1 |
Ponatinib |
Esophageal cancer |
0.024309099 |
Sensitive |
| ENSG00000267414.1 |
Ponatinib |
Esophageal cancer |
0.003282962 |
Sensitive |
| ENSG00000270115.1 |
Ponatinib |
Esophageal cancer |
0.041267073 |
Sensitive |
| ENSG00000270133.1 |
Ponatinib |
Esophageal cancer |
0.034285528 |
Sensitive |
| ENSG00000270302.1 |
Ponatinib |
Esophageal cancer |
0.027717051 |
Sensitive |
| ENSG00000270949.1 |
Ponatinib |
Esophageal cancer |
0.034783359 |
Sensitive |
| ENSG00000271234.1 |
Ponatinib |
Esophageal cancer |
0.040672031 |
Sensitive |
| ENSG00000272931.1 |
Ponatinib |
Esophageal cancer |
0.028661413 |
Sensitive |
| ENSG00000273015.1 |
Ponatinib |
Esophageal cancer |
0.018189345 |
Sensitive |
| ENSG00000172965.10 |
Ponatinib |
Brain lower grade glioma |
0.001495189 |
Sensitive |
| ENSG00000183674.7 |
Ponatinib |
Brain lower grade glioma |
0.041652893 |
Sensitive |
| ENSG00000185168.5 |
Ponatinib |
Brain lower grade glioma |
0.043719985 |
Sensitive |
| ENSG00000205444.2 |
Ponatinib |
Brain lower grade glioma |
0.013192931 |
Sensitive |
| ENSG00000222032.1 |
Ponatinib |
Brain lower grade glioma |
0.046130385 |
Sensitive |
| ENSG00000222041.6 |
Ponatinib |
Brain lower grade glioma |
0.006282227 |
Sensitive |
| ENSG00000223382.3 |
Ponatinib |
Brain lower grade glioma |
0.041689222 |
Sensitive |
| ENSG00000223485.1 |
Ponatinib |
Brain lower grade glioma |
0.039313553 |
Sensitive |
| ENSG00000223511.1 |
Ponatinib |
Brain lower grade glioma |
0.018033776 |
Sensitive |
| ENSG00000223573.2 |
Ponatinib |
Brain lower grade glioma |
0.022890885 |
Sensitive |
| ENSG00000223759.2 |
Ponatinib |
Brain lower grade glioma |
0.025643587 |
Sensitive |
| ENSG00000224269.1 |
Ponatinib |
Brain lower grade glioma |
0.043630162 |
Sensitive |
| ENSG00000224743.2 |
Ponatinib |
Brain lower grade glioma |
0.036127047 |
Sensitive |
| ENSG00000224959.1 |
Ponatinib |
Brain lower grade glioma |
0.012164077 |
Sensitive |
| ENSG00000225643.1 |
Ponatinib |
Brain lower grade glioma |
0.030279408 |
Sensitive |
| ENSG00000225676.1 |
Ponatinib |
Brain lower grade glioma |
0.01545993 |
Sensitive |
| ENSG00000225978.2 |
Ponatinib |
Brain lower grade glioma |
0.045878593 |
Sensitive |
| ENSG00000226067.2 |
Ponatinib |
Brain lower grade glioma |
0.02797818 |
Sensitive |
| ENSG00000227496.1 |
Ponatinib |
Brain lower grade glioma |
0.037758475 |
Sensitive |
| ENSG00000228013.1 |
Ponatinib |
Brain lower grade glioma |
0.03138136 |
Sensitive |
| ENSG00000228630.1 |
Ponatinib |
Brain lower grade glioma |
0.015402002 |
Sensitive |
| ENSG00000229931.1 |
Ponatinib |
Brain lower grade glioma |
0.008782434 |
Sensitive |
| ENSG00000231133.2 |
Ponatinib |
Brain lower grade glioma |
0.003185487 |
Sensitive |
| ENSG00000233215.1 |
Ponatinib |
Brain lower grade glioma |
0.03759729 |
Sensitive |
| ENSG00000233845.1 |
Ponatinib |
Brain lower grade glioma |
0.020541091 |
Sensitive |
| ENSG00000233895.1 |
Ponatinib |
Brain lower grade glioma |
0.036699166 |
Sensitive |
| ENSG00000235027.1 |
Ponatinib |
Brain lower grade glioma |
0.040295844 |
Sensitive |
| ENSG00000235033.3 |
Ponatinib |
Brain lower grade glioma |
0.019246274 |
Sensitive |
| ENSG00000235070.3 |
Ponatinib |
Brain lower grade glioma |
0.025045429 |
Sensitive |
| ENSG00000235999.1 |
Ponatinib |
Brain lower grade glioma |
0.0215139 |
Sensitive |
| ENSG00000236166.1 |
Ponatinib |
Brain lower grade glioma |
0.028961162 |
Sensitive |
| ENSG00000236318.1 |
Ponatinib |
Brain lower grade glioma |
0.034262993 |
Sensitive |
| ENSG00000237181.1 |
Ponatinib |
Brain lower grade glioma |
0.036812494 |
Sensitive |
| ENSG00000237595.2 |
Ponatinib |
Brain lower grade glioma |
0.048344372 |
Sensitive |
| ENSG00000237738.1 |
Ponatinib |
Brain lower grade glioma |
0.043357396 |
Sensitive |
| ENSG00000238005.2 |
Ponatinib |
Brain lower grade glioma |
0.015755408 |
Sensitive |
| ENSG00000238164.2 |
Ponatinib |
Brain lower grade glioma |
0.034976196 |
Sensitive |
| ENSG00000239674.2 |
Ponatinib |
Brain lower grade glioma |
0.024178063 |
Sensitive |
| ENSG00000240541.2 |
Ponatinib |
Brain lower grade glioma |
0.016621397 |
Sensitive |
| ENSG00000243243.1 |
Ponatinib |
Brain lower grade glioma |
0.027192881 |
Sensitive |
| ENSG00000243637.1 |
Ponatinib |
Brain lower grade glioma |
0.042152614 |
Sensitive |
| ENSG00000244345.1 |
Ponatinib |
Brain lower grade glioma |
0.007767907 |
Sensitive |
| ENSG00000244459.2 |
Ponatinib |
Brain lower grade glioma |
0.016776537 |
Sensitive |
| ENSG00000246523.3 |
Ponatinib |
Brain lower grade glioma |
0.011408753 |
Sensitive |
| ENSG00000248693.1 |
Ponatinib |
Brain lower grade glioma |
0.049259582 |
Sensitive |
| ENSG00000249279.1 |
Ponatinib |
Brain lower grade glioma |
0.025200793 |
Sensitive |
| ENSG00000249684.1 |
Ponatinib |
Brain lower grade glioma |
0.036008991 |
Sensitive |
| ENSG00000250101.1 |
Ponatinib |
Brain lower grade glioma |
0.012497652 |
Sensitive |
| ENSG00000251661.3 |
Ponatinib |
Brain lower grade glioma |
0.026224294 |
Sensitive |
| ENSG00000253210.1 |
Ponatinib |
Brain lower grade glioma |
0.014106835 |
Sensitive |
| ENSG00000253616.1 |
Ponatinib |
Brain lower grade glioma |
0.021268255 |
Sensitive |
| ENSG00000253737.1 |
Ponatinib |
Brain lower grade glioma |
0.044426136 |
Sensitive |
| ENSG00000254607.2 |
Ponatinib |
Brain lower grade glioma |
0.028516611 |
Sensitive |
| ENSG00000254734.1 |
Ponatinib |
Brain lower grade glioma |
0.046343149 |
Sensitive |
| ENSG00000254847.1 |
Ponatinib |
Brain lower grade glioma |
0.013461543 |
Sensitive |
| ENSG00000254910.1 |
Ponatinib |
Brain lower grade glioma |
0.044918047 |
Sensitive |
| ENSG00000255443.1 |
Ponatinib |
Brain lower grade glioma |
0.023097961 |
Sensitive |
| ENSG00000255471.1 |
Ponatinib |
Brain lower grade glioma |
0.019234824 |
Sensitive |
| ENSG00000255509.2 |
Ponatinib |
Brain lower grade glioma |
0.024034064 |
Sensitive |
| ENSG00000256721.1 |
Ponatinib |
Brain lower grade glioma |
0.015095153 |
Sensitive |
| ENSG00000256982.1 |
Ponatinib |
Brain lower grade glioma |
0.03245871 |
Sensitive |
| ENSG00000257890.1 |
Ponatinib |
Brain lower grade glioma |
0.019554654 |
Sensitive |
| ENSG00000259130.1 |
Ponatinib |
Brain lower grade glioma |
0.030263535 |
Sensitive |
| ENSG00000259863.1 |
Ponatinib |
Brain lower grade glioma |
0.035190853 |
Sensitive |
| ENSG00000260022.1 |
Ponatinib |
Brain lower grade glioma |
0.007899272 |
Sensitive |
| ENSG00000260025.1 |
Ponatinib |
Brain lower grade glioma |
0.019481583 |
Sensitive |
| ENSG00000260162.2 |
Ponatinib |
Brain lower grade glioma |
0.017525029 |
Sensitive |
| ENSG00000261327.3 |
Ponatinib |
Brain lower grade glioma |
0.017706524 |
Sensitive |
| ENSG00000261512.2 |
Ponatinib |
Brain lower grade glioma |
0.02153298 |
Sensitive |
| ENSG00000264222.1 |
Ponatinib |
Brain lower grade glioma |
0.041203094 |
Sensitive |
| ENSG00000265766.1 |
Ponatinib |
Brain lower grade glioma |
0.006750557 |
Sensitive |
| ENSG00000266088.1 |
Ponatinib |
Brain lower grade glioma |
0.042334931 |
Sensitive |
| ENSG00000266927.2 |
Ponatinib |
Brain lower grade glioma |
0.042575877 |
Sensitive |
| ENSG00000266970.1 |
Ponatinib |
Brain lower grade glioma |
0.039711983 |
Sensitive |
| ENSG00000267193.1 |
Ponatinib |
Brain lower grade glioma |
0.0480672 |
Sensitive |
| ENSG00000267530.2 |
Ponatinib |
Brain lower grade glioma |
0.041303745 |
Sensitive |
| ENSG00000267731.1 |
Ponatinib |
Brain lower grade glioma |
0.046391509 |
Sensitive |
| ENSG00000267737.1 |
Ponatinib |
Brain lower grade glioma |
0.015234336 |
Sensitive |
| ENSG00000269895.1 |
Ponatinib |
Brain lower grade glioma |
0.012781375 |
Sensitive |
| ENSG00000272236.1 |
Ponatinib |
Brain lower grade glioma |
0.018163277 |
Sensitive |
| ENSG00000272473.1 |
Ponatinib |
Brain lower grade glioma |
0.002269651 |
Sensitive |
| ENSG00000273123.1 |
Ponatinib |
Brain lower grade glioma |
0.013124113 |
Sensitive |
| ENSG00000273132.1 |
Ponatinib |
Brain lower grade glioma |
0.039866279 |
Sensitive |
| ENSG00000273209.1 |
Ponatinib |
Brain lower grade glioma |
0.032063345 |
Sensitive |
| ENSG00000153363.8 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022161844 |
Sensitive |
| ENSG00000172250.10 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028301961 |
Sensitive |
| ENSG00000225439.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022328328 |
Sensitive |
| ENSG00000226381.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.01993724 |
Sensitive |
| ENSG00000228701.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.030263587 |
Sensitive |
| ENSG00000229980.4 |
Ponatinib |
Liver hepatocellular carcinoma |
0.044527444 |
Sensitive |
| ENSG00000231789.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.025833746 |
Sensitive |
| ENSG00000232342.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.049890631 |
Sensitive |
| ENSG00000237037.5 |
Ponatinib |
Liver hepatocellular carcinoma |
0.046851973 |
Sensitive |
| ENSG00000237250.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.038417619 |
Sensitive |
| ENSG00000237298.4 |
Ponatinib |
Liver hepatocellular carcinoma |
0.037397368 |
Sensitive |
| ENSG00000237461.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.026267478 |
Sensitive |
| ENSG00000241180.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.033941648 |
Sensitive |
| ENSG00000243766.3 |
Ponatinib |
Liver hepatocellular carcinoma |
0.034129327 |
Sensitive |
| ENSG00000247679.2 |
Ponatinib |
Liver hepatocellular carcinoma |
0.022904145 |
Sensitive |
| ENSG00000248932.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.023148786 |
Sensitive |
| ENSG00000249650.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028450972 |
Sensitive |
| ENSG00000253878.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.015966576 |
Sensitive |
| ENSG00000255026.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.047149669 |
Sensitive |
| ENSG00000257410.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.040599555 |
Sensitive |
| ENSG00000259187.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.021846285 |
Sensitive |
| ENSG00000261534.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.027196038 |
Sensitive |
| ENSG00000263874.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.034698458 |
Sensitive |
| ENSG00000268093.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.028474137 |
Sensitive |
| ENSG00000270104.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.002411741 |
Sensitive |
| ENSG00000272048.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.046977572 |
Sensitive |
| ENSG00000272518.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.002718222 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.012596055 |
Sensitive |
| ENSG00000204362.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.030051444 |
Sensitive |
| ENSG00000224596.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.041958275 |
Sensitive |
| ENSG00000224609.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.028852286 |
Sensitive |
| ENSG00000224671.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040725815 |
Sensitive |
| ENSG00000224733.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037354948 |
Sensitive |
| ENSG00000224794.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031628907 |
Sensitive |
| ENSG00000224884.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005720271 |
Sensitive |
| ENSG00000225064.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005453526 |
Sensitive |
| ENSG00000225269.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033582384 |
Sensitive |
| ENSG00000225684.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.00085159 |
Sensitive |
| ENSG00000226149.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019322812 |
Sensitive |
| ENSG00000226312.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.037553664 |
Sensitive |
| ENSG00000226526.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009896882 |
Sensitive |
| ENSG00000227039.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046539335 |
Sensitive |
| ENSG00000227678.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.003902062 |
Sensitive |
| ENSG00000227925.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045059746 |
Sensitive |
| ENSG00000227938.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020722552 |
Sensitive |
| ENSG00000228742.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.006785816 |
Sensitive |
| ENSG00000229118.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005341029 |
Sensitive |
| ENSG00000229124.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.005175566 |
Sensitive |
| ENSG00000229401.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03976543 |
Sensitive |
| ENSG00000230427.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033160542 |
Sensitive |
| ENSG00000230479.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015455853 |
Sensitive |
| ENSG00000230499.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014980291 |
Sensitive |
| ENSG00000231290.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012674867 |
Sensitive |
| ENSG00000231298.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.019965927 |
Sensitive |
| ENSG00000231367.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033284408 |
Sensitive |
| ENSG00000231528.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.001043986 |
Sensitive |
| ENSG00000231652.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.005875597 |
Sensitive |
| ENSG00000231811.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.007732995 |
Sensitive |
| ENSG00000231948.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024746051 |
Sensitive |
| ENSG00000232759.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048197765 |
Sensitive |
| ENSG00000232949.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031136486 |
Sensitive |
| ENSG00000233521.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028982228 |
Sensitive |
| ENSG00000233532.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011514298 |
Sensitive |
| ENSG00000233625.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020519725 |
Sensitive |
| ENSG00000233817.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043513426 |
Sensitive |
| ENSG00000233818.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021843555 |
Sensitive |
| ENSG00000235180.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012063224 |
Sensitive |
| ENSG00000235387.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01556842 |
Sensitive |
| ENSG00000235593.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023430788 |
Sensitive |
| ENSG00000235770.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028990423 |
Sensitive |
| ENSG00000235820.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032926194 |
Sensitive |
| ENSG00000235834.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043738154 |
Sensitive |
| ENSG00000235884.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.028976215 |
Sensitive |
| ENSG00000236366.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034109851 |
Sensitive |
| ENSG00000237697.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.007886616 |
Sensitive |
| ENSG00000237705.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048275983 |
Sensitive |
| ENSG00000237768.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.005007744 |
Sensitive |
| ENSG00000237803.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017859039 |
Sensitive |
| ENSG00000237903.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042135689 |
Sensitive |
| ENSG00000238031.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048204556 |
Sensitive |
| ENSG00000238042.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039177875 |
Sensitive |
| ENSG00000240032.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008666487 |
Sensitive |
| ENSG00000240350.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008700888 |
Sensitive |
| ENSG00000241593.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020753318 |
Sensitive |
| ENSG00000242147.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042309433 |
Sensitive |
| ENSG00000243415.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.028535628 |
Sensitive |
| ENSG00000243797.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.025876209 |
Sensitive |
| ENSG00000244260.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026481214 |
Sensitive |
| ENSG00000246898.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033170968 |
Sensitive |
| ENSG00000247311.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.004755858 |
Sensitive |
| ENSG00000248752.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034289628 |
Sensitive |
| ENSG00000248996.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029550692 |
Sensitive |
| ENSG00000249035.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.035842171 |
Sensitive |
| ENSG00000250320.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029770544 |
Sensitive |
| ENSG00000250602.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01177362 |
Sensitive |
| ENSG00000250608.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001482408 |
Sensitive |
| ENSG00000250659.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.027001915 |
Sensitive |
| ENSG00000251010.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014563058 |
Sensitive |
| ENSG00000253141.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028564089 |
Sensitive |
| ENSG00000253161.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047155885 |
Sensitive |
| ENSG00000253358.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007600901 |
Sensitive |
| ENSG00000253526.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047166301 |
Sensitive |
| ENSG00000253746.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034169085 |
Sensitive |
| ENSG00000253859.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.000353374 |
Sensitive |
| ENSG00000254142.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011084681 |
Sensitive |
| ENSG00000254545.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040518509 |
Sensitive |
| ENSG00000254620.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031059194 |
Sensitive |
| ENSG00000254688.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041700221 |
Sensitive |
| ENSG00000255090.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006391441 |
Sensitive |
| ENSG00000255248.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.034712102 |
Sensitive |
| ENSG00000255446.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025590499 |
Sensitive |
| ENSG00000255606.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023109791 |
Sensitive |
| ENSG00000256151.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02906999 |
Sensitive |
| ENSG00000256195.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.04878495 |
Sensitive |
| ENSG00000256268.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001367505 |
Sensitive |
| ENSG00000256403.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026538385 |
Sensitive |
| ENSG00000256988.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025219633 |
Sensitive |
| ENSG00000257058.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026838106 |
Sensitive |
| ENSG00000257097.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004750103 |
Sensitive |
| ENSG00000257894.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036359118 |
Sensitive |
| ENSG00000258400.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04755543 |
Sensitive |
| ENSG00000258602.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015338725 |
Sensitive |
| ENSG00000258929.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003920554 |
Sensitive |
| ENSG00000259415.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038088564 |
Sensitive |
| ENSG00000259867.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048650645 |
Sensitive |
| ENSG00000259992.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030721702 |
Sensitive |
| ENSG00000260823.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049318467 |
Sensitive |
| ENSG00000261051.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036048121 |
Sensitive |
| ENSG00000261158.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034190154 |
Sensitive |
| ENSG00000261368.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044431904 |
Sensitive |
| ENSG00000261662.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021858601 |
Sensitive |
| ENSG00000261706.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045397424 |
Sensitive |
| ENSG00000263895.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018475451 |
Sensitive |
| ENSG00000266397.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04339089 |
Sensitive |
| ENSG00000267280.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030024082 |
Sensitive |
| ENSG00000267764.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0137643 |
Sensitive |
| ENSG00000269019.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044777156 |
Sensitive |
| ENSG00000269652.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015847246 |
Sensitive |
| ENSG00000269895.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043219448 |
Sensitive |
| ENSG00000270190.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018304558 |
Sensitive |
| ENSG00000271590.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009718168 |
Sensitive |
| ENSG00000271716.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009166975 |
Sensitive |
| ENSG00000271857.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031756747 |
Sensitive |
| ENSG00000272761.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048314899 |
Sensitive |
| ENSG00000272933.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033147843 |
Sensitive |
| ENSG00000273065.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001871373 |
Sensitive |
| ENSG00000171889.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005545068 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039870098 |
Sensitive |
| ENSG00000215863.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019820624 |
Sensitive |
| ENSG00000223356.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007561535 |
Sensitive |
| ENSG00000224020.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046536086 |
Sensitive |
| ENSG00000224687.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045926523 |
Sensitive |
| ENSG00000224843.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003353564 |
Sensitive |
| ENSG00000224977.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029607451 |
Sensitive |
| ENSG00000226386.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.018501626 |
Sensitive |
| ENSG00000226786.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002853748 |
Sensitive |
| ENSG00000227877.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012527727 |
Sensitive |
| ENSG00000231196.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049379391 |
Sensitive |
| ENSG00000231324.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00428603 |
Sensitive |
| ENSG00000231483.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049016759 |
Sensitive |
| ENSG00000231507.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001111404 |
Sensitive |
| ENSG00000231574.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044792851 |
Sensitive |
| ENSG00000231720.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030874644 |
Sensitive |
| ENSG00000231969.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032422927 |
Sensitive |
| ENSG00000232139.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019992112 |
Sensitive |
| ENSG00000234283.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033124153 |
Sensitive |
| ENSG00000235313.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037484016 |
Sensitive |
| ENSG00000235398.4 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00806533 |
Sensitive |
| ENSG00000237331.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048340719 |
Sensitive |
| ENSG00000239911.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017820927 |
Sensitive |
| ENSG00000245059.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024901786 |
Sensitive |
| ENSG00000246548.3 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033261203 |
Sensitive |
| ENSG00000250842.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008858548 |
Sensitive |
| ENSG00000251026.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01048433 |
Sensitive |
| ENSG00000253948.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002577133 |
Sensitive |
| ENSG00000254538.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023380402 |
Sensitive |
| ENSG00000257449.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033787937 |
Sensitive |
| ENSG00000258048.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012932182 |
Sensitive |
| ENSG00000259758.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012595732 |
Sensitive |
| ENSG00000260317.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039155397 |
Sensitive |
| ENSG00000260744.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011989019 |
Sensitive |
| ENSG00000260938.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046504684 |
Sensitive |
| ENSG00000261488.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043967507 |
Sensitive |
| ENSG00000267280.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011663447 |
Sensitive |
| ENSG00000267432.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048662737 |
Sensitive |
| ENSG00000267764.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026423999 |
Sensitive |
| ENSG00000268189.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023399196 |
Sensitive |
| ENSG00000271789.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016238848 |
Sensitive |
| ENSG00000272024.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00947669 |
Sensitive |
| ENSG00000272102.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036321434 |
Sensitive |
| ENSG00000272158.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041973657 |
Sensitive |
| ENSG00000272198.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048188863 |
Sensitive |
| ENSG00000273342.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026859346 |
Sensitive |
| ENSG00000273471.1 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021044125 |
Sensitive |
| ENSG00000223653.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.016099266 |
Sensitive |
| ENSG00000225969.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03775418 |
Sensitive |
| ENSG00000226786.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.044066187 |
Sensitive |
| ENSG00000228242.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.044245914 |
Sensitive |
| ENSG00000228742.5 |
Ponatinib |
Pancreatic adenocarcinoma |
0.016739114 |
Sensitive |
| ENSG00000232638.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.049037669 |
Sensitive |
| ENSG00000237502.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.036181175 |
Sensitive |
| ENSG00000241449.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.016368191 |
Sensitive |
| ENSG00000253678.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.005714517 |
Sensitive |
| ENSG00000253875.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.014945306 |
Sensitive |
| ENSG00000257527.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.014773307 |
Sensitive |
| ENSG00000258279.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.018916864 |
Sensitive |
| ENSG00000261117.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.003081782 |
Sensitive |
| ENSG00000266304.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.013194705 |
Sensitive |
| ENSG00000268568.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.022539507 |
Sensitive |
| ENSG00000272362.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.00676244 |
Sensitive |
| ENSG00000273175.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.010799645 |
Sensitive |
| ENSG00000175773.8 |
Ponatinib |
Sarcoma |
0.011948818 |
Sensitive |
| ENSG00000196668.3 |
Ponatinib |
Sarcoma |
0.016067999 |
Sensitive |
| ENSG00000205662.2 |
Ponatinib |
Sarcoma |
0.034596185 |
Sensitive |
| ENSG00000214955.5 |
Ponatinib |
Sarcoma |
0.042849911 |
Sensitive |
| ENSG00000215256.3 |
Ponatinib |
Sarcoma |
0.024361617 |
Sensitive |
| ENSG00000226913.1 |
Ponatinib |
Sarcoma |
0.013226003 |
Sensitive |
| ENSG00000227214.2 |
Ponatinib |
Sarcoma |
0.018650989 |
Sensitive |
| ENSG00000227619.1 |
Ponatinib |
Sarcoma |
0.020300678 |
Sensitive |
| ENSG00000232388.2 |
Ponatinib |
Sarcoma |
0.030355651 |
Sensitive |
| ENSG00000232638.1 |
Ponatinib |
Sarcoma |
0.041114839 |
Sensitive |
| ENSG00000232940.1 |
Ponatinib |
Sarcoma |
0.017527799 |
Sensitive |
| ENSG00000234428.2 |
Ponatinib |
Sarcoma |
0.039693518 |
Sensitive |
| ENSG00000241933.1 |
Ponatinib |
Sarcoma |
0.047040854 |
Sensitive |
| ENSG00000243224.1 |
Ponatinib |
Sarcoma |
0.016878604 |
Sensitive |
| ENSG00000248223.1 |
Ponatinib |
Sarcoma |
0.046762475 |
Sensitive |
| ENSG00000249684.1 |
Ponatinib |
Sarcoma |
0.023313541 |
Sensitive |
| ENSG00000250012.1 |
Ponatinib |
Sarcoma |
0.019768075 |
Sensitive |
| ENSG00000253859.2 |
Ponatinib |
Sarcoma |
0.035094937 |
Sensitive |
| ENSG00000254419.1 |
Ponatinib |
Sarcoma |
0.048431651 |
Sensitive |
| ENSG00000255139.1 |
Ponatinib |
Sarcoma |
0.040355611 |
Sensitive |
| ENSG00000256576.1 |
Ponatinib |
Sarcoma |
0.021091293 |
Sensitive |
| ENSG00000257038.1 |
Ponatinib |
Sarcoma |
0.009023177 |
Sensitive |
| ENSG00000257556.1 |
Ponatinib |
Sarcoma |
0.036573528 |
Sensitive |
| ENSG00000257808.1 |
Ponatinib |
Sarcoma |
0.008497158 |
Sensitive |
| ENSG00000258521.1 |
Ponatinib |
Sarcoma |
0.004102815 |
Sensitive |
| ENSG00000259230.1 |
Ponatinib |
Sarcoma |
0.038180831 |
Sensitive |
| ENSG00000259617.1 |
Ponatinib |
Sarcoma |
0.02835805 |
Sensitive |
| ENSG00000259687.1 |
Ponatinib |
Sarcoma |
0.015018621 |
Sensitive |
| ENSG00000267199.1 |
Ponatinib |
Sarcoma |
0.046244911 |
Sensitive |
| ENSG00000269609.1 |
Ponatinib |
Sarcoma |
0.038747904 |
Sensitive |
| ENSG00000270605.1 |
Ponatinib |
Sarcoma |
0.024178247 |
Sensitive |
| ENSG00000272657.1 |
Ponatinib |
Sarcoma |
0.021067979 |
Sensitive |
| ENSG00000272792.1 |
Ponatinib |
Sarcoma |
0.019933559 |
Sensitive |
| ENSG00000175773.8 |
Ponatinib |
Skin cutaneous melanoma |
0.039972049 |
Sensitive |
| ENSG00000223401.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048761932 |
Sensitive |
| ENSG00000223652.2 |
Ponatinib |
Skin cutaneous melanoma |
0.034826528 |
Sensitive |
| ENSG00000224649.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044349879 |
Sensitive |
| ENSG00000225506.2 |
Ponatinib |
Skin cutaneous melanoma |
0.038263114 |
Sensitive |
| ENSG00000227496.1 |
Ponatinib |
Skin cutaneous melanoma |
0.010685145 |
Sensitive |
| ENSG00000228809.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048490078 |
Sensitive |
| ENSG00000230898.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048010489 |
Sensitive |
| ENSG00000232053.2 |
Ponatinib |
Skin cutaneous melanoma |
0.0278532 |
Sensitive |
| ENSG00000232116.2 |
Ponatinib |
Skin cutaneous melanoma |
0.032475055 |
Sensitive |
| ENSG00000232131.1 |
Ponatinib |
Skin cutaneous melanoma |
0.024493848 |
Sensitive |
| ENSG00000233610.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048346921 |
Sensitive |
| ENSG00000233791.1 |
Ponatinib |
Skin cutaneous melanoma |
0.042700073 |
Sensitive |
| ENSG00000233891.3 |
Ponatinib |
Skin cutaneous melanoma |
0.035474138 |
Sensitive |
| ENSG00000234210.1 |
Ponatinib |
Skin cutaneous melanoma |
0.047278776 |
Sensitive |
| ENSG00000234350.1 |
Ponatinib |
Skin cutaneous melanoma |
0.009713763 |
Sensitive |
| ENSG00000235246.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023161086 |
Sensitive |
| ENSG00000235934.1 |
Ponatinib |
Skin cutaneous melanoma |
0.002618766 |
Sensitive |
| ENSG00000238178.2 |
Ponatinib |
Skin cutaneous melanoma |
0.007370882 |
Sensitive |
| ENSG00000243797.2 |
Ponatinib |
Skin cutaneous melanoma |
0.021419299 |
Sensitive |
| ENSG00000247844.1 |
Ponatinib |
Skin cutaneous melanoma |
0.026999637 |
Sensitive |
| ENSG00000248461.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008551391 |
Sensitive |
| ENSG00000248771.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049680519 |
Sensitive |
| ENSG00000249776.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044707416 |
Sensitive |
| ENSG00000249803.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049721545 |
Sensitive |
| ENSG00000249984.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02096191 |
Sensitive |
| ENSG00000250237.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036886925 |
Sensitive |
| ENSG00000251460.1 |
Ponatinib |
Skin cutaneous melanoma |
0.015633297 |
Sensitive |
| ENSG00000253256.1 |
Ponatinib |
Skin cutaneous melanoma |
0.021216045 |
Sensitive |
| ENSG00000254142.2 |
Ponatinib |
Skin cutaneous melanoma |
0.044354061 |
Sensitive |
| ENSG00000254401.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036530903 |
Sensitive |
| ENSG00000254878.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037223517 |
Sensitive |
| ENSG00000256690.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049904703 |
Sensitive |
| ENSG00000260011.2 |
Ponatinib |
Skin cutaneous melanoma |
0.019699283 |
Sensitive |
| ENSG00000260834.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00953095 |
Sensitive |
| ENSG00000261069.2 |
Ponatinib |
Skin cutaneous melanoma |
0.022589331 |
Sensitive |
| ENSG00000267454.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048266318 |
Sensitive |
| ENSG00000269220.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041977084 |
Sensitive |
| ENSG00000269916.1 |
Ponatinib |
Skin cutaneous melanoma |
0.03934428 |
Sensitive |
| ENSG00000272574.1 |
Ponatinib |
Skin cutaneous melanoma |
0.010513019 |
Sensitive |
| ENSG00000272966.1 |
Ponatinib |
Skin cutaneous melanoma |
0.000926361 |
Sensitive |
| ENSG00000273124.1 |
Ponatinib |
Skin cutaneous melanoma |
0.045878876 |
Sensitive |
| ENSG00000273230.1 |
Ponatinib |
Skin cutaneous melanoma |
0.006404863 |
Sensitive |
| ENSG00000179141.5 |
Ponatinib |
Stomach adenocarcinoma |
0.032366261 |
Sensitive |
| ENSG00000182376.2 |
Ponatinib |
Stomach adenocarcinoma |
0.021349756 |
Sensitive |
| ENSG00000197210.7 |
Ponatinib |
Stomach adenocarcinoma |
0.046113679 |
Sensitive |
| ENSG00000197813.4 |
Ponatinib |
Stomach adenocarcinoma |
0.039708268 |
Sensitive |
| ENSG00000203849.6 |
Ponatinib |
Stomach adenocarcinoma |
0.003237636 |
Sensitive |
| ENSG00000204706.10 |
Ponatinib |
Stomach adenocarcinoma |
0.045856901 |
Sensitive |
| ENSG00000205041.1 |
Ponatinib |
Stomach adenocarcinoma |
0.039048039 |
Sensitive |
| ENSG00000205913.2 |
Ponatinib |
Stomach adenocarcinoma |
0.004599969 |
Sensitive |
| ENSG00000223356.1 |
Ponatinib |
Stomach adenocarcinoma |
0.03856042 |
Sensitive |
| ENSG00000223791.1 |
Ponatinib |
Stomach adenocarcinoma |
0.042463631 |
Sensitive |
| ENSG00000225762.1 |
Ponatinib |
Stomach adenocarcinoma |
0.015856913 |
Sensitive |
| ENSG00000226699.1 |
Ponatinib |
Stomach adenocarcinoma |
0.015821202 |
Sensitive |
| ENSG00000226752.3 |
Ponatinib |
Stomach adenocarcinoma |
0.038522293 |
Sensitive |
| ENSG00000226852.2 |
Ponatinib |
Stomach adenocarcinoma |
0.041365139 |
Sensitive |
| ENSG00000227741.1 |
Ponatinib |
Stomach adenocarcinoma |
0.029528208 |
Sensitive |
| ENSG00000228137.1 |
Ponatinib |
Stomach adenocarcinoma |
0.031823782 |
Sensitive |
| ENSG00000228172.1 |
Ponatinib |
Stomach adenocarcinoma |
0.049489483 |
Sensitive |
| ENSG00000228350.1 |
Ponatinib |
Stomach adenocarcinoma |
0.046570592 |
Sensitive |
| ENSG00000228352.2 |
Ponatinib |
Stomach adenocarcinoma |
0.004916646 |
Sensitive |
| ENSG00000228363.2 |
Ponatinib |
Stomach adenocarcinoma |
0.040478374 |
Sensitive |
| ENSG00000229122.1 |
Ponatinib |
Stomach adenocarcinoma |
0.047193682 |
Sensitive |
| ENSG00000230555.2 |
Ponatinib |
Stomach adenocarcinoma |
0.000935776 |
Sensitive |
| ENSG00000230896.1 |
Ponatinib |
Stomach adenocarcinoma |
0.034126347 |
Sensitive |
| ENSG00000231028.4 |
Ponatinib |
Stomach adenocarcinoma |
0.014307501 |
Sensitive |
| ENSG00000231527.1 |
Ponatinib |
Stomach adenocarcinoma |
0.034069353 |
Sensitive |
| ENSG00000231789.2 |
Ponatinib |
Stomach adenocarcinoma |
0.01114998 |
Sensitive |
| ENSG00000232063.1 |
Ponatinib |
Stomach adenocarcinoma |
0.049363089 |
Sensitive |
| ENSG00000232098.2 |
Ponatinib |
Stomach adenocarcinoma |
0.002854785 |
Sensitive |
| ENSG00000232470.1 |
Ponatinib |
Stomach adenocarcinoma |
0.018934718 |
Sensitive |
| ENSG00000232732.5 |
Ponatinib |
Stomach adenocarcinoma |
0.038900178 |
Sensitive |
| ENSG00000232931.1 |
Ponatinib |
Stomach adenocarcinoma |
0.002386975 |
Sensitive |
| ENSG00000233255.1 |
Ponatinib |
Stomach adenocarcinoma |
0.002447972 |
Sensitive |
| ENSG00000234084.1 |
Ponatinib |
Stomach adenocarcinoma |
0.045707068 |
Sensitive |
| ENSG00000234917.1 |
Ponatinib |
Stomach adenocarcinoma |
0.031092089 |
Sensitive |
| ENSG00000235897.1 |
Ponatinib |
Stomach adenocarcinoma |
0.028672564 |
Sensitive |
| ENSG00000235908.1 |
Ponatinib |
Stomach adenocarcinoma |
0.025504906 |
Sensitive |
| ENSG00000236498.1 |
Ponatinib |
Stomach adenocarcinoma |
0.027295231 |
Sensitive |
| ENSG00000236537.1 |
Ponatinib |
Stomach adenocarcinoma |
0.020841537 |
Sensitive |
| ENSG00000237037.5 |
Ponatinib |
Stomach adenocarcinoma |
0.007543415 |
Sensitive |
| ENSG00000237073.1 |
Ponatinib |
Stomach adenocarcinoma |
0.019170575 |
Sensitive |
| ENSG00000237149.4 |
Ponatinib |
Stomach adenocarcinoma |
0.019674264 |
Sensitive |
| ENSG00000238141.2 |
Ponatinib |
Stomach adenocarcinoma |
0.015071918 |
Sensitive |
| ENSG00000239653.1 |
Ponatinib |
Stomach adenocarcinoma |
0.025596189 |
Sensitive |
| ENSG00000240401.4 |
Ponatinib |
Stomach adenocarcinoma |
0.041362484 |
Sensitive |
| ENSG00000240453.1 |
Ponatinib |
Stomach adenocarcinoma |
0.044587835 |
Sensitive |
| ENSG00000241886.1 |
Ponatinib |
Stomach adenocarcinoma |
0.018269931 |
Sensitive |
| ENSG00000243389.1 |
Ponatinib |
Stomach adenocarcinoma |
0.01580724 |
Sensitive |
| ENSG00000244055.1 |
Ponatinib |
Stomach adenocarcinoma |
0.008876601 |
Sensitive |
| ENSG00000244945.1 |
Ponatinib |
Stomach adenocarcinoma |
0.036142835 |
Sensitive |
| ENSG00000248508.2 |
Ponatinib |
Stomach adenocarcinoma |
0.039262614 |
Sensitive |
| ENSG00000248554.1 |
Ponatinib |
Stomach adenocarcinoma |
0.042561834 |
Sensitive |
| ENSG00000248866.1 |
Ponatinib |
Stomach adenocarcinoma |
0.003653553 |
Sensitive |
| ENSG00000250295.2 |
Ponatinib |
Stomach adenocarcinoma |
0.013801128 |
Sensitive |
| ENSG00000250410.1 |
Ponatinib |
Stomach adenocarcinoma |
0.003304539 |
Sensitive |
| ENSG00000250917.1 |
Ponatinib |
Stomach adenocarcinoma |
0.026928534 |
Sensitive |
| ENSG00000250999.1 |
Ponatinib |
Stomach adenocarcinoma |
0.009842814 |
Sensitive |
| ENSG00000251161.2 |
Ponatinib |
Stomach adenocarcinoma |
0.02304283 |
Sensitive |
| ENSG00000254034.1 |
Ponatinib |
Stomach adenocarcinoma |
0.036347821 |
Sensitive |
| ENSG00000254718.2 |
Ponatinib |
Stomach adenocarcinoma |
0.029090151 |
Sensitive |
| ENSG00000254907.1 |
Ponatinib |
Stomach adenocarcinoma |
0.024073278 |
Sensitive |
| ENSG00000255517.2 |
Ponatinib |
Stomach adenocarcinoma |
0.042137413 |
Sensitive |
| ENSG00000255970.1 |
Ponatinib |
Stomach adenocarcinoma |
0.020130216 |
Sensitive |
| ENSG00000256116.1 |
Ponatinib |
Stomach adenocarcinoma |
0.042452534 |
Sensitive |
| ENSG00000258441.1 |
Ponatinib |
Stomach adenocarcinoma |
0.045338954 |
Sensitive |
| ENSG00000259138.1 |
Ponatinib |
Stomach adenocarcinoma |
0.028170254 |
Sensitive |
| ENSG00000259298.1 |
Ponatinib |
Stomach adenocarcinoma |
0.047019455 |
Sensitive |
| ENSG00000259327.1 |
Ponatinib |
Stomach adenocarcinoma |
0.001910108 |
Sensitive |
| ENSG00000259442.1 |
Ponatinib |
Stomach adenocarcinoma |
0.034118918 |
Sensitive |
| ENSG00000259654.1 |
Ponatinib |
Stomach adenocarcinoma |
0.017928615 |
Sensitive |
| ENSG00000260219.1 |
Ponatinib |
Stomach adenocarcinoma |
0.040813264 |
Sensitive |
| ENSG00000260296.1 |
Ponatinib |
Stomach adenocarcinoma |
0.049149118 |
Sensitive |
| ENSG00000260655.1 |
Ponatinib |
Stomach adenocarcinoma |
0.005144535 |
Sensitive |
| ENSG00000260672.1 |
Ponatinib |
Stomach adenocarcinoma |
0.008765049 |
Sensitive |
| ENSG00000260853.1 |
Ponatinib |
Stomach adenocarcinoma |
0.036519816 |
Sensitive |
| ENSG00000261654.1 |
Ponatinib |
Stomach adenocarcinoma |
0.000257347 |
Sensitive |
| ENSG00000261663.1 |
Ponatinib |
Stomach adenocarcinoma |
0.016161343 |
Sensitive |
| ENSG00000262372.1 |
Ponatinib |
Stomach adenocarcinoma |
0.038515491 |
Sensitive |
| ENSG00000262468.1 |
Ponatinib |
Stomach adenocarcinoma |
0.022639244 |
Sensitive |
| ENSG00000262879.1 |
Ponatinib |
Stomach adenocarcinoma |
0.009022146 |
Sensitive |
| ENSG00000264569.1 |
Ponatinib |
Stomach adenocarcinoma |
0.003042889 |
Sensitive |
| ENSG00000264769.1 |
Ponatinib |
Stomach adenocarcinoma |
0.047109775 |
Sensitive |
| ENSG00000265511.1 |
Ponatinib |
Stomach adenocarcinoma |
0.006898356 |
Sensitive |
| ENSG00000265656.1 |
Ponatinib |
Stomach adenocarcinoma |
0.036882368 |
Sensitive |
| ENSG00000265800.1 |
Ponatinib |
Stomach adenocarcinoma |
0.017527709 |
Sensitive |
| ENSG00000266236.1 |
Ponatinib |
Stomach adenocarcinoma |
0.035183973 |
Sensitive |
| ENSG00000266993.1 |
Ponatinib |
Stomach adenocarcinoma |
0.023877357 |
Sensitive |
| ENSG00000267002.1 |
Ponatinib |
Stomach adenocarcinoma |
0.046809488 |
Sensitive |
| ENSG00000267313.2 |
Ponatinib |
Stomach adenocarcinoma |
0.049212794 |
Sensitive |
| ENSG00000267395.1 |
Ponatinib |
Stomach adenocarcinoma |
0.047727763 |
Sensitive |
| ENSG00000267858.1 |
Ponatinib |
Stomach adenocarcinoma |
0.032751717 |
Sensitive |
| ENSG00000267898.1 |
Ponatinib |
Stomach adenocarcinoma |
0.003302073 |
Sensitive |
| ENSG00000268061.1 |
Ponatinib |
Stomach adenocarcinoma |
0.00717285 |
Sensitive |
| ENSG00000268520.1 |
Ponatinib |
Stomach adenocarcinoma |
0.038090943 |
Sensitive |
| ENSG00000268947.1 |
Ponatinib |
Stomach adenocarcinoma |
0.04853817 |
Sensitive |
| ENSG00000269653.1 |
Ponatinib |
Stomach adenocarcinoma |
0.011870727 |
Sensitive |
| ENSG00000269688.1 |
Ponatinib |
Stomach adenocarcinoma |
0.015533842 |
Sensitive |
| ENSG00000269867.1 |
Ponatinib |
Stomach adenocarcinoma |
0.004545273 |
Sensitive |
| ENSG00000269910.1 |
Ponatinib |
Stomach adenocarcinoma |
0.010651721 |
Sensitive |
| ENSG00000270346.1 |
Ponatinib |
Stomach adenocarcinoma |
0.04036333 |
Sensitive |
| ENSG00000271551.1 |
Ponatinib |
Stomach adenocarcinoma |
0.021094469 |
Sensitive |
| ENSG00000271738.1 |
Ponatinib |
Stomach adenocarcinoma |
0.0077868 |
Sensitive |
| ENSG00000271757.1 |
Ponatinib |
Stomach adenocarcinoma |
0.003414383 |
Sensitive |
| ENSG00000271781.1 |
Ponatinib |
Stomach adenocarcinoma |
0.015346581 |
Sensitive |
| ENSG00000271975.1 |
Ponatinib |
Stomach adenocarcinoma |
0.024380982 |
Sensitive |
| ENSG00000272033.1 |
Ponatinib |
Stomach adenocarcinoma |
0.03151426 |
Sensitive |
| ENSG00000272156.1 |
Ponatinib |
Stomach adenocarcinoma |
0.013246931 |
Sensitive |
| ENSG00000272520.1 |
Ponatinib |
Stomach adenocarcinoma |
0.040337479 |
Sensitive |
| ENSG00000272529.1 |
Ponatinib |
Stomach adenocarcinoma |
0.048694506 |
Sensitive |
| ENSG00000272849.1 |
Ponatinib |
Stomach adenocarcinoma |
0.043625588 |
Sensitive |
| ENSG00000272905.1 |
Ponatinib |
Stomach adenocarcinoma |
0.034520622 |
Sensitive |
| ENSG00000273190.1 |
Ponatinib |
Stomach adenocarcinoma |
0.018119927 |
Sensitive |
| ENSG00000152487.6 |
Ponatinib |
Thyroid carcinoma |
0.02502682 |
Sensitive |
| ENSG00000215241.3 |
Ponatinib |
Thyroid carcinoma |
0.034242632 |
Sensitive |
| ENSG00000225981.1 |
Ponatinib |
Thyroid carcinoma |
0.016913775 |
Sensitive |
| ENSG00000230724.5 |
Ponatinib |
Thyroid carcinoma |
0.044336606 |
Sensitive |
| ENSG00000236438.2 |
Ponatinib |
Thyroid carcinoma |
0.031484382 |
Sensitive |
| ENSG00000237094.7 |
Ponatinib |
Thyroid carcinoma |
0.046994051 |
Sensitive |
| ENSG00000238113.2 |
Ponatinib |
Thyroid carcinoma |
0.047163449 |
Sensitive |
| ENSG00000241180.1 |
Ponatinib |
Thyroid carcinoma |
0.007716159 |
Sensitive |
| ENSG00000244968.2 |
Ponatinib |
Thyroid carcinoma |
0.036574046 |
Sensitive |
| ENSG00000246174.3 |
Ponatinib |
Thyroid carcinoma |
0.033634994 |
Sensitive |
| ENSG00000248323.1 |
Ponatinib |
Thyroid carcinoma |
0.023451426 |
Sensitive |
| ENSG00000248896.2 |
Ponatinib |
Thyroid carcinoma |
0.044734334 |
Sensitive |
| ENSG00000248925.1 |
Ponatinib |
Thyroid carcinoma |
0.0000863 |
Sensitive |
| ENSG00000249846.2 |
Ponatinib |
Thyroid carcinoma |
0.044076111 |
Sensitive |
| ENSG00000251221.1 |
Ponatinib |
Thyroid carcinoma |
0.013624539 |
Sensitive |
| ENSG00000253642.1 |
Ponatinib |
Thyroid carcinoma |
0.047174826 |
Sensitive |
| ENSG00000254671.1 |
Ponatinib |
Thyroid carcinoma |
0.029161951 |
Sensitive |
| ENSG00000255028.1 |
Ponatinib |
Thyroid carcinoma |
0.048041224 |
Sensitive |
| ENSG00000255029.1 |
Ponatinib |
Thyroid carcinoma |
0.029179973 |
Sensitive |
| ENSG00000255229.1 |
Ponatinib |
Thyroid carcinoma |
0.021275847 |
Sensitive |
| ENSG00000256377.1 |
Ponatinib |
Thyroid carcinoma |
0.035722503 |
Sensitive |
| ENSG00000257831.1 |
Ponatinib |
Thyroid carcinoma |
0.003288701 |
Sensitive |
| ENSG00000259883.1 |
Ponatinib |
Thyroid carcinoma |
0.032507246 |
Sensitive |
| ENSG00000260528.2 |
Ponatinib |
Thyroid carcinoma |
0.037732882 |
Sensitive |
| ENSG00000260646.1 |
Ponatinib |
Thyroid carcinoma |
0.025366012 |
Sensitive |
| ENSG00000260810.1 |
Ponatinib |
Thyroid carcinoma |
0.041484881 |
Sensitive |
| ENSG00000260874.1 |
Ponatinib |
Thyroid carcinoma |
0.005837637 |
Sensitive |
| ENSG00000261324.2 |
Ponatinib |
Thyroid carcinoma |
0.042791478 |
Sensitive |
| ENSG00000266601.1 |
Ponatinib |
Thyroid carcinoma |
0.038310515 |
Sensitive |
| ENSG00000267397.1 |
Ponatinib |
Thyroid carcinoma |
0.036608038 |
Sensitive |
| ENSG00000267565.1 |
Ponatinib |
Thyroid carcinoma |
0.038421713 |
Sensitive |
| ENSG00000267834.1 |
Ponatinib |
Thyroid carcinoma |
0.024983587 |
Sensitive |
| ENSG00000268573.1 |
Ponatinib |
Thyroid carcinoma |
0.025509233 |
Sensitive |
| ENSG00000270332.1 |
Ponatinib |
Thyroid carcinoma |
0.008124688 |
Sensitive |
| ENSG00000271762.1 |
Ponatinib |
Thyroid carcinoma |
0.006765086 |
Sensitive |
| ENSG00000271826.1 |
Ponatinib |
Thyroid carcinoma |
0.043047738 |
Sensitive |
| ENSG00000272250.1 |
Ponatinib |
Thyroid carcinoma |
0.025710355 |
Sensitive |
| ENSG00000272463.1 |
Ponatinib |
Thyroid carcinoma |
0.01263193 |
Sensitive |
| ENSG00000272518.1 |
Ponatinib |
Thyroid carcinoma |
0.013481518 |
Sensitive |
| ENSG00000272902.1 |
Ponatinib |
Thyroid carcinoma |
0.032994005 |
Sensitive |
| ENSG00000272949.1 |
Ponatinib |
Thyroid carcinoma |
0.048016979 |
Sensitive |
| ENSG00000273471.1 |
Ponatinib |
Thyroid carcinoma |
0.039231127 |
Sensitive |
| ENSG00000174365.15 |
Ponatinib |
Bladder urothelial carcinoma |
0.018021848 |
Resistant |
| ENSG00000175147.7 |
Ponatinib |
Bladder urothelial carcinoma |
0.026552517 |
Resistant |
| ENSG00000224888.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.022684668 |
Resistant |
| ENSG00000227070.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.042071873 |
Resistant |
| ENSG00000227172.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.047082586 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.01696431 |
Resistant |
| ENSG00000228135.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.007350958 |
Resistant |
| ENSG00000229953.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.046423576 |
Resistant |
| ENSG00000230400.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.023386399 |
Resistant |
| ENSG00000230850.3 |
Ponatinib |
Bladder urothelial carcinoma |
0.017472731 |
Resistant |
| ENSG00000232412.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039702802 |
Resistant |
| ENSG00000234183.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044807197 |
Resistant |
| ENSG00000234350.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044305014 |
Resistant |
| ENSG00000235831.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.046693153 |
Resistant |
| ENSG00000235872.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.020719176 |
Resistant |
| ENSG00000236799.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.043903974 |
Resistant |
| ENSG00000238221.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.00789615 |
Resistant |
| ENSG00000241269.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.004211498 |
Resistant |
| ENSG00000242622.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.03253045 |
Resistant |
| ENSG00000248494.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.019050113 |
Resistant |
| ENSG00000251611.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.037509233 |
Resistant |
| ENSG00000258929.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.043171112 |
Resistant |
| ENSG00000259359.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.030343812 |
Resistant |
| ENSG00000259426.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.041902074 |
Resistant |
| ENSG00000259476.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.049209258 |
Resistant |
| ENSG00000260954.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.00870289 |
Resistant |
| ENSG00000260979.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.038421591 |
Resistant |
| ENSG00000261731.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.049596583 |
Resistant |
| ENSG00000261801.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.032013399 |
Resistant |
| ENSG00000264920.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.001371842 |
Resistant |
| ENSG00000269919.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.032049156 |
Resistant |
| ENSG00000270964.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.024043405 |
Resistant |
| ENSG00000271826.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.035866598 |
Resistant |
| ENSG00000272659.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045401414 |
Resistant |
| ENSG00000273065.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.04882937 |
Resistant |
| ENSG00000273125.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039707767 |
Resistant |
| ENSG00000273143.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.041719838 |
Resistant |
| ENSG00000180422.3 |
Ponatinib |
Breast invasive carcinoma |
0.023612181 |
Resistant |
| ENSG00000203496.4 |
Ponatinib |
Breast invasive carcinoma |
0.041633287 |
Resistant |
| ENSG00000204934.6 |
Ponatinib |
Breast invasive carcinoma |
0.043173874 |
Resistant |
| ENSG00000224441.1 |
Ponatinib |
Breast invasive carcinoma |
0.033298424 |
Resistant |
| ENSG00000228350.1 |
Ponatinib |
Breast invasive carcinoma |
0.030195375 |
Resistant |
| ENSG00000228989.1 |
Ponatinib |
Breast invasive carcinoma |
0.016367922 |
Resistant |
| ENSG00000230310.1 |
Ponatinib |
Breast invasive carcinoma |
0.036876795 |
Resistant |
| ENSG00000235296.1 |
Ponatinib |
Breast invasive carcinoma |
0.026184692 |
Resistant |
| ENSG00000235830.1 |
Ponatinib |
Breast invasive carcinoma |
0.044900567 |
Resistant |
| ENSG00000237310.1 |
Ponatinib |
Breast invasive carcinoma |
0.029591981 |
Resistant |
| ENSG00000246465.1 |
Ponatinib |
Breast invasive carcinoma |
0.049192419 |
Resistant |
| ENSG00000247311.2 |
Ponatinib |
Breast invasive carcinoma |
0.027757868 |
Resistant |
| ENSG00000250057.1 |
Ponatinib |
Breast invasive carcinoma |
0.019937683 |
Resistant |
| ENSG00000256458.1 |
Ponatinib |
Breast invasive carcinoma |
0.006972608 |
Resistant |
| ENSG00000258378.1 |
Ponatinib |
Breast invasive carcinoma |
0.0107651 |
Resistant |
| ENSG00000258731.1 |
Ponatinib |
Breast invasive carcinoma |
0.01872143 |
Resistant |
| ENSG00000260369.2 |
Ponatinib |
Breast invasive carcinoma |
0.042083823 |
Resistant |
| ENSG00000264222.1 |
Ponatinib |
Breast invasive carcinoma |
0.040064099 |
Resistant |
| ENSG00000266933.1 |
Ponatinib |
Breast invasive carcinoma |
0.015402589 |
Resistant |
| ENSG00000267666.1 |
Ponatinib |
Breast invasive carcinoma |
0.042989387 |
Resistant |
| ENSG00000269483.1 |
Ponatinib |
Breast invasive carcinoma |
0.03860279 |
Resistant |
| ENSG00000272848.1 |
Ponatinib |
Breast invasive carcinoma |
0.040824648 |
Resistant |
| ENSG00000272914.1 |
Ponatinib |
Breast invasive carcinoma |
0.040323221 |
Resistant |
| ENSG00000273156.1 |
Ponatinib |
Breast invasive carcinoma |
0.012415183 |
Resistant |
| ENSG00000273240.1 |
Ponatinib |
Breast invasive carcinoma |
0.022574905 |
Resistant |
| ENSG00000124915.6 |
Ponatinib |
Colon adenocarcinoma |
0.042676609 |
Resistant |
| ENSG00000175611.7 |
Ponatinib |
Colon adenocarcinoma |
0.00173401 |
Resistant |
| ENSG00000182165.13 |
Ponatinib |
Colon adenocarcinoma |
0.015432251 |
Resistant |
| ENSG00000196810.4 |
Ponatinib |
Colon adenocarcinoma |
0.007603405 |
Resistant |
| ENSG00000224046.1 |
Ponatinib |
Colon adenocarcinoma |
0.006267506 |
Resistant |
| ENSG00000225675.2 |
Ponatinib |
Colon adenocarcinoma |
0.00065439 |
Resistant |
| ENSG00000226562.2 |
Ponatinib |
Colon adenocarcinoma |
0.006882101 |
Resistant |
| ENSG00000226754.1 |
Ponatinib |
Colon adenocarcinoma |
0.049882777 |
Resistant |
| ENSG00000227542.1 |
Ponatinib |
Colon adenocarcinoma |
0.029907481 |
Resistant |
| ENSG00000227589.1 |
Ponatinib |
Colon adenocarcinoma |
0.025352856 |
Resistant |
| ENSG00000228113.3 |
Ponatinib |
Colon adenocarcinoma |
0.026641452 |
Resistant |
| ENSG00000228643.1 |
Ponatinib |
Colon adenocarcinoma |
0.000514808 |
Resistant |
| ENSG00000228786.1 |
Ponatinib |
Colon adenocarcinoma |
0.025374576 |
Resistant |
| ENSG00000230337.1 |
Ponatinib |
Colon adenocarcinoma |
0.0146691 |
Resistant |
| ENSG00000230424.1 |
Ponatinib |
Colon adenocarcinoma |
0.000409231 |
Resistant |
| ENSG00000230648.1 |
Ponatinib |
Colon adenocarcinoma |
0.003200133 |
Resistant |
| ENSG00000230679.1 |
Ponatinib |
Colon adenocarcinoma |
0.033315811 |
Resistant |
| ENSG00000231172.2 |
Ponatinib |
Colon adenocarcinoma |
0.041573131 |
Resistant |
| ENSG00000231327.1 |
Ponatinib |
Colon adenocarcinoma |
0.003261388 |
Resistant |
| ENSG00000233509.2 |
Ponatinib |
Colon adenocarcinoma |
0.016660546 |
Resistant |
| ENSG00000233554.1 |
Ponatinib |
Colon adenocarcinoma |
0.001084671 |
Resistant |
| ENSG00000233621.1 |
Ponatinib |
Colon adenocarcinoma |
0.016057498 |
Resistant |
| ENSG00000233757.2 |
Ponatinib |
Colon adenocarcinoma |
0.026398904 |
Resistant |
| ENSG00000235078.1 |
Ponatinib |
Colon adenocarcinoma |
0.020480447 |
Resistant |
| ENSG00000235586.1 |
Ponatinib |
Colon adenocarcinoma |
0.032216148 |
Resistant |
| ENSG00000235741.1 |
Ponatinib |
Colon adenocarcinoma |
0.042448747 |
Resistant |
| ENSG00000237250.3 |
Ponatinib |
Colon adenocarcinoma |
0.027723135 |
Resistant |
| ENSG00000237253.1 |
Ponatinib |
Colon adenocarcinoma |
0.032410783 |
Resistant |
| ENSG00000237343.1 |
Ponatinib |
Colon adenocarcinoma |
0.042108569 |
Resistant |
| ENSG00000237883.1 |
Ponatinib |
Colon adenocarcinoma |
0.020163833 |
Resistant |
| ENSG00000239569.2 |
Ponatinib |
Colon adenocarcinoma |
0.023405263 |
Resistant |
| ENSG00000240050.1 |
Ponatinib |
Colon adenocarcinoma |
0.04811233 |
Resistant |
| ENSG00000240453.1 |
Ponatinib |
Colon adenocarcinoma |
0.038132703 |
Resistant |
| ENSG00000241280.1 |
Ponatinib |
Colon adenocarcinoma |
0.014639478 |
Resistant |
| ENSG00000242136.1 |
Ponatinib |
Colon adenocarcinoma |
0.043038869 |
Resistant |
| ENSG00000243944.1 |
Ponatinib |
Colon adenocarcinoma |
0.042807493 |
Resistant |
| ENSG00000248049.2 |
Ponatinib |
Colon adenocarcinoma |
0.03171052 |
Resistant |
| ENSG00000248161.1 |
Ponatinib |
Colon adenocarcinoma |
0.033737491 |
Resistant |
| ENSG00000249348.1 |
Ponatinib |
Colon adenocarcinoma |
0.039612822 |
Resistant |
| ENSG00000250156.3 |
Ponatinib |
Colon adenocarcinoma |
0.022763342 |
Resistant |
| ENSG00000251393.3 |
Ponatinib |
Colon adenocarcinoma |
0.006699124 |
Resistant |
| ENSG00000253133.1 |
Ponatinib |
Colon adenocarcinoma |
0.036289177 |
Resistant |
| ENSG00000254718.2 |
Ponatinib |
Colon adenocarcinoma |
0.041729785 |
Resistant |
| ENSG00000255153.1 |
Ponatinib |
Colon adenocarcinoma |
0.040922756 |
Resistant |
| ENSG00000255310.2 |
Ponatinib |
Colon adenocarcinoma |
0.027944878 |
Resistant |
| ENSG00000255474.1 |
Ponatinib |
Colon adenocarcinoma |
0.027133272 |
Resistant |
| ENSG00000256150.1 |
Ponatinib |
Colon adenocarcinoma |
0.007244474 |
Resistant |
| ENSG00000257433.1 |
Ponatinib |
Colon adenocarcinoma |
0.04436875 |
Resistant |
| ENSG00000259274.1 |
Ponatinib |
Colon adenocarcinoma |
0.023033874 |
Resistant |
| ENSG00000259802.1 |
Ponatinib |
Colon adenocarcinoma |
0.04835968 |
Resistant |
| ENSG00000259867.1 |
Ponatinib |
Colon adenocarcinoma |
0.029715431 |
Resistant |
| ENSG00000260081.1 |
Ponatinib |
Colon adenocarcinoma |
0.038015597 |
Resistant |
| ENSG00000260086.1 |
Ponatinib |
Colon adenocarcinoma |
0.019547539 |
Resistant |
| ENSG00000260136.1 |
Ponatinib |
Colon adenocarcinoma |
0.003661773 |
Resistant |
| ENSG00000260176.1 |
Ponatinib |
Colon adenocarcinoma |
0.048705527 |
Resistant |
| ENSG00000260219.1 |
Ponatinib |
Colon adenocarcinoma |
0.034414546 |
Resistant |
| ENSG00000260281.1 |
Ponatinib |
Colon adenocarcinoma |
0.046277907 |
Resistant |
| ENSG00000260360.1 |
Ponatinib |
Colon adenocarcinoma |
0.028515609 |
Resistant |
| ENSG00000260874.1 |
Ponatinib |
Colon adenocarcinoma |
0.043930917 |
Resistant |
| ENSG00000260919.1 |
Ponatinib |
Colon adenocarcinoma |
0.017979828 |
Resistant |
| ENSG00000260936.1 |
Ponatinib |
Colon adenocarcinoma |
0.021229615 |
Resistant |
| ENSG00000260954.1 |
Ponatinib |
Colon adenocarcinoma |
0.014372243 |
Resistant |
| ENSG00000261204.1 |
Ponatinib |
Colon adenocarcinoma |
0.028251572 |
Resistant |
| ENSG00000261318.1 |
Ponatinib |
Colon adenocarcinoma |
0.03097654 |
Resistant |
| ENSG00000261455.1 |
Ponatinib |
Colon adenocarcinoma |
0.00270352 |
Resistant |
| ENSG00000262412.1 |
Ponatinib |
Colon adenocarcinoma |
0.039315504 |
Resistant |
| ENSG00000263011.1 |
Ponatinib |
Colon adenocarcinoma |
0.008590806 |
Resistant |
| ENSG00000263050.1 |
Ponatinib |
Colon adenocarcinoma |
0.0446538 |
Resistant |
| ENSG00000263627.1 |
Ponatinib |
Colon adenocarcinoma |
0.025767639 |
Resistant |
| ENSG00000266850.1 |
Ponatinib |
Colon adenocarcinoma |
0.038256664 |
Resistant |
| ENSG00000266921.1 |
Ponatinib |
Colon adenocarcinoma |
0.008527314 |
Resistant |
| ENSG00000267248.1 |
Ponatinib |
Colon adenocarcinoma |
0.021296853 |
Resistant |
| ENSG00000267289.1 |
Ponatinib |
Colon adenocarcinoma |
0.035356348 |
Resistant |
| ENSG00000267302.1 |
Ponatinib |
Colon adenocarcinoma |
0.007000117 |
Resistant |
| ENSG00000269293.2 |
Ponatinib |
Colon adenocarcinoma |
0.007224339 |
Resistant |
| ENSG00000269600.1 |
Ponatinib |
Colon adenocarcinoma |
0.044719354 |
Resistant |
| ENSG00000269843.1 |
Ponatinib |
Colon adenocarcinoma |
0.019256485 |
Resistant |
| ENSG00000271780.1 |
Ponatinib |
Colon adenocarcinoma |
0.045893663 |
Resistant |
| ENSG00000272264.1 |
Ponatinib |
Colon adenocarcinoma |
0.003247355 |
Resistant |
| ENSG00000272432.1 |
Ponatinib |
Colon adenocarcinoma |
0.011733893 |
Resistant |
| ENSG00000272524.1 |
Ponatinib |
Colon adenocarcinoma |
0.016131685 |
Resistant |
| ENSG00000272558.1 |
Ponatinib |
Colon adenocarcinoma |
0.011639829 |
Resistant |
| ENSG00000272717.1 |
Ponatinib |
Colon adenocarcinoma |
0.00567785 |
Resistant |
| ENSG00000272940.1 |
Ponatinib |
Colon adenocarcinoma |
0.033820184 |
Resistant |
| ENSG00000273035.1 |
Ponatinib |
Colon adenocarcinoma |
0.038160205 |
Resistant |
| ENSG00000273117.1 |
Ponatinib |
Colon adenocarcinoma |
0.02779067 |
Resistant |
| ENSG00000273293.1 |
Ponatinib |
Colon adenocarcinoma |
0.004337637 |
Resistant |
| ENSG00000273338.1 |
Ponatinib |
Colon adenocarcinoma |
0.010076483 |
Resistant |
| ENSG00000175701.6 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008999404 |
Resistant |
| ENSG00000186842.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042252306 |
Resistant |
| ENSG00000205500.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020460064 |
Resistant |
| ENSG00000215241.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034547435 |
Resistant |
| ENSG00000223396.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046706895 |
Resistant |
| ENSG00000223466.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033804923 |
Resistant |
| ENSG00000223960.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042004797 |
Resistant |
| ENSG00000224101.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019201688 |
Resistant |
| ENSG00000224536.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031856497 |
Resistant |
| ENSG00000224789.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013131146 |
Resistant |
| ENSG00000224885.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030285671 |
Resistant |
| ENSG00000226380.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042312232 |
Resistant |
| ENSG00000228022.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023679493 |
Resistant |
| ENSG00000228526.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048582945 |
Resistant |
| ENSG00000229105.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040865567 |
Resistant |
| ENSG00000229688.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048779562 |
Resistant |
| ENSG00000229874.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048230883 |
Resistant |
| ENSG00000229990.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014254882 |
Resistant |
| ENSG00000230736.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019428763 |
Resistant |
| ENSG00000230815.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009139323 |
Resistant |
| ENSG00000230896.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018119138 |
Resistant |
| ENSG00000231613.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00611147 |
Resistant |
| ENSG00000232623.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001409637 |
Resistant |
| ENSG00000233559.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046552868 |
Resistant |
| ENSG00000234650.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025206863 |
Resistant |
| ENSG00000235659.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03313694 |
Resistant |
| ENSG00000236434.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002043105 |
Resistant |
| ENSG00000236449.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047556565 |
Resistant |
| ENSG00000236936.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040765513 |
Resistant |
| ENSG00000237903.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043270796 |
Resistant |
| ENSG00000240207.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039570469 |
Resistant |
| ENSG00000240535.4 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016376137 |
Resistant |
| ENSG00000241954.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015648254 |
Resistant |
| ENSG00000243944.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03267655 |
Resistant |
| ENSG00000244040.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04189988 |
Resistant |
| ENSG00000244265.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043995468 |
Resistant |
| ENSG00000246695.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016047096 |
Resistant |
| ENSG00000246889.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045438189 |
Resistant |
| ENSG00000247193.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036827396 |
Resistant |
| ENSG00000248668.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014418254 |
Resistant |
| ENSG00000249249.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040030862 |
Resistant |
| ENSG00000249417.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040735333 |
Resistant |
| ENSG00000251562.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031041097 |
Resistant |
| ENSG00000253385.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0004141 |
Resistant |
| ENSG00000253911.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020269447 |
Resistant |
| ENSG00000254615.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044335311 |
Resistant |
| ENSG00000255557.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038778483 |
Resistant |
| ENSG00000257681.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039321057 |
Resistant |
| ENSG00000258407.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045115115 |
Resistant |
| ENSG00000258486.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012004475 |
Resistant |
| ENSG00000258561.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041917947 |
Resistant |
| ENSG00000258646.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004201428 |
Resistant |
| ENSG00000258730.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011803502 |
Resistant |
| ENSG00000259081.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001358663 |
Resistant |
| ENSG00000259668.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024358161 |
Resistant |
| ENSG00000259792.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044751926 |
Resistant |
| ENSG00000259926.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038244698 |
Resistant |
| ENSG00000260077.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004385883 |
Resistant |
| ENSG00000260931.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039057599 |
Resistant |
| ENSG00000260940.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042776305 |
Resistant |
| ENSG00000261656.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048839796 |
Resistant |
| ENSG00000261816.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048432384 |
Resistant |
| ENSG00000264031.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039912931 |
Resistant |
| ENSG00000264112.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006761754 |
Resistant |
| ENSG00000265801.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025870353 |
Resistant |
| ENSG00000266538.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018413752 |
Resistant |
| ENSG00000266903.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046593142 |
Resistant |
| ENSG00000267159.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009221986 |
Resistant |
| ENSG00000267169.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006659101 |
Resistant |
| ENSG00000267248.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00989288 |
Resistant |
| ENSG00000267278.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043879689 |
Resistant |
| ENSG00000267457.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035394959 |
Resistant |
| ENSG00000267658.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04170298 |
Resistant |
| ENSG00000267764.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022507353 |
Resistant |
| ENSG00000267798.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018811542 |
Resistant |
| ENSG00000268751.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020161808 |
Resistant |
| ENSG00000269202.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034194265 |
Resistant |
| ENSG00000269906.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003581296 |
Resistant |
| ENSG00000270048.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044166471 |
Resistant |
| ENSG00000270157.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044842895 |
Resistant |
| ENSG00000270557.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02085912 |
Resistant |
| ENSG00000270720.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011236727 |
Resistant |
| ENSG00000271204.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033514652 |
Resistant |
| ENSG00000271359.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020281506 |
Resistant |
| ENSG00000271938.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042961326 |
Resistant |
| ENSG00000272275.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022208857 |
Resistant |
| ENSG00000272702.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012573686 |
Resistant |
| ENSG00000273319.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039366707 |
Resistant |
| ENSG00000206176.5 |
Ponatinib |
Esophageal cancer |
0.003082913 |
Resistant |
| ENSG00000224174.2 |
Ponatinib |
Esophageal cancer |
0.004695326 |
Resistant |
| ENSG00000224541.1 |
Ponatinib |
Esophageal cancer |
0.003305143 |
Resistant |
| ENSG00000225439.2 |
Ponatinib |
Esophageal cancer |
0.019771938 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Esophageal cancer |
0.030295958 |
Resistant |
| ENSG00000227502.2 |
Ponatinib |
Esophageal cancer |
0.030535306 |
Resistant |
| ENSG00000228604.3 |
Ponatinib |
Esophageal cancer |
0.028001718 |
Resistant |
| ENSG00000230368.2 |
Ponatinib |
Esophageal cancer |
0.000988711 |
Resistant |
| ENSG00000230415.1 |
Ponatinib |
Esophageal cancer |
0.014899247 |
Resistant |
| ENSG00000231795.1 |
Ponatinib |
Esophageal cancer |
0.028498771 |
Resistant |
| ENSG00000232224.1 |
Ponatinib |
Esophageal cancer |
0.029174177 |
Resistant |
| ENSG00000232613.2 |
Ponatinib |
Esophageal cancer |
0.025984619 |
Resistant |
| ENSG00000234290.2 |
Ponatinib |
Esophageal cancer |
0.003185914 |
Resistant |
| ENSG00000234509.1 |
Ponatinib |
Esophageal cancer |
0.023695124 |
Resistant |
| ENSG00000234650.1 |
Ponatinib |
Esophageal cancer |
0.01318299 |
Resistant |
| ENSG00000234945.3 |
Ponatinib |
Esophageal cancer |
0.027998624 |
Resistant |
| ENSG00000235029.1 |
Ponatinib |
Esophageal cancer |
0.011922856 |
Resistant |
| ENSG00000235269.1 |
Ponatinib |
Esophageal cancer |
0.013554823 |
Resistant |
| ENSG00000235565.1 |
Ponatinib |
Esophageal cancer |
0.01960422 |
Resistant |
| ENSG00000235781.1 |
Ponatinib |
Esophageal cancer |
0.015698745 |
Resistant |
| ENSG00000236140.1 |
Ponatinib |
Esophageal cancer |
0.043360179 |
Resistant |
| ENSG00000237476.1 |
Ponatinib |
Esophageal cancer |
0.0000153 |
Resistant |
| ENSG00000237595.2 |
Ponatinib |
Esophageal cancer |
0.010575713 |
Resistant |
| ENSG00000237689.1 |
Ponatinib |
Esophageal cancer |
0.01091894 |
Resistant |
| ENSG00000239219.2 |
Ponatinib |
Esophageal cancer |
0.024776135 |
Resistant |
| ENSG00000240401.4 |
Ponatinib |
Esophageal cancer |
0.043800377 |
Resistant |
| ENSG00000250608.1 |
Ponatinib |
Esophageal cancer |
0.030046253 |
Resistant |
| ENSG00000251396.2 |
Ponatinib |
Esophageal cancer |
0.047337419 |
Resistant |
| ENSG00000251532.1 |
Ponatinib |
Esophageal cancer |
0.005864696 |
Resistant |
| ENSG00000253636.1 |
Ponatinib |
Esophageal cancer |
0.030023462 |
Resistant |
| ENSG00000255052.3 |
Ponatinib |
Esophageal cancer |
0.036362172 |
Resistant |
| ENSG00000255471.1 |
Ponatinib |
Esophageal cancer |
0.032026041 |
Resistant |
| ENSG00000257702.3 |
Ponatinib |
Esophageal cancer |
0.024856844 |
Resistant |
| ENSG00000258096.1 |
Ponatinib |
Esophageal cancer |
0.047103375 |
Resistant |
| ENSG00000258821.1 |
Ponatinib |
Esophageal cancer |
0.013130428 |
Resistant |
| ENSG00000258959.1 |
Ponatinib |
Esophageal cancer |
0.035967384 |
Resistant |
| ENSG00000259212.1 |
Ponatinib |
Esophageal cancer |
0.011636386 |
Resistant |
| ENSG00000259294.1 |
Ponatinib |
Esophageal cancer |
0.038394116 |
Resistant |
| ENSG00000259442.1 |
Ponatinib |
Esophageal cancer |
0.032662036 |
Resistant |
| ENSG00000259645.1 |
Ponatinib |
Esophageal cancer |
0.008676626 |
Resistant |
| ENSG00000259774.1 |
Ponatinib |
Esophageal cancer |
0.042079462 |
Resistant |
| ENSG00000259921.1 |
Ponatinib |
Esophageal cancer |
0.04438978 |
Resistant |
| ENSG00000260891.1 |
Ponatinib |
Esophageal cancer |
0.033251393 |
Resistant |
| ENSG00000260977.1 |
Ponatinib |
Esophageal cancer |
0.02517709 |
Resistant |
| ENSG00000261051.1 |
Ponatinib |
Esophageal cancer |
0.001372259 |
Resistant |
| ENSG00000261064.1 |
Ponatinib |
Esophageal cancer |
0.036733384 |
Resistant |
| ENSG00000263874.1 |
Ponatinib |
Esophageal cancer |
0.045596547 |
Resistant |
| ENSG00000266895.1 |
Ponatinib |
Esophageal cancer |
0.020526305 |
Resistant |
| ENSG00000267138.1 |
Ponatinib |
Esophageal cancer |
0.017068021 |
Resistant |
| ENSG00000267221.1 |
Ponatinib |
Esophageal cancer |
0.04811652 |
Resistant |
| ENSG00000267322.1 |
Ponatinib |
Esophageal cancer |
0.037948627 |
Resistant |
| ENSG00000269815.1 |
Ponatinib |
Esophageal cancer |
0.048974504 |
Resistant |
| ENSG00000270010.1 |
Ponatinib |
Esophageal cancer |
0.029583592 |
Resistant |
| ENSG00000270640.1 |
Ponatinib |
Esophageal cancer |
0.049105173 |
Resistant |
| ENSG00000272372.1 |
Ponatinib |
Esophageal cancer |
0.008808544 |
Resistant |
| ENSG00000272463.1 |
Ponatinib |
Esophageal cancer |
0.011032734 |
Resistant |
| ENSG00000273131.1 |
Ponatinib |
Esophageal cancer |
0.002482376 |
Resistant |
| ENSG00000124835.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.01286222 |
Resistant |
| ENSG00000175773.8 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.00692102 |
Resistant |
| ENSG00000204815.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.001520379 |
Resistant |
| ENSG00000205500.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.039393334 |
Resistant |
| ENSG00000206417.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.019812345 |
Resistant |
| ENSG00000224358.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.04742167 |
Resistant |
| ENSG00000224977.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.045521947 |
Resistant |
| ENSG00000226051.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.019670524 |
Resistant |
| ENSG00000226877.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.035647321 |
Resistant |
| ENSG00000227028.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.012347572 |
Resistant |
| ENSG00000227036.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.046774291 |
Resistant |
| ENSG00000227210.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.041856341 |
Resistant |
| ENSG00000227218.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.005151138 |
Resistant |
| ENSG00000228430.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.015482498 |
Resistant |
| ENSG00000228573.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.047550782 |
Resistant |
| ENSG00000228775.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.03370591 |
Resistant |
| ENSG00000229291.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.034271786 |
Resistant |
| ENSG00000230303.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.013112495 |
Resistant |
| ENSG00000230732.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.01762255 |
Resistant |
| ENSG00000231512.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.002700139 |
Resistant |
| ENSG00000232876.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.028809283 |
Resistant |
| ENSG00000232931.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.022529688 |
Resistant |
| ENSG00000234263.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.028557677 |
Resistant |
| ENSG00000234390.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.018108415 |
Resistant |
| ENSG00000235005.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.032156812 |
Resistant |
| ENSG00000235527.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.028950048 |
Resistant |
| ENSG00000236514.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.004030963 |
Resistant |
| ENSG00000237125.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.005916199 |
Resistant |
| ENSG00000237280.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.00311252 |
Resistant |
| ENSG00000237756.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.008903246 |
Resistant |
| ENSG00000240032.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.018702403 |
Resistant |
| ENSG00000240057.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.02059705 |
Resistant |
| ENSG00000240137.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.020648519 |
Resistant |
| ENSG00000242791.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.002986125 |
Resistant |
| ENSG00000244879.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.009437133 |
Resistant |
| ENSG00000249348.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.04924083 |
Resistant |
| ENSG00000249846.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.00709662 |
Resistant |
| ENSG00000250326.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.022957558 |
Resistant |
| ENSG00000256128.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.04508675 |
Resistant |
| ENSG00000257526.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.004716402 |
Resistant |
| ENSG00000258959.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.031167192 |
Resistant |
| ENSG00000259408.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.018512343 |
Resistant |
| ENSG00000259423.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.012171691 |
Resistant |
| ENSG00000259514.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.027524909 |
Resistant |
| ENSG00000259656.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.000148747 |
Resistant |
| ENSG00000259715.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.049116305 |
Resistant |
| ENSG00000259881.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.000607598 |
Resistant |
| ENSG00000260018.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.004997019 |
Resistant |
| ENSG00000260360.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.037799007 |
Resistant |
| ENSG00000260418.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.031980503 |
Resistant |
| ENSG00000260470.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.042858504 |
Resistant |
| ENSG00000260616.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.027765943 |
Resistant |
| ENSG00000260796.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.04111315 |
Resistant |
| ENSG00000260816.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.026832587 |
Resistant |
| ENSG00000261079.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.001736503 |
Resistant |
| ENSG00000261597.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.026672419 |
Resistant |
| ENSG00000261692.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.03970461 |
Resistant |
| ENSG00000263683.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.002381203 |
Resistant |
| ENSG00000263753.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.041413573 |
Resistant |
| ENSG00000264575.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.01156486 |
Resistant |
| ENSG00000265091.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.015239237 |
Resistant |
| ENSG00000265148.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.046719856 |
Resistant |
| ENSG00000265282.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.038142592 |
Resistant |
| ENSG00000265478.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.021714076 |
Resistant |
| ENSG00000266930.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.024400089 |
Resistant |
| ENSG00000267040.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.039913985 |
Resistant |
| ENSG00000267565.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.026353195 |
Resistant |
| ENSG00000267586.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.042903282 |
Resistant |
| ENSG00000267787.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.026972492 |
Resistant |
| ENSG00000269091.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.010799973 |
Resistant |
| ENSG00000269386.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.031917178 |
Resistant |
| ENSG00000269745.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.049477672 |
Resistant |
| ENSG00000269959.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.037956274 |
Resistant |
| ENSG00000269961.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.022088298 |
Resistant |
| ENSG00000270237.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.046842511 |
Resistant |
| ENSG00000270673.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.007630315 |
Resistant |
| ENSG00000271427.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.040622751 |
Resistant |
| ENSG00000271755.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.031998506 |
Resistant |
| ENSG00000272010.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.01561242 |
Resistant |
| ENSG00000272137.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.042184442 |
Resistant |
| ENSG00000272217.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.014051696 |
Resistant |
| ENSG00000272288.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.013519371 |
Resistant |
| ENSG00000272343.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.0000595 |
Resistant |
| ENSG00000272449.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.003605243 |
Resistant |
| ENSG00000273179.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.045500556 |
Resistant |
| ENSG00000273437.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.026646311 |
Resistant |
| ENSG00000273456.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.011060897 |
Resistant |
| ENSG00000273472.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.007446177 |
Resistant |
| ENSG00000228509.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.03045917 |
Resistant |
| ENSG00000230790.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.044056521 |
Resistant |
| ENSG00000232455.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.027178349 |
Resistant |
| ENSG00000232693.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.013055427 |
Resistant |
| ENSG00000235586.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.001155323 |
Resistant |
| ENSG00000236269.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.01505491 |
Resistant |
| ENSG00000247372.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.047854747 |
Resistant |
| ENSG00000255920.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.038748955 |
Resistant |
| ENSG00000256164.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.040349742 |
Resistant |
| ENSG00000259462.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.015902083 |
Resistant |
| ENSG00000261186.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.049213818 |
Resistant |
| ENSG00000261291.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.038044747 |
Resistant |
| ENSG00000261864.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.022653128 |
Resistant |
| ENSG00000263860.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.048986438 |
Resistant |
| ENSG00000266079.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.019469666 |
Resistant |
| ENSG00000267159.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.048165593 |
Resistant |
| ENSG00000269944.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.019254479 |
Resistant |
| ENSG00000273375.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.044497844 |
Resistant |
| ENSG00000182109.3 |
Ponatinib |
Brain lower grade glioma |
0.038555338 |
Resistant |
| ENSG00000185495.6 |
Ponatinib |
Brain lower grade glioma |
0.01692359 |
Resistant |
| ENSG00000196668.3 |
Ponatinib |
Brain lower grade glioma |
0.015641006 |
Resistant |
| ENSG00000204625.6 |
Ponatinib |
Brain lower grade glioma |
0.049214938 |
Resistant |
| ENSG00000206142.5 |
Ponatinib |
Brain lower grade glioma |
0.046376108 |
Resistant |
| ENSG00000212694.4 |
Ponatinib |
Brain lower grade glioma |
0.027548782 |
Resistant |
| ENSG00000213468.3 |
Ponatinib |
Brain lower grade glioma |
0.032084707 |
Resistant |
| ENSG00000215039.2 |
Ponatinib |
Brain lower grade glioma |
0.011267986 |
Resistant |
| ENSG00000224031.1 |
Ponatinib |
Brain lower grade glioma |
0.003398216 |
Resistant |
| ENSG00000225218.1 |
Ponatinib |
Brain lower grade glioma |
0.047987865 |
Resistant |
| ENSG00000225891.1 |
Ponatinib |
Brain lower grade glioma |
0.023484899 |
Resistant |
| ENSG00000225952.1 |
Ponatinib |
Brain lower grade glioma |
0.043161633 |
Resistant |
| ENSG00000227117.2 |
Ponatinib |
Brain lower grade glioma |
0.043875749 |
Resistant |
| ENSG00000227161.1 |
Ponatinib |
Brain lower grade glioma |
0.008428026 |
Resistant |
| ENSG00000228060.1 |
Ponatinib |
Brain lower grade glioma |
0.003983781 |
Resistant |
| ENSG00000228679.1 |
Ponatinib |
Brain lower grade glioma |
0.015606761 |
Resistant |
| ENSG00000228886.1 |
Ponatinib |
Brain lower grade glioma |
0.031964966 |
Resistant |
| ENSG00000229127.1 |
Ponatinib |
Brain lower grade glioma |
0.018165288 |
Resistant |
| ENSG00000230679.1 |
Ponatinib |
Brain lower grade glioma |
0.020629504 |
Resistant |
| ENSG00000230724.5 |
Ponatinib |
Brain lower grade glioma |
0.011869865 |
Resistant |
| ENSG00000230914.2 |
Ponatinib |
Brain lower grade glioma |
0.034725203 |
Resistant |
| ENSG00000231193.1 |
Ponatinib |
Brain lower grade glioma |
0.030892016 |
Resistant |
| ENSG00000231305.3 |
Ponatinib |
Brain lower grade glioma |
0.038936233 |
Resistant |
| ENSG00000231795.1 |
Ponatinib |
Brain lower grade glioma |
0.027200121 |
Resistant |
| ENSG00000232611.1 |
Ponatinib |
Brain lower grade glioma |
0.012767893 |
Resistant |
| ENSG00000233246.1 |
Ponatinib |
Brain lower grade glioma |
0.028783807 |
Resistant |
| ENSG00000234006.1 |
Ponatinib |
Brain lower grade glioma |
0.034885409 |
Resistant |
| ENSG00000234062.3 |
Ponatinib |
Brain lower grade glioma |
0.008853592 |
Resistant |
| ENSG00000234181.1 |
Ponatinib |
Brain lower grade glioma |
0.030455853 |
Resistant |
| ENSG00000234818.1 |
Ponatinib |
Brain lower grade glioma |
0.046246294 |
Resistant |
| ENSG00000235052.1 |
Ponatinib |
Brain lower grade glioma |
0.048083291 |
Resistant |
| ENSG00000235373.1 |
Ponatinib |
Brain lower grade glioma |
0.031012428 |
Resistant |
| ENSG00000235703.1 |
Ponatinib |
Brain lower grade glioma |
0.018098612 |
Resistant |
| ENSG00000236559.1 |
Ponatinib |
Brain lower grade glioma |
0.032019527 |
Resistant |
| ENSG00000236896.1 |
Ponatinib |
Brain lower grade glioma |
0.032531665 |
Resistant |
| ENSG00000236936.1 |
Ponatinib |
Brain lower grade glioma |
0.032450537 |
Resistant |
| ENSG00000237094.7 |
Ponatinib |
Brain lower grade glioma |
0.03219404 |
Resistant |
| ENSG00000237852.1 |
Ponatinib |
Brain lower grade glioma |
0.022101297 |
Resistant |
| ENSG00000237934.1 |
Ponatinib |
Brain lower grade glioma |
0.030727675 |
Resistant |
| ENSG00000240254.1 |
Ponatinib |
Brain lower grade glioma |
0.040000656 |
Resistant |
| ENSG00000241679.2 |
Ponatinib |
Brain lower grade glioma |
0.020401847 |
Resistant |
| ENSG00000241769.3 |
Ponatinib |
Brain lower grade glioma |
0.027991809 |
Resistant |
| ENSG00000241860.2 |
Ponatinib |
Brain lower grade glioma |
0.027658251 |
Resistant |
| ENSG00000243960.1 |
Ponatinib |
Brain lower grade glioma |
0.028940332 |
Resistant |
| ENSG00000245532.4 |
Ponatinib |
Brain lower grade glioma |
0.032987366 |
Resistant |
| ENSG00000247373.2 |
Ponatinib |
Brain lower grade glioma |
0.002529992 |
Resistant |
| ENSG00000248243.1 |
Ponatinib |
Brain lower grade glioma |
0.022389667 |
Resistant |
| ENSG00000249207.1 |
Ponatinib |
Brain lower grade glioma |
0.042783663 |
Resistant |
| ENSG00000249791.1 |
Ponatinib |
Brain lower grade glioma |
0.023760159 |
Resistant |
| ENSG00000249846.2 |
Ponatinib |
Brain lower grade glioma |
0.011207002 |
Resistant |
| ENSG00000250286.1 |
Ponatinib |
Brain lower grade glioma |
0.012241756 |
Resistant |
| ENSG00000250692.1 |
Ponatinib |
Brain lower grade glioma |
0.033859657 |
Resistant |
| ENSG00000251175.1 |
Ponatinib |
Brain lower grade glioma |
0.02732868 |
Resistant |
| ENSG00000251298.1 |
Ponatinib |
Brain lower grade glioma |
0.027977432 |
Resistant |
| ENSG00000253222.1 |
Ponatinib |
Brain lower grade glioma |
0.034373136 |
Resistant |
| ENSG00000253284.2 |
Ponatinib |
Brain lower grade glioma |
0.015899384 |
Resistant |
| ENSG00000253327.2 |
Ponatinib |
Brain lower grade glioma |
0.027074033 |
Resistant |
| ENSG00000253744.1 |
Ponatinib |
Brain lower grade glioma |
0.020636831 |
Resistant |
| ENSG00000254180.1 |
Ponatinib |
Brain lower grade glioma |
0.030880424 |
Resistant |
| ENSG00000254419.1 |
Ponatinib |
Brain lower grade glioma |
0.038358956 |
Resistant |
| ENSG00000254451.2 |
Ponatinib |
Brain lower grade glioma |
0.045978678 |
Resistant |
| ENSG00000254577.1 |
Ponatinib |
Brain lower grade glioma |
0.00229688 |
Resistant |
| ENSG00000254718.2 |
Ponatinib |
Brain lower grade glioma |
0.044645047 |
Resistant |
| ENSG00000254985.1 |
Ponatinib |
Brain lower grade glioma |
0.035432247 |
Resistant |
| ENSG00000255182.1 |
Ponatinib |
Brain lower grade glioma |
0.040182279 |
Resistant |
| ENSG00000255229.1 |
Ponatinib |
Brain lower grade glioma |
0.008971439 |
Resistant |
| ENSG00000256116.1 |
Ponatinib |
Brain lower grade glioma |
0.032789119 |
Resistant |
| ENSG00000256588.1 |
Ponatinib |
Brain lower grade glioma |
0.008012721 |
Resistant |
| ENSG00000256603.1 |
Ponatinib |
Brain lower grade glioma |
0.017979085 |
Resistant |
| ENSG00000257176.1 |
Ponatinib |
Brain lower grade glioma |
0.039974629 |
Resistant |
| ENSG00000257718.1 |
Ponatinib |
Brain lower grade glioma |
0.022680597 |
Resistant |
| ENSG00000257808.1 |
Ponatinib |
Brain lower grade glioma |
0.024813171 |
Resistant |
| ENSG00000258188.1 |
Ponatinib |
Brain lower grade glioma |
0.036359353 |
Resistant |
| ENSG00000258260.1 |
Ponatinib |
Brain lower grade glioma |
0.015618665 |
Resistant |
| ENSG00000258302.1 |
Ponatinib |
Brain lower grade glioma |
0.010607307 |
Resistant |
| ENSG00000258323.1 |
Ponatinib |
Brain lower grade glioma |
0.010754773 |
Resistant |
| ENSG00000258345.1 |
Ponatinib |
Brain lower grade glioma |
0.034484941 |
Resistant |
| ENSG00000258658.1 |
Ponatinib |
Brain lower grade glioma |
0.008557122 |
Resistant |
| ENSG00000258891.1 |
Ponatinib |
Brain lower grade glioma |
0.045224956 |
Resistant |
| ENSG00000259116.1 |
Ponatinib |
Brain lower grade glioma |
0.013585664 |
Resistant |
| ENSG00000259298.1 |
Ponatinib |
Brain lower grade glioma |
0.014031136 |
Resistant |
| ENSG00000259410.1 |
Ponatinib |
Brain lower grade glioma |
0.016338221 |
Resistant |
| ENSG00000259453.1 |
Ponatinib |
Brain lower grade glioma |
0.000511339 |
Resistant |
| ENSG00000259644.1 |
Ponatinib |
Brain lower grade glioma |
0.004399328 |
Resistant |
| ENSG00000259818.1 |
Ponatinib |
Brain lower grade glioma |
0.04725832 |
Resistant |
| ENSG00000260059.1 |
Ponatinib |
Brain lower grade glioma |
0.027532898 |
Resistant |
| ENSG00000260093.1 |
Ponatinib |
Brain lower grade glioma |
0.015993608 |
Resistant |
| ENSG00000260179.1 |
Ponatinib |
Brain lower grade glioma |
0.035469904 |
Resistant |
| ENSG00000260425.1 |
Ponatinib |
Brain lower grade glioma |
0.015780621 |
Resistant |
| ENSG00000260493.1 |
Ponatinib |
Brain lower grade glioma |
0.037812289 |
Resistant |
| ENSG00000260528.2 |
Ponatinib |
Brain lower grade glioma |
0.022304021 |
Resistant |
| ENSG00000260773.1 |
Ponatinib |
Brain lower grade glioma |
0.012758735 |
Resistant |
| ENSG00000261043.2 |
Ponatinib |
Brain lower grade glioma |
0.049506539 |
Resistant |
| ENSG00000261131.1 |
Ponatinib |
Brain lower grade glioma |
0.002672875 |
Resistant |
| ENSG00000261159.1 |
Ponatinib |
Brain lower grade glioma |
0.009228063 |
Resistant |
| ENSG00000261172.1 |
Ponatinib |
Brain lower grade glioma |
0.036211236 |
Resistant |
| ENSG00000261355.1 |
Ponatinib |
Brain lower grade glioma |
0.034848362 |
Resistant |
| ENSG00000261519.2 |
Ponatinib |
Brain lower grade glioma |
0.043091726 |
Resistant |
| ENSG00000261610.1 |
Ponatinib |
Brain lower grade glioma |
0.031014129 |
Resistant |
| ENSG00000261634.2 |
Ponatinib |
Brain lower grade glioma |
0.043935795 |
Resistant |
| ENSG00000262171.1 |
Ponatinib |
Brain lower grade glioma |
0.025327954 |
Resistant |
| ENSG00000262228.1 |
Ponatinib |
Brain lower grade glioma |
0.03230693 |
Resistant |
| ENSG00000262292.2 |
Ponatinib |
Brain lower grade glioma |
0.034995376 |
Resistant |
| ENSG00000262652.1 |
Ponatinib |
Brain lower grade glioma |
0.013572045 |
Resistant |
| ENSG00000262837.1 |
Ponatinib |
Brain lower grade glioma |
0.04725452 |
Resistant |
| ENSG00000263033.1 |
Ponatinib |
Brain lower grade glioma |
0.0416604 |
Resistant |
| ENSG00000263182.1 |
Ponatinib |
Brain lower grade glioma |
0.015003231 |
Resistant |
| ENSG00000264829.1 |
Ponatinib |
Brain lower grade glioma |
0.043098749 |
Resistant |
| ENSG00000264895.1 |
Ponatinib |
Brain lower grade glioma |
0.007383868 |
Resistant |
| ENSG00000265094.1 |
Ponatinib |
Brain lower grade glioma |
0.014384633 |
Resistant |
| ENSG00000265542.1 |
Ponatinib |
Brain lower grade glioma |
0.033972028 |
Resistant |
| ENSG00000265912.1 |
Ponatinib |
Brain lower grade glioma |
0.021844899 |
Resistant |
| ENSG00000266654.1 |
Ponatinib |
Brain lower grade glioma |
0.014494811 |
Resistant |
| ENSG00000266975.1 |
Ponatinib |
Brain lower grade glioma |
0.0433691 |
Resistant |
| ENSG00000267067.1 |
Ponatinib |
Brain lower grade glioma |
0.034575034 |
Resistant |
| ENSG00000267347.1 |
Ponatinib |
Brain lower grade glioma |
0.010643977 |
Resistant |
| ENSG00000267535.1 |
Ponatinib |
Brain lower grade glioma |
0.048217921 |
Resistant |
| ENSG00000268947.1 |
Ponatinib |
Brain lower grade glioma |
0.049313941 |
Resistant |
| ENSG00000269194.1 |
Ponatinib |
Brain lower grade glioma |
0.040840917 |
Resistant |
| ENSG00000269737.1 |
Ponatinib |
Brain lower grade glioma |
0.017005772 |
Resistant |
| ENSG00000269892.1 |
Ponatinib |
Brain lower grade glioma |
0.029479102 |
Resistant |
| ENSG00000270140.1 |
Ponatinib |
Brain lower grade glioma |
0.040521715 |
Resistant |
| ENSG00000270482.1 |
Ponatinib |
Brain lower grade glioma |
0.045033248 |
Resistant |
| ENSG00000270557.1 |
Ponatinib |
Brain lower grade glioma |
0.044769125 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Brain lower grade glioma |
0.048558364 |
Resistant |
| ENSG00000271192.1 |
Ponatinib |
Brain lower grade glioma |
0.037645288 |
Resistant |
| ENSG00000271398.1 |
Ponatinib |
Brain lower grade glioma |
0.045064939 |
Resistant |
| ENSG00000271821.1 |
Ponatinib |
Brain lower grade glioma |
0.032131309 |
Resistant |
| ENSG00000271840.1 |
Ponatinib |
Brain lower grade glioma |
0.003787196 |
Resistant |
| ENSG00000272033.1 |
Ponatinib |
Brain lower grade glioma |
0.016043487 |
Resistant |
| ENSG00000272076.1 |
Ponatinib |
Brain lower grade glioma |
0.044418338 |
Resistant |
| ENSG00000272420.1 |
Ponatinib |
Brain lower grade glioma |
0.046636024 |
Resistant |
| ENSG00000272455.1 |
Ponatinib |
Brain lower grade glioma |
0.048437535 |
Resistant |
| ENSG00000272556.1 |
Ponatinib |
Brain lower grade glioma |
0.033222706 |
Resistant |
| ENSG00000272610.1 |
Ponatinib |
Brain lower grade glioma |
0.005264242 |
Resistant |
| ENSG00000272754.1 |
Ponatinib |
Brain lower grade glioma |
0.036722905 |
Resistant |
| ENSG00000273233.1 |
Ponatinib |
Brain lower grade glioma |
0.036937458 |
Resistant |
| ENSG00000273481.1 |
Ponatinib |
Brain lower grade glioma |
0.036122449 |
Resistant |
| ENSG00000157306.10 |
Ponatinib |
Lung squamous cell carcinoma |
0.04324824 |
Resistant |
| ENSG00000178803.6 |
Ponatinib |
Lung squamous cell carcinoma |
0.023371651 |
Resistant |
| ENSG00000179935.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.012926313 |
Resistant |
| ENSG00000185044.10 |
Ponatinib |
Lung squamous cell carcinoma |
0.03871716 |
Resistant |
| ENSG00000196421.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.044993127 |
Resistant |
| ENSG00000197291.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.028726789 |
Resistant |
| ENSG00000203325.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.012845943 |
Resistant |
| ENSG00000203335.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.042010626 |
Resistant |
| ENSG00000203362.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.000429888 |
Resistant |
| ENSG00000203808.6 |
Ponatinib |
Lung squamous cell carcinoma |
0.015184452 |
Resistant |
| ENSG00000203987.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024125374 |
Resistant |
| ENSG00000204044.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.04546166 |
Resistant |
| ENSG00000214105.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044550914 |
Resistant |
| ENSG00000216863.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.031473502 |
Resistant |
| ENSG00000220925.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046841935 |
Resistant |
| ENSG00000223834.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.012766323 |
Resistant |
| ENSG00000223884.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043679956 |
Resistant |
| ENSG00000224128.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041086449 |
Resistant |
| ENSG00000224394.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034213571 |
Resistant |
| ENSG00000224525.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.047647999 |
Resistant |
| ENSG00000224568.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048371367 |
Resistant |
| ENSG00000224713.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.013716937 |
Resistant |
| ENSG00000224717.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036964979 |
Resistant |
| ENSG00000224883.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018039888 |
Resistant |
| ENSG00000224885.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013849838 |
Resistant |
| ENSG00000224995.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047552635 |
Resistant |
| ENSG00000225194.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043380285 |
Resistant |
| ENSG00000225300.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022844517 |
Resistant |
| ENSG00000225439.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043788776 |
Resistant |
| ENSG00000225546.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048699085 |
Resistant |
| ENSG00000225572.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003786369 |
Resistant |
| ENSG00000225606.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024550329 |
Resistant |
| ENSG00000225948.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043621716 |
Resistant |
| ENSG00000226113.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036136937 |
Resistant |
| ENSG00000226627.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042942104 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003485934 |
Resistant |
| ENSG00000226791.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.045004164 |
Resistant |
| ENSG00000226920.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01439276 |
Resistant |
| ENSG00000226957.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018449636 |
Resistant |
| ENSG00000227197.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027610315 |
Resistant |
| ENSG00000227253.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.019127655 |
Resistant |
| ENSG00000227285.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019184055 |
Resistant |
| ENSG00000227352.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030846842 |
Resistant |
| ENSG00000227392.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036487708 |
Resistant |
| ENSG00000227487.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.00742825 |
Resistant |
| ENSG00000227617.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.014938032 |
Resistant |
| ENSG00000227811.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033747704 |
Resistant |
| ENSG00000227895.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.027461242 |
Resistant |
| ENSG00000227911.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.035844347 |
Resistant |
| ENSG00000228108.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023958006 |
Resistant |
| ENSG00000228153.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01148573 |
Resistant |
| ENSG00000228293.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030696969 |
Resistant |
| ENSG00000228389.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01494051 |
Resistant |
| ENSG00000228412.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.035393744 |
Resistant |
| ENSG00000228487.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030567824 |
Resistant |
| ENSG00000228794.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.005137254 |
Resistant |
| ENSG00000228839.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006218898 |
Resistant |
| ENSG00000228973.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.000669776 |
Resistant |
| ENSG00000229214.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022905024 |
Resistant |
| ENSG00000229233.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036912467 |
Resistant |
| ENSG00000229294.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018640496 |
Resistant |
| ENSG00000229311.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04394008 |
Resistant |
| ENSG00000229502.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047556092 |
Resistant |
| ENSG00000229727.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.034560138 |
Resistant |
| ENSG00000229891.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017802357 |
Resistant |
| ENSG00000230172.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049185816 |
Resistant |
| ENSG00000230212.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011898501 |
Resistant |
| ENSG00000230333.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.009474144 |
Resistant |
| ENSG00000230433.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043019154 |
Resistant |
| ENSG00000230530.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012257898 |
Resistant |
| ENSG00000230536.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049464726 |
Resistant |
| ENSG00000230736.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.015548051 |
Resistant |
| ENSG00000230922.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017568116 |
Resistant |
| ENSG00000231010.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017161241 |
Resistant |
| ENSG00000231104.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.00446392 |
Resistant |
| ENSG00000231227.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041664886 |
Resistant |
| ENSG00000231329.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.040204822 |
Resistant |
| ENSG00000231465.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.04270007 |
Resistant |
| ENSG00000231728.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.01232482 |
Resistant |
| ENSG00000231769.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.03648637 |
Resistant |
| ENSG00000231842.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001239145 |
Resistant |
| ENSG00000231889.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.003811798 |
Resistant |
| ENSG00000232044.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.037176469 |
Resistant |
| ENSG00000232363.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032666445 |
Resistant |
| ENSG00000232586.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01495261 |
Resistant |
| ENSG00000232593.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020539969 |
Resistant |
| ENSG00000232611.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024593129 |
Resistant |
| ENSG00000232712.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.019293894 |
Resistant |
| ENSG00000232732.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.015824697 |
Resistant |
| ENSG00000232827.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.028771559 |
Resistant |
| ENSG00000232986.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019045924 |
Resistant |
| ENSG00000233223.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.021063236 |
Resistant |
| ENSG00000233242.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.026999301 |
Resistant |
| ENSG00000233246.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033771976 |
Resistant |
| ENSG00000233255.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040967696 |
Resistant |
| ENSG00000233334.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.006727317 |
Resistant |
| ENSG00000233602.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037660863 |
Resistant |
| ENSG00000233644.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042074978 |
Resistant |
| ENSG00000233651.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.00851542 |
Resistant |
| ENSG00000233757.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.010887578 |
Resistant |
| ENSG00000234006.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04218725 |
Resistant |
| ENSG00000234050.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023113306 |
Resistant |
| ENSG00000234084.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005530381 |
Resistant |
| ENSG00000234156.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029384914 |
Resistant |
| ENSG00000234252.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011942462 |
Resistant |
| ENSG00000234352.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.040466434 |
Resistant |
| ENSG00000234423.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022210046 |
Resistant |
| ENSG00000234915.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014380521 |
Resistant |
| ENSG00000234921.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018065266 |
Resistant |
| ENSG00000235033.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.018114074 |
Resistant |
| ENSG00000235189.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022114032 |
Resistant |
| ENSG00000235461.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023558621 |
Resistant |
| ENSG00000235586.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011750533 |
Resistant |
| ENSG00000235785.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014880024 |
Resistant |
| ENSG00000235910.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.000214762 |
Resistant |
| ENSG00000236031.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042350152 |
Resistant |
| ENSG00000236194.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.010446342 |
Resistant |
| ENSG00000236556.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026332564 |
Resistant |
| ENSG00000236558.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.0219411 |
Resistant |
| ENSG00000236668.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.039442178 |
Resistant |
| ENSG00000236703.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023077489 |
Resistant |
| ENSG00000236711.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.034934484 |
Resistant |
| ENSG00000236869.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005584623 |
Resistant |
| ENSG00000237021.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.019025656 |
Resistant |
| ENSG00000237027.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005398532 |
Resistant |
| ENSG00000237138.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034068223 |
Resistant |
| ENSG00000237159.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021396986 |
Resistant |
| ENSG00000237385.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024129438 |
Resistant |
| ENSG00000237457.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.037796098 |
Resistant |
| ENSG00000237512.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033574718 |
Resistant |
| ENSG00000237587.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.038213163 |
Resistant |
| ENSG00000237605.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037434245 |
Resistant |
| ENSG00000237750.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020794799 |
Resistant |
| ENSG00000237751.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.006337958 |
Resistant |
| ENSG00000237919.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046949997 |
Resistant |
| ENSG00000237980.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042439459 |
Resistant |
| ENSG00000238261.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.046067074 |
Resistant |
| ENSG00000239219.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.048528526 |
Resistant |
| ENSG00000239994.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.015917759 |
Resistant |
| ENSG00000240401.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.025327834 |
Resistant |
| ENSG00000241054.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023177509 |
Resistant |
| ENSG00000241505.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03331288 |
Resistant |
| ENSG00000241570.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.011994203 |
Resistant |
| ENSG00000241720.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.017769881 |
Resistant |
| ENSG00000241954.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00924591 |
Resistant |
| ENSG00000242042.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027129647 |
Resistant |
| ENSG00000242540.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.014327164 |
Resistant |
| ENSG00000243533.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044200051 |
Resistant |
| ENSG00000243810.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024230731 |
Resistant |
| ENSG00000244124.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021818386 |
Resistant |
| ENSG00000244345.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040378056 |
Resistant |
| ENSG00000244998.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049055226 |
Resistant |
| ENSG00000246528.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.008645493 |
Resistant |
| ENSG00000246820.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033952529 |
Resistant |
| ENSG00000247199.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.026871804 |
Resistant |
| ENSG00000247416.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.037762552 |
Resistant |
| ENSG00000248150.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034515098 |
Resistant |
| ENSG00000248730.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044152064 |
Resistant |
| ENSG00000248774.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001229049 |
Resistant |
| ENSG00000248896.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044626513 |
Resistant |
| ENSG00000249430.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015497393 |
Resistant |
| ENSG00000249509.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025076633 |
Resistant |
| ENSG00000249725.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036566276 |
Resistant |
| ENSG00000250027.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00399515 |
Resistant |
| ENSG00000250056.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040545504 |
Resistant |
| ENSG00000250069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007826783 |
Resistant |
| ENSG00000250366.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.017455137 |
Resistant |
| ENSG00000250490.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029024241 |
Resistant |
| ENSG00000250519.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.016693148 |
Resistant |
| ENSG00000251072.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.023386364 |
Resistant |
| ENSG00000251497.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.046752318 |
Resistant |
| ENSG00000253168.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042458774 |
Resistant |
| ENSG00000253230.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.041208887 |
Resistant |
| ENSG00000253317.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04858225 |
Resistant |
| ENSG00000253596.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049761392 |
Resistant |
| ENSG00000253607.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034186081 |
Resistant |
| ENSG00000253618.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030472447 |
Resistant |
| ENSG00000253733.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.042514367 |
Resistant |
| ENSG00000253865.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018725335 |
Resistant |
| ENSG00000253973.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.038008753 |
Resistant |
| ENSG00000254162.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020451517 |
Resistant |
| ENSG00000254302.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040272532 |
Resistant |
| ENSG00000254427.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012329809 |
Resistant |
| ENSG00000254468.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024238065 |
Resistant |
| ENSG00000254477.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00589097 |
Resistant |
| ENSG00000254510.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010954043 |
Resistant |
| ENSG00000254577.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04783423 |
Resistant |
| ENSG00000254654.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038513707 |
Resistant |
| ENSG00000254990.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004439378 |
Resistant |
| ENSG00000255027.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.025571382 |
Resistant |
| ENSG00000255410.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02407687 |
Resistant |
| ENSG00000255428.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013706947 |
Resistant |
| ENSG00000255571.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.004985036 |
Resistant |
| ENSG00000255693.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048294834 |
Resistant |
| ENSG00000255929.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013989266 |
Resistant |
| ENSG00000256031.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020056181 |
Resistant |
| ENSG00000256249.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046252521 |
Resistant |
| ENSG00000256250.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027162697 |
Resistant |
| ENSG00000256278.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020466338 |
Resistant |
| ENSG00000256299.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040561299 |
Resistant |
| ENSG00000256381.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015007217 |
Resistant |
| ENSG00000256588.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024015102 |
Resistant |
| ENSG00000256596.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042950998 |
Resistant |
| ENSG00000257056.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.013611001 |
Resistant |
| ENSG00000257095.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047138047 |
Resistant |
| ENSG00000257272.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048511757 |
Resistant |
| ENSG00000257467.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021978162 |
Resistant |
| ENSG00000258260.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009020596 |
Resistant |
| ENSG00000258442.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025261566 |
Resistant |
| ENSG00000258525.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009609108 |
Resistant |
| ENSG00000258526.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04982735 |
Resistant |
| ENSG00000258592.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023887713 |
Resistant |
| ENSG00000258609.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043461254 |
Resistant |
| ENSG00000258913.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035443263 |
Resistant |
| ENSG00000259058.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04820249 |
Resistant |
| ENSG00000259219.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038502165 |
Resistant |
| ENSG00000259235.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022604977 |
Resistant |
| ENSG00000259296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014793586 |
Resistant |
| ENSG00000259377.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041173172 |
Resistant |
| ENSG00000259652.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027594348 |
Resistant |
| ENSG00000259714.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034353356 |
Resistant |
| ENSG00000259736.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046794122 |
Resistant |
| ENSG00000259834.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049788281 |
Resistant |
| ENSG00000259937.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047443314 |
Resistant |
| ENSG00000259954.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025070009 |
Resistant |
| ENSG00000259969.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034330897 |
Resistant |
| ENSG00000259994.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006225767 |
Resistant |
| ENSG00000260198.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044547842 |
Resistant |
| ENSG00000260293.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046969758 |
Resistant |
| ENSG00000260296.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041700899 |
Resistant |
| ENSG00000260331.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022471773 |
Resistant |
| ENSG00000260400.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007204199 |
Resistant |
| ENSG00000260411.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.016556109 |
Resistant |
| ENSG00000260558.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036664978 |
Resistant |
| ENSG00000260583.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008324497 |
Resistant |
| ENSG00000260614.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016933463 |
Resistant |
| ENSG00000260743.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.002105474 |
Resistant |
| ENSG00000260805.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041233496 |
Resistant |
| ENSG00000260831.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00437565 |
Resistant |
| ENSG00000260855.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047002601 |
Resistant |
| ENSG00000260912.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001395721 |
Resistant |
| ENSG00000260931.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018060936 |
Resistant |
| ENSG00000260949.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033810164 |
Resistant |
| ENSG00000261013.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035739525 |
Resistant |
| ENSG00000261024.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.021657958 |
Resistant |
| ENSG00000261168.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029101749 |
Resistant |
| ENSG00000261170.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024939022 |
Resistant |
| ENSG00000261185.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030788104 |
Resistant |
| ENSG00000261374.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038589075 |
Resistant |
| ENSG00000261384.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025649472 |
Resistant |
| ENSG00000261433.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007090749 |
Resistant |
| ENSG00000261462.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043039523 |
Resistant |
| ENSG00000261496.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030201935 |
Resistant |
| ENSG00000261670.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02799547 |
Resistant |
| ENSG00000261797.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046007535 |
Resistant |
| ENSG00000262179.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.039690797 |
Resistant |
| ENSG00000262434.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003632708 |
Resistant |
| ENSG00000262768.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029694117 |
Resistant |
| ENSG00000263015.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035065272 |
Resistant |
| ENSG00000263438.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029582285 |
Resistant |
| ENSG00000263499.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005601073 |
Resistant |
| ENSG00000263603.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.022417568 |
Resistant |
| ENSG00000263674.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013955798 |
Resistant |
| ENSG00000263717.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046677866 |
Resistant |
| ENSG00000263862.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014776273 |
Resistant |
| ENSG00000263906.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028517176 |
Resistant |
| ENSG00000263916.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.000442561 |
Resistant |
| ENSG00000263938.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008755408 |
Resistant |
| ENSG00000263982.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033613113 |
Resistant |
| ENSG00000264273.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04321357 |
Resistant |
| ENSG00000264365.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005747485 |
Resistant |
| ENSG00000264589.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.03402276 |
Resistant |
| ENSG00000265043.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038332738 |
Resistant |
| ENSG00000265094.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042111174 |
Resistant |
| ENSG00000265130.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006558999 |
Resistant |
| ENSG00000265204.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004853984 |
Resistant |
| ENSG00000265316.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030898381 |
Resistant |
| ENSG00000265408.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033208437 |
Resistant |
| ENSG00000265496.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.033821433 |
Resistant |
| ENSG00000265728.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029028463 |
Resistant |
| ENSG00000266290.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018204587 |
Resistant |
| ENSG00000266446.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026704869 |
Resistant |
| ENSG00000266498.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040593863 |
Resistant |
| ENSG00000266911.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040316527 |
Resistant |
| ENSG00000266912.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04392922 |
Resistant |
| ENSG00000266999.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047620693 |
Resistant |
| ENSG00000267004.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.025157187 |
Resistant |
| ENSG00000267040.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.024044471 |
Resistant |
| ENSG00000267138.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00878606 |
Resistant |
| ENSG00000267167.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015303237 |
Resistant |
| ENSG00000267202.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00785592 |
Resistant |
| ENSG00000267230.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040362146 |
Resistant |
| ENSG00000267298.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00177793 |
Resistant |
| ENSG00000267304.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013137706 |
Resistant |
| ENSG00000267347.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042695786 |
Resistant |
| ENSG00000267613.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031303337 |
Resistant |
| ENSG00000267642.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048432371 |
Resistant |
| ENSG00000267651.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020050728 |
Resistant |
| ENSG00000267672.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004905473 |
Resistant |
| ENSG00000267758.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003510875 |
Resistant |
| ENSG00000267765.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041128121 |
Resistant |
| ENSG00000267787.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031848081 |
Resistant |
| ENSG00000267874.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036650816 |
Resistant |
| ENSG00000267940.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006101977 |
Resistant |
| ENSG00000268047.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042357435 |
Resistant |
| ENSG00000268307.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032581527 |
Resistant |
| ENSG00000268536.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039151844 |
Resistant |
| ENSG00000268670.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003060956 |
Resistant |
| ENSG00000268987.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040908405 |
Resistant |
| ENSG00000269694.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019740744 |
Resistant |
| ENSG00000269836.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044887642 |
Resistant |
| ENSG00000269903.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043763461 |
Resistant |
| ENSG00000269938.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001358694 |
Resistant |
| ENSG00000269971.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014040889 |
Resistant |
| ENSG00000269978.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049332748 |
Resistant |
| ENSG00000270009.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009734723 |
Resistant |
| ENSG00000270035.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024861791 |
Resistant |
| ENSG00000270039.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007280051 |
Resistant |
| ENSG00000270072.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028393203 |
Resistant |
| ENSG00000270154.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037105176 |
Resistant |
| ENSG00000270189.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019365004 |
Resistant |
| ENSG00000270223.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004554845 |
Resistant |
| ENSG00000270605.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016579122 |
Resistant |
| ENSG00000270988.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031614832 |
Resistant |
| ENSG00000271576.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040723377 |
Resistant |
| ENSG00000271738.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008198925 |
Resistant |
| ENSG00000271757.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021791774 |
Resistant |
| ENSG00000271782.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043810469 |
Resistant |
| ENSG00000271803.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004096629 |
Resistant |
| ENSG00000271830.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043367353 |
Resistant |
| ENSG00000271848.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028745609 |
Resistant |
| ENSG00000271927.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012436653 |
Resistant |
| ENSG00000271948.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010842095 |
Resistant |
| ENSG00000271981.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014629938 |
Resistant |
| ENSG00000272002.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035446921 |
Resistant |
| ENSG00000272005.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019647437 |
Resistant |
| ENSG00000272077.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006381132 |
Resistant |
| ENSG00000272372.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02741152 |
Resistant |
| ENSG00000272379.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.002518527 |
Resistant |
| ENSG00000272416.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011135646 |
Resistant |
| ENSG00000272452.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024121957 |
Resistant |
| ENSG00000272516.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009586663 |
Resistant |
| ENSG00000272677.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013754971 |
Resistant |
| ENSG00000272699.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011198853 |
Resistant |
| ENSG00000272717.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028925977 |
Resistant |
| ENSG00000272733.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038746408 |
Resistant |
| ENSG00000272777.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017050252 |
Resistant |
| ENSG00000272797.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048905084 |
Resistant |
| ENSG00000272871.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.011511887 |
Resistant |
| ENSG00000273056.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018060918 |
Resistant |
| ENSG00000273156.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009123104 |
Resistant |
| ENSG00000273175.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029097654 |
Resistant |
| ENSG00000273293.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.024474878 |
Resistant |
| ENSG00000273321.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02424154 |
Resistant |
| ENSG00000273372.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005266029 |
Resistant |
| ENSG00000273442.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040180022 |
Resistant |
| ENSG00000219159.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.001827128 |
Resistant |
| ENSG00000223528.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.037130708 |
Resistant |
| ENSG00000225187.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.000157822 |
Resistant |
| ENSG00000225731.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039718212 |
Resistant |
| ENSG00000226308.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.04780722 |
Resistant |
| ENSG00000226310.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.038719865 |
Resistant |
| ENSG00000226629.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.022082495 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.046085351 |
Resistant |
| ENSG00000226876.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.032213725 |
Resistant |
| ENSG00000228677.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.02039457 |
Resistant |
| ENSG00000230333.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.036894368 |
Resistant |
| ENSG00000231039.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.02013589 |
Resistant |
| ENSG00000231483.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.021598097 |
Resistant |
| ENSG00000231612.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.016001875 |
Resistant |
| ENSG00000235121.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.025188492 |
Resistant |
| ENSG00000235781.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.005031727 |
Resistant |
| ENSG00000236358.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.046662214 |
Resistant |
| ENSG00000237786.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.04433937 |
Resistant |
| ENSG00000240618.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.04259369 |
Resistant |
| ENSG00000245148.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.035734641 |
Resistant |
| ENSG00000249125.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039910873 |
Resistant |
| ENSG00000250303.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.004418902 |
Resistant |
| ENSG00000253263.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.001274845 |
Resistant |
| ENSG00000254495.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03415219 |
Resistant |
| ENSG00000255507.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029658001 |
Resistant |
| ENSG00000256325.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.009987944 |
Resistant |
| ENSG00000257221.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.018046278 |
Resistant |
| ENSG00000257924.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.007857465 |
Resistant |
| ENSG00000259442.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033162493 |
Resistant |
| ENSG00000259444.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.048620602 |
Resistant |
| ENSG00000259884.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.035297233 |
Resistant |
| ENSG00000260657.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.011034002 |
Resistant |
| ENSG00000261216.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.038958689 |
Resistant |
| ENSG00000262094.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.021493652 |
Resistant |
| ENSG00000262296.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.00106525 |
Resistant |
| ENSG00000262952.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.025640022 |
Resistant |
| ENSG00000265142.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.008079718 |
Resistant |
| ENSG00000266498.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039561593 |
Resistant |
| ENSG00000269202.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.037692018 |
Resistant |
| ENSG00000135253.9 |
Ponatinib |
Sarcoma |
0.019340805 |
Resistant |
| ENSG00000172965.10 |
Ponatinib |
Sarcoma |
0.019243836 |
Resistant |
| ENSG00000185186.4 |
Ponatinib |
Sarcoma |
0.020764074 |
Resistant |
| ENSG00000186019.10 |
Ponatinib |
Sarcoma |
0.02399677 |
Resistant |
| ENSG00000203327.2 |
Ponatinib |
Sarcoma |
0.005158789 |
Resistant |
| ENSG00000204837.2 |
Ponatinib |
Sarcoma |
0.025088856 |
Resistant |
| ENSG00000223799.1 |
Ponatinib |
Sarcoma |
0.035245694 |
Resistant |
| ENSG00000223975.1 |
Ponatinib |
Sarcoma |
0.026809991 |
Resistant |
| ENSG00000224043.3 |
Ponatinib |
Sarcoma |
0.008022792 |
Resistant |
| ENSG00000224959.1 |
Ponatinib |
Sarcoma |
0.011837858 |
Resistant |
| ENSG00000225498.1 |
Ponatinib |
Sarcoma |
0.035492614 |
Resistant |
| ENSG00000225675.2 |
Ponatinib |
Sarcoma |
0.04643162 |
Resistant |
| ENSG00000228065.6 |
Ponatinib |
Sarcoma |
0.021210746 |
Resistant |
| ENSG00000228363.2 |
Ponatinib |
Sarcoma |
0.01634713 |
Resistant |
| ENSG00000229558.1 |
Ponatinib |
Sarcoma |
0.02687581 |
Resistant |
| ENSG00000232160.2 |
Ponatinib |
Sarcoma |
0.000894463 |
Resistant |
| ENSG00000232284.3 |
Ponatinib |
Sarcoma |
0.009767888 |
Resistant |
| ENSG00000232694.2 |
Ponatinib |
Sarcoma |
0.04666699 |
Resistant |
| ENSG00000232814.2 |
Ponatinib |
Sarcoma |
0.001118138 |
Resistant |
| ENSG00000233775.1 |
Ponatinib |
Sarcoma |
0.045579695 |
Resistant |
| ENSG00000234459.1 |
Ponatinib |
Sarcoma |
0.008507055 |
Resistant |
| ENSG00000236003.1 |
Ponatinib |
Sarcoma |
0.012598234 |
Resistant |
| ENSG00000236188.1 |
Ponatinib |
Sarcoma |
0.03167754 |
Resistant |
| ENSG00000236953.1 |
Ponatinib |
Sarcoma |
0.01677821 |
Resistant |
| ENSG00000238039.1 |
Ponatinib |
Sarcoma |
0.027620482 |
Resistant |
| ENSG00000242516.1 |
Ponatinib |
Sarcoma |
0.002643203 |
Resistant |
| ENSG00000245748.1 |
Ponatinib |
Sarcoma |
0.028815103 |
Resistant |
| ENSG00000248476.1 |
Ponatinib |
Sarcoma |
0.010327653 |
Resistant |
| ENSG00000248544.2 |
Ponatinib |
Sarcoma |
0.031108456 |
Resistant |
| ENSG00000250734.2 |
Ponatinib |
Sarcoma |
0.041219271 |
Resistant |
| ENSG00000250899.3 |
Ponatinib |
Sarcoma |
0.034284557 |
Resistant |
| ENSG00000254027.1 |
Ponatinib |
Sarcoma |
0.030026966 |
Resistant |
| ENSG00000254224.1 |
Ponatinib |
Sarcoma |
0.018352538 |
Resistant |
| ENSG00000255435.2 |
Ponatinib |
Sarcoma |
0.028576144 |
Resistant |
| ENSG00000257526.1 |
Ponatinib |
Sarcoma |
0.008129078 |
Resistant |
| ENSG00000258454.1 |
Ponatinib |
Sarcoma |
0.027627502 |
Resistant |
| ENSG00000258733.1 |
Ponatinib |
Sarcoma |
0.009232209 |
Resistant |
| ENSG00000258938.1 |
Ponatinib |
Sarcoma |
0.039169165 |
Resistant |
| ENSG00000260796.1 |
Ponatinib |
Sarcoma |
0.039899458 |
Resistant |
| ENSG00000260830.1 |
Ponatinib |
Sarcoma |
0.012193167 |
Resistant |
| ENSG00000261399.1 |
Ponatinib |
Sarcoma |
0.00635409 |
Resistant |
| ENSG00000264868.1 |
Ponatinib |
Sarcoma |
0.04998825 |
Resistant |
| ENSG00000266313.1 |
Ponatinib |
Sarcoma |
0.001435676 |
Resistant |
| ENSG00000267003.1 |
Ponatinib |
Sarcoma |
0.048187862 |
Resistant |
| ENSG00000267018.1 |
Ponatinib |
Sarcoma |
0.00919193 |
Resistant |
| ENSG00000267183.1 |
Ponatinib |
Sarcoma |
0.021616019 |
Resistant |
| ENSG00000267874.1 |
Ponatinib |
Sarcoma |
0.047467284 |
Resistant |
| ENSG00000268655.1 |
Ponatinib |
Sarcoma |
0.026455398 |
Resistant |
| ENSG00000269652.1 |
Ponatinib |
Sarcoma |
0.042244538 |
Resistant |
| ENSG00000270109.1 |
Ponatinib |
Sarcoma |
0.029237212 |
Resistant |
| ENSG00000271938.1 |
Ponatinib |
Sarcoma |
0.001043328 |
Resistant |
| ENSG00000272198.1 |
Ponatinib |
Sarcoma |
0.047117956 |
Resistant |
| ENSG00000272604.1 |
Ponatinib |
Sarcoma |
0.030694246 |
Resistant |
| ENSG00000273230.1 |
Ponatinib |
Sarcoma |
0.046412142 |
Resistant |
| ENSG00000273270.1 |
Ponatinib |
Sarcoma |
0.046643375 |
Resistant |
| ENSG00000273329.1 |
Ponatinib |
Sarcoma |
0.025578101 |
Resistant |
| ENSG00000273472.1 |
Ponatinib |
Sarcoma |
0.02361268 |
Resistant |
| ENSG00000136315.3 |
Ponatinib |
Skin cutaneous melanoma |
0.029429341 |
Resistant |
| ENSG00000205293.3 |
Ponatinib |
Skin cutaneous melanoma |
0.035575575 |
Resistant |
| ENSG00000226786.2 |
Ponatinib |
Skin cutaneous melanoma |
0.045286906 |
Resistant |
| ENSG00000227888.3 |
Ponatinib |
Skin cutaneous melanoma |
0.047576005 |
Resistant |
| ENSG00000231185.2 |
Ponatinib |
Skin cutaneous melanoma |
0.031468583 |
Resistant |
| ENSG00000233244.2 |
Ponatinib |
Skin cutaneous melanoma |
0.046031692 |
Resistant |
| ENSG00000235597.1 |
Ponatinib |
Skin cutaneous melanoma |
0.043759254 |
Resistant |
| ENSG00000243008.2 |
Ponatinib |
Skin cutaneous melanoma |
0.025843751 |
Resistant |
| ENSG00000254847.1 |
Ponatinib |
Skin cutaneous melanoma |
0.012271039 |
Resistant |
| ENSG00000259687.1 |
Ponatinib |
Skin cutaneous melanoma |
0.03511614 |
Resistant |
| ENSG00000260871.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040076925 |
Resistant |
| ENSG00000261438.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035204661 |
Resistant |
| ENSG00000264125.1 |
Ponatinib |
Skin cutaneous melanoma |
0.022602311 |
Resistant |
| ENSG00000270361.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044232466 |
Resistant |
| ENSG00000271584.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048154041 |
Resistant |
| ENSG00000272823.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02990057 |
Resistant |
| ENSG00000273084.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048155462 |
Resistant |
| ENSG00000185904.7 |
Ponatinib |
Bladder urothelial carcinoma |
0.005849731 |
Sensitive |
| ENSG00000225353.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.047618658 |
Sensitive |
| ENSG00000228679.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.015763582 |
Sensitive |
| ENSG00000231536.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.000898678 |
Sensitive |
| ENSG00000233496.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.006016026 |
Sensitive |
| ENSG00000244265.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044428187 |
Sensitive |
| ENSG00000251381.2 |
Ponatinib |
Bladder urothelial carcinoma |
0.017538893 |
Sensitive |
| ENSG00000253921.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.038108271 |
Sensitive |
| ENSG00000254165.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045236902 |
Sensitive |
| ENSG00000260977.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.045997188 |
Sensitive |
| ENSG00000266895.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.039130403 |
Sensitive |
| ENSG00000267758.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.026050362 |
Sensitive |
| ENSG00000271367.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.024261468 |
Sensitive |
| ENSG00000273035.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.048034707 |
Sensitive |
| ENSG00000185168.5 |
Ponatinib |
Breast invasive carcinoma |
0.020081831 |
Sensitive |
| ENSG00000212163.2 |
Ponatinib |
Breast invasive carcinoma |
0.046510788 |
Sensitive |
| ENSG00000223829.1 |
Ponatinib |
Breast invasive carcinoma |
0.049343806 |
Sensitive |
| ENSG00000223935.1 |
Ponatinib |
Breast invasive carcinoma |
0.013751693 |
Sensitive |
| ENSG00000225285.1 |
Ponatinib |
Breast invasive carcinoma |
0.041647486 |
Sensitive |
| ENSG00000225578.1 |
Ponatinib |
Breast invasive carcinoma |
0.025976031 |
Sensitive |
| ENSG00000227945.1 |
Ponatinib |
Breast invasive carcinoma |
0.017000119 |
Sensitive |
| ENSG00000228060.1 |
Ponatinib |
Breast invasive carcinoma |
0.009444721 |
Sensitive |
| ENSG00000228697.1 |
Ponatinib |
Breast invasive carcinoma |
0.009816661 |
Sensitive |
| ENSG00000229263.1 |
Ponatinib |
Breast invasive carcinoma |
0.046133222 |
Sensitive |
| ENSG00000231609.1 |
Ponatinib |
Breast invasive carcinoma |
0.012799172 |
Sensitive |
| ENSG00000231768.1 |
Ponatinib |
Breast invasive carcinoma |
0.035513396 |
Sensitive |
| ENSG00000232739.1 |
Ponatinib |
Breast invasive carcinoma |
0.02934583 |
Sensitive |
| ENSG00000233221.2 |
Ponatinib |
Breast invasive carcinoma |
0.03713056 |
Sensitive |
| ENSG00000236426.3 |
Ponatinib |
Breast invasive carcinoma |
0.034991083 |
Sensitive |
| ENSG00000242516.1 |
Ponatinib |
Breast invasive carcinoma |
0.032405443 |
Sensitive |
| ENSG00000242861.1 |
Ponatinib |
Breast invasive carcinoma |
0.00842053 |
Sensitive |
| ENSG00000249356.1 |
Ponatinib |
Breast invasive carcinoma |
0.033133236 |
Sensitive |
| ENSG00000249417.1 |
Ponatinib |
Breast invasive carcinoma |
0.017933015 |
Sensitive |
| ENSG00000251136.4 |
Ponatinib |
Breast invasive carcinoma |
0.042553051 |
Sensitive |
| ENSG00000251533.2 |
Ponatinib |
Breast invasive carcinoma |
0.035664011 |
Sensitive |
| ENSG00000253385.1 |
Ponatinib |
Breast invasive carcinoma |
0.040798864 |
Sensitive |
| ENSG00000254006.1 |
Ponatinib |
Breast invasive carcinoma |
0.006657643 |
Sensitive |
| ENSG00000255120.1 |
Ponatinib |
Breast invasive carcinoma |
0.007506763 |
Sensitive |
| ENSG00000256433.1 |
Ponatinib |
Breast invasive carcinoma |
0.038389411 |
Sensitive |
| ENSG00000257671.1 |
Ponatinib |
Breast invasive carcinoma |
0.002290362 |
Sensitive |
| ENSG00000257830.1 |
Ponatinib |
Breast invasive carcinoma |
0.0200709 |
Sensitive |
| ENSG00000258661.1 |
Ponatinib |
Breast invasive carcinoma |
0.044094538 |
Sensitive |
| ENSG00000259234.1 |
Ponatinib |
Breast invasive carcinoma |
0.042171465 |
Sensitive |
| ENSG00000259348.1 |
Ponatinib |
Breast invasive carcinoma |
0.032642015 |
Sensitive |
| ENSG00000259423.1 |
Ponatinib |
Breast invasive carcinoma |
0.043087963 |
Sensitive |
| ENSG00000259604.1 |
Ponatinib |
Breast invasive carcinoma |
0.004911076 |
Sensitive |
| ENSG00000259702.1 |
Ponatinib |
Breast invasive carcinoma |
0.012349409 |
Sensitive |
| ENSG00000260008.1 |
Ponatinib |
Breast invasive carcinoma |
0.045801141 |
Sensitive |
| ENSG00000266955.1 |
Ponatinib |
Breast invasive carcinoma |
0.017599096 |
Sensitive |
| ENSG00000269962.1 |
Ponatinib |
Breast invasive carcinoma |
0.030029347 |
Sensitive |
| ENSG00000272275.1 |
Ponatinib |
Breast invasive carcinoma |
0.043752929 |
Sensitive |
| ENSG00000272639.1 |
Ponatinib |
Breast invasive carcinoma |
0.006519558 |
Sensitive |
| ENSG00000272808.1 |
Ponatinib |
Breast invasive carcinoma |
0.010512739 |
Sensitive |
| ENSG00000196668.3 |
Ponatinib |
Colon adenocarcinoma |
0.031701395 |
Sensitive |
| ENSG00000205890.3 |
Ponatinib |
Colon adenocarcinoma |
0.043252283 |
Sensitive |
| ENSG00000223697.2 |
Ponatinib |
Colon adenocarcinoma |
0.0085651 |
Sensitive |
| ENSG00000223956.1 |
Ponatinib |
Colon adenocarcinoma |
0.009186265 |
Sensitive |
| ENSG00000225075.1 |
Ponatinib |
Colon adenocarcinoma |
0.017155532 |
Sensitive |
| ENSG00000225092.2 |
Ponatinib |
Colon adenocarcinoma |
0.031790768 |
Sensitive |
| ENSG00000225278.3 |
Ponatinib |
Colon adenocarcinoma |
0.042719461 |
Sensitive |
| ENSG00000226067.2 |
Ponatinib |
Colon adenocarcinoma |
0.013871587 |
Sensitive |
| ENSG00000228386.2 |
Ponatinib |
Colon adenocarcinoma |
0.027392403 |
Sensitive |
| ENSG00000231566.1 |
Ponatinib |
Colon adenocarcinoma |
0.004475756 |
Sensitive |
| ENSG00000231840.1 |
Ponatinib |
Colon adenocarcinoma |
0.02237597 |
Sensitive |
| ENSG00000231969.1 |
Ponatinib |
Colon adenocarcinoma |
0.014218462 |
Sensitive |
| ENSG00000232406.2 |
Ponatinib |
Colon adenocarcinoma |
0.046906663 |
Sensitive |
| ENSG00000233101.6 |
Ponatinib |
Colon adenocarcinoma |
0.042557494 |
Sensitive |
| ENSG00000233144.1 |
Ponatinib |
Colon adenocarcinoma |
0.015162596 |
Sensitive |
| ENSG00000237756.1 |
Ponatinib |
Colon adenocarcinoma |
0.029210219 |
Sensitive |
| ENSG00000238178.2 |
Ponatinib |
Colon adenocarcinoma |
0.00717448 |
Sensitive |
| ENSG00000243243.1 |
Ponatinib |
Colon adenocarcinoma |
0.049142812 |
Sensitive |
| ENSG00000243849.1 |
Ponatinib |
Colon adenocarcinoma |
0.034818195 |
Sensitive |
| ENSG00000248367.1 |
Ponatinib |
Colon adenocarcinoma |
0.034822087 |
Sensitive |
| ENSG00000251136.4 |
Ponatinib |
Colon adenocarcinoma |
0.040173367 |
Sensitive |
| ENSG00000254428.1 |
Ponatinib |
Colon adenocarcinoma |
0.021075281 |
Sensitive |
| ENSG00000254554.1 |
Ponatinib |
Colon adenocarcinoma |
0.022123663 |
Sensitive |
| ENSG00000254676.1 |
Ponatinib |
Colon adenocarcinoma |
0.008785674 |
Sensitive |
| ENSG00000255449.1 |
Ponatinib |
Colon adenocarcinoma |
0.042659786 |
Sensitive |
| ENSG00000257027.1 |
Ponatinib |
Colon adenocarcinoma |
0.043312223 |
Sensitive |
| ENSG00000259448.2 |
Ponatinib |
Colon adenocarcinoma |
0.018218237 |
Sensitive |
| ENSG00000259523.1 |
Ponatinib |
Colon adenocarcinoma |
0.032733107 |
Sensitive |
| ENSG00000260441.1 |
Ponatinib |
Colon adenocarcinoma |
0.047210589 |
Sensitive |
| ENSG00000262294.1 |
Ponatinib |
Colon adenocarcinoma |
0.02179095 |
Sensitive |
| ENSG00000263624.1 |
Ponatinib |
Colon adenocarcinoma |
0.033546809 |
Sensitive |
| ENSG00000266340.1 |
Ponatinib |
Colon adenocarcinoma |
0.033567193 |
Sensitive |
| ENSG00000267530.2 |
Ponatinib |
Colon adenocarcinoma |
0.028549615 |
Sensitive |
| ENSG00000267871.1 |
Ponatinib |
Colon adenocarcinoma |
0.030034022 |
Sensitive |
| ENSG00000271824.1 |
Ponatinib |
Colon adenocarcinoma |
0.032237762 |
Sensitive |
| ENSG00000272763.1 |
Ponatinib |
Colon adenocarcinoma |
0.042506714 |
Sensitive |
| ENSG00000205056.8 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046344872 |
Sensitive |
| ENSG00000223882.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04700228 |
Sensitive |
| ENSG00000224020.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043684921 |
Sensitive |
| ENSG00000224093.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048252222 |
Sensitive |
| ENSG00000227197.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041232692 |
Sensitive |
| ENSG00000228005.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047846844 |
Sensitive |
| ENSG00000230937.5 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029816171 |
Sensitive |
| ENSG00000231025.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033206545 |
Sensitive |
| ENSG00000233060.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044579686 |
Sensitive |
| ENSG00000233251.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043379251 |
Sensitive |
| ENSG00000236234.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044594586 |
Sensitive |
| ENSG00000236423.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017765816 |
Sensitive |
| ENSG00000236894.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016914925 |
Sensitive |
| ENSG00000236901.3 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035228379 |
Sensitive |
| ENSG00000237594.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025804296 |
Sensitive |
| ENSG00000244332.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011462599 |
Sensitive |
| ENSG00000246790.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046054546 |
Sensitive |
| ENSG00000248367.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036974221 |
Sensitive |
| ENSG00000250312.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019157326 |
Sensitive |
| ENSG00000250541.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046655979 |
Sensitive |
| ENSG00000260037.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044705232 |
Sensitive |
| ENSG00000260196.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026343186 |
Sensitive |
| ENSG00000260924.2 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049352651 |
Sensitive |
| ENSG00000261218.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038473109 |
Sensitive |
| ENSG00000263982.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018766133 |
Sensitive |
| ENSG00000266922.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043940541 |
Sensitive |
| ENSG00000266923.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032335492 |
Sensitive |
| ENSG00000267016.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047699649 |
Sensitive |
| ENSG00000268201.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040995613 |
Sensitive |
| ENSG00000268970.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021797091 |
Sensitive |
| ENSG00000269102.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009437566 |
Sensitive |
| ENSG00000269825.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031556711 |
Sensitive |
| ENSG00000271757.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012170052 |
Sensitive |
| ENSG00000152487.6 |
Ponatinib |
Esophageal cancer |
0.038214092 |
Sensitive |
| ENSG00000203499.6 |
Ponatinib |
Esophageal cancer |
0.001625902 |
Sensitive |
| ENSG00000224597.5 |
Ponatinib |
Esophageal cancer |
0.048357201 |
Sensitive |
| ENSG00000227681.1 |
Ponatinib |
Esophageal cancer |
0.033994267 |
Sensitive |
| ENSG00000230082.1 |
Ponatinib |
Esophageal cancer |
0.014774913 |
Sensitive |
| ENSG00000232023.2 |
Ponatinib |
Esophageal cancer |
0.044996795 |
Sensitive |
| ENSG00000233844.1 |
Ponatinib |
Esophageal cancer |
0.008512279 |
Sensitive |
| ENSG00000237512.2 |
Ponatinib |
Esophageal cancer |
0.043345538 |
Sensitive |
| ENSG00000240063.1 |
Ponatinib |
Esophageal cancer |
0.025570097 |
Sensitive |
| ENSG00000241599.1 |
Ponatinib |
Esophageal cancer |
0.037419767 |
Sensitive |
| ENSG00000244265.1 |
Ponatinib |
Esophageal cancer |
0.007915679 |
Sensitive |
| ENSG00000247498.5 |
Ponatinib |
Esophageal cancer |
0.038470147 |
Sensitive |
| ENSG00000249664.1 |
Ponatinib |
Esophageal cancer |
0.016718437 |
Sensitive |
| ENSG00000253172.1 |
Ponatinib |
Esophageal cancer |
0.008923181 |
Sensitive |
| ENSG00000254560.1 |
Ponatinib |
Esophageal cancer |
0.001839609 |
Sensitive |
| ENSG00000254973.1 |
Ponatinib |
Esophageal cancer |
0.02912941 |
Sensitive |
| ENSG00000255717.2 |
Ponatinib |
Esophageal cancer |
0.008109285 |
Sensitive |
| ENSG00000258355.1 |
Ponatinib |
Esophageal cancer |
0.019216301 |
Sensitive |
| ENSG00000260260.1 |
Ponatinib |
Esophageal cancer |
0.015005971 |
Sensitive |
| ENSG00000261183.1 |
Ponatinib |
Esophageal cancer |
0.046634837 |
Sensitive |
| ENSG00000263731.1 |
Ponatinib |
Esophageal cancer |
0.04076953 |
Sensitive |
| ENSG00000267327.1 |
Ponatinib |
Esophageal cancer |
0.038455106 |
Sensitive |
| ENSG00000268095.1 |
Ponatinib |
Esophageal cancer |
0.00627588 |
Sensitive |
| ENSG00000269949.1 |
Ponatinib |
Esophageal cancer |
0.026006092 |
Sensitive |
| ENSG00000270170.1 |
Ponatinib |
Esophageal cancer |
0.004222019 |
Sensitive |
| ENSG00000272707.1 |
Ponatinib |
Esophageal cancer |
0.042142815 |
Sensitive |
| ENSG00000273004.1 |
Ponatinib |
Esophageal cancer |
0.036259384 |
Sensitive |
| ENSG00000182057.4 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.040106028 |
Sensitive |
| ENSG00000226476.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.015569046 |
Sensitive |
| ENSG00000231903.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.033901358 |
Sensitive |
| ENSG00000235890.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.032293415 |
Sensitive |
| ENSG00000236671.3 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.049428509 |
Sensitive |
| ENSG00000249084.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.008960565 |
Sensitive |
| ENSG00000251365.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.040759973 |
Sensitive |
| ENSG00000253307.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.028966742 |
Sensitive |
| ENSG00000259005.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.047138753 |
Sensitive |
| ENSG00000259692.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.021392053 |
Sensitive |
| ENSG00000265206.2 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.049231869 |
Sensitive |
| ENSG00000267327.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.025464413 |
Sensitive |
| ENSG00000267712.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.022436262 |
Sensitive |
| ENSG00000272327.1 |
Ponatinib |
Head and neck squamous cell carcinoma |
0.046721559 |
Sensitive |
| ENSG00000176728.3 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.002210467 |
Sensitive |
| ENSG00000215159.3 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.01760877 |
Sensitive |
| ENSG00000224238.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.032153157 |
Sensitive |
| ENSG00000225393.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.005608291 |
Sensitive |
| ENSG00000226609.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.012050992 |
Sensitive |
| ENSG00000226747.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.025413384 |
Sensitive |
| ENSG00000226822.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.043338725 |
Sensitive |
| ENSG00000227374.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.021133097 |
Sensitive |
| ENSG00000227953.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.010661443 |
Sensitive |
| ENSG00000228016.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.04114356 |
Sensitive |
| ENSG00000228614.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.04641085 |
Sensitive |
| ENSG00000228624.3 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.035382204 |
Sensitive |
| ENSG00000228679.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.017428223 |
Sensitive |
| ENSG00000228988.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.026758205 |
Sensitive |
| ENSG00000229276.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.003572472 |
Sensitive |
| ENSG00000229625.3 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.04440853 |
Sensitive |
| ENSG00000229905.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.018767669 |
Sensitive |
| ENSG00000230410.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.028572627 |
Sensitive |
| ENSG00000230606.6 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.046658165 |
Sensitive |
| ENSG00000232788.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.042579122 |
Sensitive |
| ENSG00000233334.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.0471003 |
Sensitive |
| ENSG00000234617.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.01701061 |
Sensitive |
| ENSG00000237407.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.025298571 |
Sensitive |
| ENSG00000245526.4 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.025132624 |
Sensitive |
| ENSG00000248636.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.026366668 |
Sensitive |
| ENSG00000249684.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.042237873 |
Sensitive |
| ENSG00000250802.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.044688406 |
Sensitive |
| ENSG00000254869.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.006550855 |
Sensitive |
| ENSG00000256481.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.044464207 |
Sensitive |
| ENSG00000257900.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.007985416 |
Sensitive |
| ENSG00000259182.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.000475303 |
Sensitive |
| ENSG00000259380.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.026762001 |
Sensitive |
| ENSG00000259426.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.047014677 |
Sensitive |
| ENSG00000259606.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.018570616 |
Sensitive |
| ENSG00000260093.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.025591071 |
Sensitive |
| ENSG00000260366.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.039535175 |
Sensitive |
| ENSG00000260647.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.007188262 |
Sensitive |
| ENSG00000260855.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.0081734 |
Sensitive |
| ENSG00000260919.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.036685464 |
Sensitive |
| ENSG00000260949.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.029454861 |
Sensitive |
| ENSG00000261646.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.010138899 |
Sensitive |
| ENSG00000262151.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.032292998 |
Sensitive |
| ENSG00000262410.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.028203758 |
Sensitive |
| ENSG00000267136.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.019257511 |
Sensitive |
| ENSG00000267141.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.022725814 |
Sensitive |
| ENSG00000267169.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.01146838 |
Sensitive |
| ENSG00000267397.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.013223982 |
Sensitive |
| ENSG00000267503.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.039331457 |
Sensitive |
| ENSG00000267749.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.025379131 |
Sensitive |
| ENSG00000269054.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.015319712 |
Sensitive |
| ENSG00000269161.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.034874962 |
Sensitive |
| ENSG00000270141.2 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.031923768 |
Sensitive |
| ENSG00000271270.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.014171613 |
Sensitive |
| ENSG00000271327.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.03000475 |
Sensitive |
| ENSG00000271553.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.046396084 |
Sensitive |
| ENSG00000271738.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.039297312 |
Sensitive |
| ENSG00000272746.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.008116798 |
Sensitive |
| ENSG00000272940.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.009045074 |
Sensitive |
| ENSG00000273058.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.011850569 |
Sensitive |
| ENSG00000273257.1 |
Ponatinib |
Chronic Lymphocytic Leukemia |
0.044504389 |
Sensitive |
| ENSG00000185904.7 |
Ponatinib |
Brain lower grade glioma |
0.027081364 |
Sensitive |
| ENSG00000204792.2 |
Ponatinib |
Brain lower grade glioma |
0.037232791 |
Sensitive |
| ENSG00000224812.2 |
Ponatinib |
Brain lower grade glioma |
0.049531946 |
Sensitive |
| ENSG00000225138.3 |
Ponatinib |
Brain lower grade glioma |
0.042972915 |
Sensitive |
| ENSG00000225187.1 |
Ponatinib |
Brain lower grade glioma |
0.036164055 |
Sensitive |
| ENSG00000229983.1 |
Ponatinib |
Brain lower grade glioma |
0.036007945 |
Sensitive |
| ENSG00000232192.1 |
Ponatinib |
Brain lower grade glioma |
0.040429565 |
Sensitive |
| ENSG00000232325.3 |
Ponatinib |
Brain lower grade glioma |
0.04200024 |
Sensitive |
| ENSG00000238184.1 |
Ponatinib |
Brain lower grade glioma |
0.034293355 |
Sensitive |
| ENSG00000240093.1 |
Ponatinib |
Brain lower grade glioma |
0.026808625 |
Sensitive |
| ENSG00000248429.1 |
Ponatinib |
Brain lower grade glioma |
0.04125408 |
Sensitive |
| ENSG00000250604.1 |
Ponatinib |
Brain lower grade glioma |
0.040542502 |
Sensitive |
| ENSG00000258982.1 |
Ponatinib |
Brain lower grade glioma |
0.04683482 |
Sensitive |
| ENSG00000271782.1 |
Ponatinib |
Brain lower grade glioma |
0.042510192 |
Sensitive |
| ENSG00000272142.1 |
Ponatinib |
Brain lower grade glioma |
0.036388026 |
Sensitive |
| ENSG00000031544.10 |
Ponatinib |
Lung squamous cell carcinoma |
0.043544691 |
Sensitive |
| ENSG00000132204.9 |
Ponatinib |
Lung squamous cell carcinoma |
0.037341197 |
Sensitive |
| ENSG00000146666.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.015759739 |
Sensitive |
| ENSG00000177337.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.007157159 |
Sensitive |
| ENSG00000182648.7 |
Ponatinib |
Lung squamous cell carcinoma |
0.006836229 |
Sensitive |
| ENSG00000183535.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.024787931 |
Sensitive |
| ENSG00000189223.9 |
Ponatinib |
Lung squamous cell carcinoma |
0.041271518 |
Sensitive |
| ENSG00000196243.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.030574635 |
Sensitive |
| ENSG00000203999.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.029213055 |
Sensitive |
| ENSG00000204362.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.044689873 |
Sensitive |
| ENSG00000204792.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.021575169 |
Sensitive |
| ENSG00000215841.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.0485027 |
Sensitive |
| ENSG00000223552.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018319764 |
Sensitive |
| ENSG00000223759.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.017427867 |
Sensitive |
| ENSG00000223855.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044602273 |
Sensitive |
| ENSG00000224000.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0469084 |
Sensitive |
| ENSG00000224574.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014983765 |
Sensitive |
| ENSG00000224596.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.020122606 |
Sensitive |
| ENSG00000225039.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020111445 |
Sensitive |
| ENSG00000225111.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045859877 |
Sensitive |
| ENSG00000225684.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.004213312 |
Sensitive |
| ENSG00000226067.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.013837407 |
Sensitive |
| ENSG00000226172.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.043880541 |
Sensitive |
| ENSG00000226330.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037284071 |
Sensitive |
| ENSG00000226598.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043788917 |
Sensitive |
| ENSG00000227112.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034292269 |
Sensitive |
| ENSG00000227486.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031875098 |
Sensitive |
| ENSG00000227678.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.004878264 |
Sensitive |
| ENSG00000227702.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041455587 |
Sensitive |
| ENSG00000227925.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.038258074 |
Sensitive |
| ENSG00000228792.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044079768 |
Sensitive |
| ENSG00000229491.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020490658 |
Sensitive |
| ENSG00000229563.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.037240482 |
Sensitive |
| ENSG00000229953.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.000816516 |
Sensitive |
| ENSG00000230020.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046463365 |
Sensitive |
| ENSG00000230408.3 |
Ponatinib |
Lung squamous cell carcinoma |
0.036302457 |
Sensitive |
| ENSG00000230649.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.03103453 |
Sensitive |
| ENSG00000230815.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028366616 |
Sensitive |
| ENSG00000230834.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.0443833 |
Sensitive |
| ENSG00000231107.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015199301 |
Sensitive |
| ENSG00000231170.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044787135 |
Sensitive |
| ENSG00000231172.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.047401905 |
Sensitive |
| ENSG00000231185.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.002641731 |
Sensitive |
| ENSG00000231298.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.032447691 |
Sensitive |
| ENSG00000231528.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003401096 |
Sensitive |
| ENSG00000232053.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.031998218 |
Sensitive |
| ENSG00000232386.5 |
Ponatinib |
Lung squamous cell carcinoma |
0.048807531 |
Sensitive |
| ENSG00000232693.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.026833457 |
Sensitive |
| ENSG00000232725.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.00700896 |
Sensitive |
| ENSG00000233017.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028541769 |
Sensitive |
| ENSG00000233077.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039742883 |
Sensitive |
| ENSG00000233532.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015508233 |
Sensitive |
| ENSG00000234197.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018351865 |
Sensitive |
| ENSG00000234255.4 |
Ponatinib |
Lung squamous cell carcinoma |
0.028935978 |
Sensitive |
| ENSG00000234311.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045913834 |
Sensitive |
| ENSG00000234869.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005289516 |
Sensitive |
| ENSG00000235042.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017726526 |
Sensitive |
| ENSG00000235427.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016712064 |
Sensitive |
| ENSG00000235529.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035174123 |
Sensitive |
| ENSG00000235770.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045853736 |
Sensitive |
| ENSG00000235781.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017613033 |
Sensitive |
| ENSG00000235831.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.026815103 |
Sensitive |
| ENSG00000235899.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.018296483 |
Sensitive |
| ENSG00000235999.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012031788 |
Sensitive |
| ENSG00000236039.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049557668 |
Sensitive |
| ENSG00000236209.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032873467 |
Sensitive |
| ENSG00000236366.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026151014 |
Sensitive |
| ENSG00000236471.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.029387733 |
Sensitive |
| ENSG00000236658.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.005281313 |
Sensitive |
| ENSG00000237476.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032257251 |
Sensitive |
| ENSG00000237520.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04639011 |
Sensitive |
| ENSG00000237819.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039162875 |
Sensitive |
| ENSG00000237886.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036686689 |
Sensitive |
| ENSG00000238042.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039313517 |
Sensitive |
| ENSG00000242207.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048460336 |
Sensitive |
| ENSG00000242753.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032620888 |
Sensitive |
| ENSG00000246582.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.010065044 |
Sensitive |
| ENSG00000246640.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007602367 |
Sensitive |
| ENSG00000246898.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004243308 |
Sensitive |
| ENSG00000247774.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.028616252 |
Sensitive |
| ENSG00000248243.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01290897 |
Sensitive |
| ENSG00000248370.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027280156 |
Sensitive |
| ENSG00000248473.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045352617 |
Sensitive |
| ENSG00000249647.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.020463863 |
Sensitive |
| ENSG00000249706.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046228081 |
Sensitive |
| ENSG00000249942.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.017754603 |
Sensitive |
| ENSG00000250033.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026520478 |
Sensitive |
| ENSG00000250159.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.013657201 |
Sensitive |
| ENSG00000250413.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044112075 |
Sensitive |
| ENSG00000251093.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.007054722 |
Sensitive |
| ENSG00000251152.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.049723122 |
Sensitive |
| ENSG00000251169.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.00184839 |
Sensitive |
| ENSG00000251194.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.044173645 |
Sensitive |
| ENSG00000253266.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.002498352 |
Sensitive |
| ENSG00000253522.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.010545693 |
Sensitive |
| ENSG00000253530.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.006131996 |
Sensitive |
| ENSG00000254119.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030581816 |
Sensitive |
| ENSG00000254142.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.011228624 |
Sensitive |
| ENSG00000254231.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026213438 |
Sensitive |
| ENSG00000254973.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048333258 |
Sensitive |
| ENSG00000255002.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.028485597 |
Sensitive |
| ENSG00000255227.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043311265 |
Sensitive |
| ENSG00000255241.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.02035501 |
Sensitive |
| ENSG00000255521.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.044101831 |
Sensitive |
| ENSG00000255959.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.043525719 |
Sensitive |
| ENSG00000256050.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.009076519 |
Sensitive |
| ENSG00000256083.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.031971464 |
Sensitive |
| ENSG00000256128.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035607072 |
Sensitive |
| ENSG00000256268.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019333316 |
Sensitive |
| ENSG00000256542.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026297779 |
Sensitive |
| ENSG00000257038.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037501254 |
Sensitive |
| ENSG00000257595.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.005637784 |
Sensitive |
| ENSG00000258082.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.046544754 |
Sensitive |
| ENSG00000258181.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.035443154 |
Sensitive |
| ENSG00000258534.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008581935 |
Sensitive |
| ENSG00000258689.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023134728 |
Sensitive |
| ENSG00000258736.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.014137999 |
Sensitive |
| ENSG00000258760.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.012654223 |
Sensitive |
| ENSG00000258858.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010147073 |
Sensitive |
| ENSG00000258902.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015991519 |
Sensitive |
| ENSG00000258914.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004493116 |
Sensitive |
| ENSG00000258929.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.003179708 |
Sensitive |
| ENSG00000259065.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.01648215 |
Sensitive |
| ENSG00000259508.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.020908761 |
Sensitive |
| ENSG00000259604.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.042385598 |
Sensitive |
| ENSG00000259732.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016765268 |
Sensitive |
| ENSG00000259925.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045216724 |
Sensitive |
| ENSG00000260328.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.032443995 |
Sensitive |
| ENSG00000260496.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.029386558 |
Sensitive |
| ENSG00000260507.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.030194833 |
Sensitive |
| ENSG00000260792.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019219579 |
Sensitive |
| ENSG00000260877.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.001037466 |
Sensitive |
| ENSG00000260953.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045340351 |
Sensitive |
| ENSG00000261055.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.033909134 |
Sensitive |
| ENSG00000261253.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.009295437 |
Sensitive |
| ENSG00000261394.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.039724138 |
Sensitive |
| ENSG00000261736.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.010812903 |
Sensitive |
| ENSG00000261757.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013021779 |
Sensitive |
| ENSG00000262001.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015410321 |
Sensitive |
| ENSG00000262294.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.027245571 |
Sensitive |
| ENSG00000262521.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.04693554 |
Sensitive |
| ENSG00000262558.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041522001 |
Sensitive |
| ENSG00000265349.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008000318 |
Sensitive |
| ENSG00000266088.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.026225874 |
Sensitive |
| ENSG00000266304.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047214504 |
Sensitive |
| ENSG00000267079.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.047424594 |
Sensitive |
| ENSG00000267147.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008369441 |
Sensitive |
| ENSG00000267279.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.021770665 |
Sensitive |
| ENSG00000267311.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.045045814 |
Sensitive |
| ENSG00000267344.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.023952799 |
Sensitive |
| ENSG00000269481.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008900967 |
Sensitive |
| ENSG00000269553.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.016105747 |
Sensitive |
| ENSG00000269640.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.013622887 |
Sensitive |
| ENSG00000270069.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.019765808 |
Sensitive |
| ENSG00000270190.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036776159 |
Sensitive |
| ENSG00000271716.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.034168377 |
Sensitive |
| ENSG00000272068.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.000269229 |
Sensitive |
| ENSG00000272088.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004133216 |
Sensitive |
| ENSG00000272255.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.048032104 |
Sensitive |
| ENSG00000272639.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.041664669 |
Sensitive |
| ENSG00000272763.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.036016109 |
Sensitive |
| ENSG00000272808.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.040522168 |
Sensitive |
| ENSG00000272917.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.015666066 |
Sensitive |
| ENSG00000273065.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.004801438 |
Sensitive |
| ENSG00000273443.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008509221 |
Sensitive |
| ENSG00000273445.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.037056355 |
Sensitive |
| ENSG00000197332.7 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045225074 |
Sensitive |
| ENSG00000197989.9 |
Ponatinib |
Pancreatic adenocarcinoma |
0.035538547 |
Sensitive |
| ENSG00000219665.4 |
Ponatinib |
Pancreatic adenocarcinoma |
0.005954594 |
Sensitive |
| ENSG00000222041.6 |
Ponatinib |
Pancreatic adenocarcinoma |
0.031425446 |
Sensitive |
| ENSG00000223380.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045064591 |
Sensitive |
| ENSG00000223461.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.030158849 |
Sensitive |
| ENSG00000224930.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.041012373 |
Sensitive |
| ENSG00000225302.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.020918643 |
Sensitive |
| ENSG00000225335.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029640248 |
Sensitive |
| ENSG00000225721.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042745069 |
Sensitive |
| ENSG00000227354.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.021517756 |
Sensitive |
| ENSG00000227398.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.032046525 |
Sensitive |
| ENSG00000229512.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.031117496 |
Sensitive |
| ENSG00000229852.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.004489545 |
Sensitive |
| ENSG00000230798.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.009348628 |
Sensitive |
| ENSG00000231999.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039743436 |
Sensitive |
| ENSG00000233330.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.046718277 |
Sensitive |
| ENSG00000234160.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.033791129 |
Sensitive |
| ENSG00000235927.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.02452204 |
Sensitive |
| ENSG00000235954.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.024008658 |
Sensitive |
| ENSG00000236540.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.041736579 |
Sensitive |
| ENSG00000236850.4 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042221166 |
Sensitive |
| ENSG00000238107.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029431611 |
Sensitive |
| ENSG00000248161.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.010757667 |
Sensitive |
| ENSG00000250012.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03082276 |
Sensitive |
| ENSG00000250899.3 |
Ponatinib |
Pancreatic adenocarcinoma |
0.004662757 |
Sensitive |
| ENSG00000251161.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.018512896 |
Sensitive |
| ENSG00000254162.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042560934 |
Sensitive |
| ENSG00000254389.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.045984199 |
Sensitive |
| ENSG00000255717.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.044613987 |
Sensitive |
| ENSG00000257027.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.042777478 |
Sensitive |
| ENSG00000257058.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.04399906 |
Sensitive |
| ENSG00000257527.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.047759282 |
Sensitive |
| ENSG00000259354.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.041954098 |
Sensitive |
| ENSG00000259438.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.030682196 |
Sensitive |
| ENSG00000260317.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.002692322 |
Sensitive |
| ENSG00000260927.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.047129468 |
Sensitive |
| ENSG00000261280.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.026800193 |
Sensitive |
| ENSG00000261366.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.041671568 |
Sensitive |
| ENSG00000261512.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.011825245 |
Sensitive |
| ENSG00000261533.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.0308089 |
Sensitive |
| ENSG00000263050.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.011040852 |
Sensitive |
| ENSG00000264235.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.043727763 |
Sensitive |
| ENSG00000266445.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.013413666 |
Sensitive |
| ENSG00000266930.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.010807498 |
Sensitive |
| ENSG00000267104.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029514481 |
Sensitive |
| ENSG00000267765.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.034381961 |
Sensitive |
| ENSG00000269473.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.003051722 |
Sensitive |
| ENSG00000269487.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.0297207 |
Sensitive |
| ENSG00000269867.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.043834798 |
Sensitive |
| ENSG00000269946.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.03745586 |
Sensitive |
| ENSG00000270145.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.020144755 |
Sensitive |
| ENSG00000271991.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.01420805 |
Sensitive |
| ENSG00000272263.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.018677783 |
Sensitive |
| ENSG00000272960.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.039433914 |
Sensitive |
| ENSG00000273281.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.002693777 |
Sensitive |
| ENSG00000273343.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.029166797 |
Sensitive |
| ENSG00000213742.2 |
Ponatinib |
Sarcoma |
0.045652751 |
Sensitive |
| ENSG00000219665.4 |
Ponatinib |
Sarcoma |
0.009137919 |
Sensitive |
| ENSG00000227674.1 |
Ponatinib |
Sarcoma |
0.048228922 |
Sensitive |
| ENSG00000229463.2 |
Ponatinib |
Sarcoma |
0.039227193 |
Sensitive |
| ENSG00000232455.2 |
Ponatinib |
Sarcoma |
0.042850237 |
Sensitive |
| ENSG00000233847.1 |
Ponatinib |
Sarcoma |
0.03936905 |
Sensitive |
| ENSG00000234006.1 |
Ponatinib |
Sarcoma |
0.002213975 |
Sensitive |
| ENSG00000234915.1 |
Ponatinib |
Sarcoma |
0.031398175 |
Sensitive |
| ENSG00000240770.1 |
Ponatinib |
Sarcoma |
0.00166726 |
Sensitive |
| ENSG00000240859.1 |
Ponatinib |
Sarcoma |
0.035345042 |
Sensitive |
| ENSG00000250069.1 |
Ponatinib |
Sarcoma |
0.017029243 |
Sensitive |
| ENSG00000259618.1 |
Ponatinib |
Sarcoma |
0.044684468 |
Sensitive |
| ENSG00000259656.1 |
Ponatinib |
Sarcoma |
0.033601636 |
Sensitive |
| ENSG00000261798.1 |
Ponatinib |
Sarcoma |
0.007600594 |
Sensitive |
| ENSG00000273059.1 |
Ponatinib |
Sarcoma |
0.013859881 |
Sensitive |
| ENSG00000177822.3 |
Ponatinib |
Skin cutaneous melanoma |
0.00738384 |
Sensitive |
| ENSG00000184274.3 |
Ponatinib |
Skin cutaneous melanoma |
0.012656331 |
Sensitive |
| ENSG00000188206.5 |
Ponatinib |
Skin cutaneous melanoma |
0.042680361 |
Sensitive |
| ENSG00000203321.2 |
Ponatinib |
Skin cutaneous melanoma |
0.008378674 |
Sensitive |
| ENSG00000204792.2 |
Ponatinib |
Skin cutaneous melanoma |
0.031548058 |
Sensitive |
| ENSG00000205628.2 |
Ponatinib |
Skin cutaneous melanoma |
0.037090089 |
Sensitive |
| ENSG00000206573.4 |
Ponatinib |
Skin cutaneous melanoma |
0.015474474 |
Sensitive |
| ENSG00000215417.6 |
Ponatinib |
Skin cutaneous melanoma |
0.041251399 |
Sensitive |
| ENSG00000215424.5 |
Ponatinib |
Skin cutaneous melanoma |
0.022480095 |
Sensitive |
| ENSG00000215447.3 |
Ponatinib |
Skin cutaneous melanoma |
0.004826924 |
Sensitive |
| ENSG00000223768.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00587207 |
Sensitive |
| ENSG00000223834.2 |
Ponatinib |
Skin cutaneous melanoma |
0.019807654 |
Sensitive |
| ENSG00000224271.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020942047 |
Sensitive |
| ENSG00000224358.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00439515 |
Sensitive |
| ENSG00000224490.1 |
Ponatinib |
Skin cutaneous melanoma |
0.034068086 |
Sensitive |
| ENSG00000224614.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02600298 |
Sensitive |
| ENSG00000225075.1 |
Ponatinib |
Skin cutaneous melanoma |
0.014193522 |
Sensitive |
| ENSG00000225077.2 |
Ponatinib |
Skin cutaneous melanoma |
0.017841283 |
Sensitive |
| ENSG00000225518.2 |
Ponatinib |
Skin cutaneous melanoma |
0.003221901 |
Sensitive |
| ENSG00000225675.2 |
Ponatinib |
Skin cutaneous melanoma |
0.020394923 |
Sensitive |
| ENSG00000226026.1 |
Ponatinib |
Skin cutaneous melanoma |
0.004991845 |
Sensitive |
| ENSG00000227006.1 |
Ponatinib |
Skin cutaneous melanoma |
0.006194801 |
Sensitive |
| ENSG00000227407.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044775979 |
Sensitive |
| ENSG00000227542.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036113381 |
Sensitive |
| ENSG00000227637.1 |
Ponatinib |
Skin cutaneous melanoma |
0.009498715 |
Sensitive |
| ENSG00000227698.1 |
Ponatinib |
Skin cutaneous melanoma |
0.021104412 |
Sensitive |
| ENSG00000227896.2 |
Ponatinib |
Skin cutaneous melanoma |
0.018071049 |
Sensitive |
| ENSG00000228060.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035189351 |
Sensitive |
| ENSG00000228192.3 |
Ponatinib |
Skin cutaneous melanoma |
0.005693385 |
Sensitive |
| ENSG00000228437.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0297998 |
Sensitive |
| ENSG00000228506.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035711938 |
Sensitive |
| ENSG00000228527.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041549772 |
Sensitive |
| ENSG00000228554.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00417891 |
Sensitive |
| ENSG00000230124.2 |
Ponatinib |
Skin cutaneous melanoma |
0.006512156 |
Sensitive |
| ENSG00000230289.1 |
Ponatinib |
Skin cutaneous melanoma |
0.045701411 |
Sensitive |
| ENSG00000230747.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018054187 |
Sensitive |
| ENSG00000230914.2 |
Ponatinib |
Skin cutaneous melanoma |
0.032860896 |
Sensitive |
| ENSG00000231327.1 |
Ponatinib |
Skin cutaneous melanoma |
0.006331174 |
Sensitive |
| ENSG00000231663.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017230347 |
Sensitive |
| ENSG00000231704.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039312643 |
Sensitive |
| ENSG00000231770.1 |
Ponatinib |
Skin cutaneous melanoma |
0.006335768 |
Sensitive |
| ENSG00000231927.1 |
Ponatinib |
Skin cutaneous melanoma |
0.013687469 |
Sensitive |
| ENSG00000231966.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036711661 |
Sensitive |
| ENSG00000232104.2 |
Ponatinib |
Skin cutaneous melanoma |
0.04635331 |
Sensitive |
| ENSG00000232116.2 |
Ponatinib |
Skin cutaneous melanoma |
0.025249098 |
Sensitive |
| ENSG00000232194.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041957468 |
Sensitive |
| ENSG00000232442.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008532912 |
Sensitive |
| ENSG00000232586.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044151623 |
Sensitive |
| ENSG00000232874.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035282018 |
Sensitive |
| ENSG00000232936.1 |
Ponatinib |
Skin cutaneous melanoma |
0.032228764 |
Sensitive |
| ENSG00000233101.6 |
Ponatinib |
Skin cutaneous melanoma |
0.043814857 |
Sensitive |
| ENSG00000233117.2 |
Ponatinib |
Skin cutaneous melanoma |
0.038986479 |
Sensitive |
| ENSG00000233184.2 |
Ponatinib |
Skin cutaneous melanoma |
0.045796402 |
Sensitive |
| ENSG00000233515.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037290999 |
Sensitive |
| ENSG00000233654.1 |
Ponatinib |
Skin cutaneous melanoma |
0.002808598 |
Sensitive |
| ENSG00000233847.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00375754 |
Sensitive |
| ENSG00000233937.2 |
Ponatinib |
Skin cutaneous melanoma |
0.004610733 |
Sensitive |
| ENSG00000234072.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00456935 |
Sensitive |
| ENSG00000234171.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008624909 |
Sensitive |
| ENSG00000234789.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036653648 |
Sensitive |
| ENSG00000234936.1 |
Ponatinib |
Skin cutaneous melanoma |
0.014751951 |
Sensitive |
| ENSG00000235078.1 |
Ponatinib |
Skin cutaneous melanoma |
0.027679493 |
Sensitive |
| ENSG00000235214.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02124871 |
Sensitive |
| ENSG00000235313.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037282158 |
Sensitive |
| ENSG00000235335.2 |
Ponatinib |
Skin cutaneous melanoma |
0.015516282 |
Sensitive |
| ENSG00000235408.2 |
Ponatinib |
Skin cutaneous melanoma |
0.018322261 |
Sensitive |
| ENSG00000235635.1 |
Ponatinib |
Skin cutaneous melanoma |
0.019206542 |
Sensitive |
| ENSG00000235806.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039949694 |
Sensitive |
| ENSG00000236088.5 |
Ponatinib |
Skin cutaneous melanoma |
0.00780475 |
Sensitive |
| ENSG00000236209.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035496751 |
Sensitive |
| ENSG00000236889.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020381128 |
Sensitive |
| ENSG00000237222.3 |
Ponatinib |
Skin cutaneous melanoma |
0.007810465 |
Sensitive |
| ENSG00000237491.4 |
Ponatinib |
Skin cutaneous melanoma |
0.005532208 |
Sensitive |
| ENSG00000237756.1 |
Ponatinib |
Skin cutaneous melanoma |
0.045114442 |
Sensitive |
| ENSG00000237938.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038477499 |
Sensitive |
| ENSG00000237950.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036541368 |
Sensitive |
| ENSG00000238260.1 |
Ponatinib |
Skin cutaneous melanoma |
0.005005182 |
Sensitive |
| ENSG00000238287.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038779509 |
Sensitive |
| ENSG00000239002.2 |
Ponatinib |
Skin cutaneous melanoma |
0.019499132 |
Sensitive |
| ENSG00000240050.1 |
Ponatinib |
Skin cutaneous melanoma |
0.030228769 |
Sensitive |
| ENSG00000240373.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017570514 |
Sensitive |
| ENSG00000240618.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049753536 |
Sensitive |
| ENSG00000242125.2 |
Ponatinib |
Skin cutaneous melanoma |
0.033005183 |
Sensitive |
| ENSG00000242282.2 |
Ponatinib |
Skin cutaneous melanoma |
0.016353305 |
Sensitive |
| ENSG00000242474.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023178753 |
Sensitive |
| ENSG00000243224.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039564718 |
Sensitive |
| ENSG00000243368.2 |
Ponatinib |
Skin cutaneous melanoma |
0.048102343 |
Sensitive |
| ENSG00000244286.1 |
Ponatinib |
Skin cutaneous melanoma |
0.04702934 |
Sensitive |
| ENSG00000244332.1 |
Ponatinib |
Skin cutaneous melanoma |
0.03230468 |
Sensitive |
| ENSG00000244879.3 |
Ponatinib |
Skin cutaneous melanoma |
0.04124613 |
Sensitive |
| ENSG00000246334.2 |
Ponatinib |
Skin cutaneous melanoma |
0.000436216 |
Sensitive |
| ENSG00000247092.2 |
Ponatinib |
Skin cutaneous melanoma |
0.005089309 |
Sensitive |
| ENSG00000247373.2 |
Ponatinib |
Skin cutaneous melanoma |
0.036735828 |
Sensitive |
| ENSG00000247400.3 |
Ponatinib |
Skin cutaneous melanoma |
0.036175181 |
Sensitive |
| ENSG00000248131.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018226913 |
Sensitive |
| ENSG00000248416.1 |
Ponatinib |
Skin cutaneous melanoma |
0.022094774 |
Sensitive |
| ENSG00000249655.1 |
Ponatinib |
Skin cutaneous melanoma |
0.025027556 |
Sensitive |
| ENSG00000250027.1 |
Ponatinib |
Skin cutaneous melanoma |
0.01484407 |
Sensitive |
| ENSG00000250295.2 |
Ponatinib |
Skin cutaneous melanoma |
0.026905597 |
Sensitive |
| ENSG00000250988.3 |
Ponatinib |
Skin cutaneous melanoma |
0.000754543 |
Sensitive |
| ENSG00000251365.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049698804 |
Sensitive |
| ENSG00000251604.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048387942 |
Sensitive |
| ENSG00000251623.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017786632 |
Sensitive |
| ENSG00000253347.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0160717 |
Sensitive |
| ENSG00000253406.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038154084 |
Sensitive |
| ENSG00000254177.1 |
Ponatinib |
Skin cutaneous melanoma |
0.032618137 |
Sensitive |
| ENSG00000254459.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041345616 |
Sensitive |
| ENSG00000254812.1 |
Ponatinib |
Skin cutaneous melanoma |
0.013625832 |
Sensitive |
| ENSG00000255050.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041576824 |
Sensitive |
| ENSG00000255153.1 |
Ponatinib |
Skin cutaneous melanoma |
0.012960957 |
Sensitive |
| ENSG00000255237.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018059296 |
Sensitive |
| ENSG00000255545.3 |
Ponatinib |
Skin cutaneous melanoma |
0.01242806 |
Sensitive |
| ENSG00000256448.1 |
Ponatinib |
Skin cutaneous melanoma |
0.043954107 |
Sensitive |
| ENSG00000256690.1 |
Ponatinib |
Skin cutaneous melanoma |
0.043575749 |
Sensitive |
| ENSG00000257354.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038890917 |
Sensitive |
| ENSG00000257596.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00949013 |
Sensitive |
| ENSG00000257647.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018072783 |
Sensitive |
| ENSG00000257808.1 |
Ponatinib |
Skin cutaneous melanoma |
0.007736985 |
Sensitive |
| ENSG00000257831.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037133577 |
Sensitive |
| ENSG00000257913.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038939846 |
Sensitive |
| ENSG00000258314.2 |
Ponatinib |
Skin cutaneous melanoma |
0.040429346 |
Sensitive |
| ENSG00000258334.1 |
Ponatinib |
Skin cutaneous melanoma |
0.046018662 |
Sensitive |
| ENSG00000258344.1 |
Ponatinib |
Skin cutaneous melanoma |
0.003870225 |
Sensitive |
| ENSG00000258851.1 |
Ponatinib |
Skin cutaneous melanoma |
0.004398392 |
Sensitive |
| ENSG00000259438.1 |
Ponatinib |
Skin cutaneous melanoma |
0.012799825 |
Sensitive |
| ENSG00000259469.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041161096 |
Sensitive |
| ENSG00000259488.1 |
Ponatinib |
Skin cutaneous melanoma |
0.005717203 |
Sensitive |
| ENSG00000259606.2 |
Ponatinib |
Skin cutaneous melanoma |
0.019705913 |
Sensitive |
| ENSG00000259645.1 |
Ponatinib |
Skin cutaneous melanoma |
0.030574342 |
Sensitive |
| ENSG00000259659.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020817018 |
Sensitive |
| ENSG00000259894.1 |
Ponatinib |
Skin cutaneous melanoma |
0.046263009 |
Sensitive |
| ENSG00000259999.1 |
Ponatinib |
Skin cutaneous melanoma |
0.030709889 |
Sensitive |
| ENSG00000260167.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0248394 |
Sensitive |
| ENSG00000260260.1 |
Ponatinib |
Skin cutaneous melanoma |
0.005441575 |
Sensitive |
| ENSG00000260310.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018312842 |
Sensitive |
| ENSG00000260589.1 |
Ponatinib |
Skin cutaneous melanoma |
0.000361412 |
Sensitive |
| ENSG00000260591.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0292387 |
Sensitive |
| ENSG00000260672.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041842971 |
Sensitive |
| ENSG00000260757.1 |
Ponatinib |
Skin cutaneous melanoma |
0.013760686 |
Sensitive |
| ENSG00000260938.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001999132 |
Sensitive |
| ENSG00000260941.1 |
Ponatinib |
Skin cutaneous melanoma |
0.04497925 |
Sensitive |
| ENSG00000260942.1 |
Ponatinib |
Skin cutaneous melanoma |
0.004507195 |
Sensitive |
| ENSG00000261187.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001894257 |
Sensitive |
| ENSG00000261188.1 |
Ponatinib |
Skin cutaneous melanoma |
0.002438314 |
Sensitive |
| ENSG00000261251.1 |
Ponatinib |
Skin cutaneous melanoma |
0.011358124 |
Sensitive |
| ENSG00000261360.1 |
Ponatinib |
Skin cutaneous melanoma |
0.036375902 |
Sensitive |
| ENSG00000261366.1 |
Ponatinib |
Skin cutaneous melanoma |
0.016913174 |
Sensitive |
| ENSG00000261386.2 |
Ponatinib |
Skin cutaneous melanoma |
0.01497218 |
Sensitive |
| ENSG00000261476.1 |
Ponatinib |
Skin cutaneous melanoma |
0.021162527 |
Sensitive |
| ENSG00000261574.1 |
Ponatinib |
Skin cutaneous melanoma |
0.046607834 |
Sensitive |
| ENSG00000261697.1 |
Ponatinib |
Skin cutaneous melanoma |
0.027128824 |
Sensitive |
| ENSG00000261712.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038243939 |
Sensitive |
| ENSG00000261723.1 |
Ponatinib |
Skin cutaneous melanoma |
0.045783984 |
Sensitive |
| ENSG00000262136.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008834089 |
Sensitive |
| ENSG00000262514.1 |
Ponatinib |
Skin cutaneous melanoma |
0.029652505 |
Sensitive |
| ENSG00000262692.1 |
Ponatinib |
Skin cutaneous melanoma |
0.004879479 |
Sensitive |
| ENSG00000263412.1 |
Ponatinib |
Skin cutaneous melanoma |
0.030552186 |
Sensitive |
| ENSG00000263466.1 |
Ponatinib |
Skin cutaneous melanoma |
0.048207084 |
Sensitive |
| ENSG00000263786.1 |
Ponatinib |
Skin cutaneous melanoma |
0.007911399 |
Sensitive |
| ENSG00000264548.1 |
Ponatinib |
Skin cutaneous melanoma |
0.022761927 |
Sensitive |
| ENSG00000264860.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020973381 |
Sensitive |
| ENSG00000264914.1 |
Ponatinib |
Skin cutaneous melanoma |
0.026710297 |
Sensitive |
| ENSG00000265688.1 |
Ponatinib |
Skin cutaneous melanoma |
0.011463722 |
Sensitive |
| ENSG00000266401.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018760937 |
Sensitive |
| ENSG00000266456.1 |
Ponatinib |
Skin cutaneous melanoma |
0.021525558 |
Sensitive |
| ENSG00000266651.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023963355 |
Sensitive |
| ENSG00000266975.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020418866 |
Sensitive |
| ENSG00000266983.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020568494 |
Sensitive |
| ENSG00000267016.1 |
Ponatinib |
Skin cutaneous melanoma |
0.042150068 |
Sensitive |
| ENSG00000267018.1 |
Ponatinib |
Skin cutaneous melanoma |
0.031348319 |
Sensitive |
| ENSG00000267042.1 |
Ponatinib |
Skin cutaneous melanoma |
0.033185806 |
Sensitive |
| ENSG00000267199.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039369208 |
Sensitive |
| ENSG00000267212.1 |
Ponatinib |
Skin cutaneous melanoma |
0.010180923 |
Sensitive |
| ENSG00000267304.1 |
Ponatinib |
Skin cutaneous melanoma |
0.038814284 |
Sensitive |
| ENSG00000267395.1 |
Ponatinib |
Skin cutaneous melanoma |
0.025794017 |
Sensitive |
| ENSG00000267405.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040092722 |
Sensitive |
| ENSG00000268536.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039836388 |
Sensitive |
| ENSG00000268584.1 |
Ponatinib |
Skin cutaneous melanoma |
0.039382149 |
Sensitive |
| ENSG00000268913.1 |
Ponatinib |
Skin cutaneous melanoma |
0.02889931 |
Sensitive |
| ENSG00000269161.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049032689 |
Sensitive |
| ENSG00000269399.1 |
Ponatinib |
Skin cutaneous melanoma |
0.026192703 |
Sensitive |
| ENSG00000269489.1 |
Ponatinib |
Skin cutaneous melanoma |
0.044583576 |
Sensitive |
| ENSG00000269814.1 |
Ponatinib |
Skin cutaneous melanoma |
0.035798333 |
Sensitive |
| ENSG00000269894.1 |
Ponatinib |
Skin cutaneous melanoma |
0.04504321 |
Sensitive |
| ENSG00000269942.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049771132 |
Sensitive |
| ENSG00000269959.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017765814 |
Sensitive |
| ENSG00000270006.1 |
Ponatinib |
Skin cutaneous melanoma |
0.037593574 |
Sensitive |
| ENSG00000270012.1 |
Ponatinib |
Skin cutaneous melanoma |
0.015897594 |
Sensitive |
| ENSG00000270019.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023818053 |
Sensitive |
| ENSG00000270133.1 |
Ponatinib |
Skin cutaneous melanoma |
0.01767214 |
Sensitive |
| ENSG00000270159.1 |
Ponatinib |
Skin cutaneous melanoma |
0.026372668 |
Sensitive |
| ENSG00000270332.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001305213 |
Sensitive |
| ENSG00000270462.1 |
Ponatinib |
Skin cutaneous melanoma |
0.033416357 |
Sensitive |
| ENSG00000270720.1 |
Ponatinib |
Skin cutaneous melanoma |
0.008282544 |
Sensitive |
| ENSG00000270933.1 |
Ponatinib |
Skin cutaneous melanoma |
0.018985769 |
Sensitive |
| ENSG00000271127.1 |
Ponatinib |
Skin cutaneous melanoma |
0.0446201 |
Sensitive |
| ENSG00000271200.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00153076 |
Sensitive |
| ENSG00000271308.1 |
Ponatinib |
Skin cutaneous melanoma |
0.017701594 |
Sensitive |
| ENSG00000271359.1 |
Ponatinib |
Skin cutaneous melanoma |
0.00274438 |
Sensitive |
| ENSG00000271398.1 |
Ponatinib |
Skin cutaneous melanoma |
0.027863339 |
Sensitive |
| ENSG00000271576.1 |
Ponatinib |
Skin cutaneous melanoma |
0.010700434 |
Sensitive |
| ENSG00000271862.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001221841 |
Sensitive |
| ENSG00000271983.1 |
Ponatinib |
Skin cutaneous melanoma |
0.023528699 |
Sensitive |
| ENSG00000271993.1 |
Ponatinib |
Skin cutaneous melanoma |
0.003608428 |
Sensitive |
| ENSG00000272143.1 |
Ponatinib |
Skin cutaneous melanoma |
0.049331969 |
Sensitive |
| ENSG00000272148.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001589346 |
Sensitive |
| ENSG00000272240.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041087658 |
Sensitive |
| ENSG00000272420.1 |
Ponatinib |
Skin cutaneous melanoma |
0.043050413 |
Sensitive |
| ENSG00000272455.1 |
Ponatinib |
Skin cutaneous melanoma |
0.000503402 |
Sensitive |
| ENSG00000272498.1 |
Ponatinib |
Skin cutaneous melanoma |
0.009087383 |
Sensitive |
| ENSG00000272524.1 |
Ponatinib |
Skin cutaneous melanoma |
0.011601028 |
Sensitive |
| ENSG00000272525.1 |
Ponatinib |
Skin cutaneous melanoma |
0.003833252 |
Sensitive |
| ENSG00000272529.1 |
Ponatinib |
Skin cutaneous melanoma |
0.041939711 |
Sensitive |
| ENSG00000272662.1 |
Ponatinib |
Skin cutaneous melanoma |
0.013634073 |
Sensitive |
| ENSG00000272716.1 |
Ponatinib |
Skin cutaneous melanoma |
0.024007709 |
Sensitive |
| ENSG00000272800.1 |
Ponatinib |
Skin cutaneous melanoma |
0.016439062 |
Sensitive |
| ENSG00000272812.1 |
Ponatinib |
Skin cutaneous melanoma |
0.011855512 |
Sensitive |
| ENSG00000272892.1 |
Ponatinib |
Skin cutaneous melanoma |
0.01435563 |
Sensitive |
| ENSG00000272989.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040885887 |
Sensitive |
| ENSG00000273008.1 |
Ponatinib |
Skin cutaneous melanoma |
0.020493172 |
Sensitive |
| ENSG00000273162.1 |
Ponatinib |
Skin cutaneous melanoma |
0.031520785 |
Sensitive |
| ENSG00000273186.1 |
Ponatinib |
Skin cutaneous melanoma |
0.001104011 |
Sensitive |
| ENSG00000273230.1 |
Ponatinib |
Skin cutaneous melanoma |
0.002268229 |
Sensitive |
| ENSG00000273237.1 |
Ponatinib |
Skin cutaneous melanoma |
0.015340561 |
Sensitive |
| ENSG00000273295.1 |
Ponatinib |
Skin cutaneous melanoma |
0.040596126 |
Sensitive |
